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ABSTRACT 
Bladder cancer is a common type of neoplasm that can cause substantial morbidity and 
mortality among patients. Bladder cancer causes 16,870 deaths per year in the United States. It is 
expected that 76,030 new bladder cancer cases will be diagnosed in 2017. Multi-detector row CT 
(MDCT), and specifically MDCT when used for urography (CTU), has become the imaging 
modality of choice for evaluation of most urinary tract abnormalities. Interpretation of MDCT 
urograms that commonly exceeds 400 images. This is a demanding task for radiologists who 
have to visually track the entire upper and lower urinary tract and look for lesions that usually 
are small in size. Using a computer-aided diagnosis (CAD) system as an adjunct for the 
radiologist may reduce the number of lesions that are missed by the radiologists. To create a 
CAD system for detection of bladder lesions, we have developed methods and software to 
perform the following specific tasks: (1) segment the bladder; (2) detect bladder lesion 
candidates; (3) segment the bladder lesion candidates; (4) extract features from the segmented 
lesion candidates; (4) classify lesion candidates as true lesion findings or false positives using the 
extracted features; (5) detect bladder wall thickenings. 
Correct staging of bladder cancer is crucial in determining the need for neoadjuvant 
chemotherapy treatment and minimizing the risk of under-treatment or over-treatment. Also, 
reliable assessment of the response to neoadjuvant therapy at an early stage is vital for 
identifying patients who do not respond to this treatment and allows the physician to discontinue 
ineffective treatment and its undesired adverse effects on a patient’s physical condition. We have 
developed prototype predictive models for both bladder cancer staging and bladder cancer 
response to neoadjuvant treatment by adapting the methodology of feature classification that 
merges image-based biomarkers. The bladder lesion segmentation modules were used to extract 
the image-based biomarkers as input to the models. Early detection of bladder cancer, accurate 
tumor staging, and early prediction of treatment response could reduce mortality and morbidity, 
and improve quality of life for surviving patients. 
This dissertation presents the methods that we developed to automatically segment the 
bladder on CTU, and automatically detect masses and wall thickenings with sensitivity near 90% 
xxi 
 
with a relatively low number of false positive findings. We have developed a system that 
distinguishes between muscle-invasive and non-muscle-invasive cancer, which is a clinical 
threshold used to determine treatment. We have also developed a system that uses the pre-
treatment and post-treatment CTU scans to estimate the likelihood that the patient has fully 
responded to treatment. This system has achieved performance comparable to the radiologists, 
with area under the receiver operator characteristic curve (AUC) values in the range of 0.69 to 
0.77. We performed an observer performance study where we saw that our system of predicting 
complete response to treatment improves the performance of the clinicians when they read the 
pre- and post-treatment scans with the aid of the system. On average, the clinician AUC 
increased with statistical significance from 0.74 to 0.77. 
Early detection of bladder cancer, accurate staging of tumors, and early prediction of 
treatment response can reduce mortality and morbidity, and improve the quality of life for 
surviving patients. These studies show possible methods for performing those tasks. 
 
1 
 
Chapter I 
Introduction
 
1.1 Motivation 
Bladder cancer is a common type of neoplasm that can cause substantial morbidity and 
mortality among patients. Bladder cancer causes 16,870 deaths per year in the United States. It is 
expected that 76,030 new bladder cancer cases will be diagnosed in 2017. Multi-detector row CT 
(MDCT), and specifically when used in CT urography (CTU), has become the imaging modality 
of choice for most urinary tract abnormalities. For my PhD dissertation, I have developed a 
computer-aided image analysis and decision support system for bladder cancer. This system will 
be useful for two major applications: (1) computer-aided diagnosis (CAD) system for bladder 
lesion detection, and (2) computerized bladder cancer staging and monitoring of treatment 
response. 
Interpretation of MDCT urograms usually requires reviewing more than 400 
reconstructed images. This is a demanding task for radiologists who have to visually track the 
upper and lower urinary tract and look for lesions that usually are small in size. Using a CAD 
system as an adjunct for the radiologist may reduce the number of lesions that are missed by the 
radiologists. To develop a CAD system for detection of bladder lesions, we will develop methods 
and software to perform the following specific tasks: (1) segment the bladder; (2) detect bladder 
lesion candidates within the contrast-enhanced and non-contrast enhanced regions of the bladder; 
(3) segment the bladder lesion candidates; (4) extract features from the segmented lesion 
candidates; (4) classify lesion candidates as true lesion findings or false positives using the 
extracted features; (5) detect bladder wall thickenings. In our preliminary studies, we have 
demonstrated the feasibility of automatic segmentation of the bladder and automatic detection of 
bladder masses within the contrast-enhanced region. If successfully developed, the CAD system, 
used for decision support by radiologists, can potentially improve the performance of the 
radiologists in detecting bladder lesions. 
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Correct staging of bladder cancer is crucial in determining the need for neoadjuvant 
chemotherapy treatment and minimizing the risk of under-treatment or over-treatment. A reliable 
assessment of the response to neoadjuvant therapy at an early stage is vital for identifying 
patients who do not respond, allowing a clinician to cease ineffective treatment that can have 
adverse effects on a patient’s physical condition. Decision support systems that can combine 
available data with statistical models will help clinicians determine more objectively and 
quantitatively bladder cancer stage and monitor treatment response. Bladder lesion segmentation 
and feature classification play a central role in such decision support systems.  Accurate bladder 
lesion segmentation defines the region where the image-based biomarkers are extracted and used 
as input to build the predictive models for decision support. We have developed prototype 
predictive models for bladder cancer stage and response to neoadjuvant treatment by adapting 
the methodology of feature classification to merge image-based biomarkers (tumor 
characteristics such as tumor volume, morphology, textures, etc., and their changes) and non-
image-based clinical biomarkers (examination under anesthesia). Early detection of bladder 
cancer, accurate staging of tumors, and early prediction of treatment response would reduce 
patient mortality and morbidity, and improve quality of life for surviving patients. 
 
1.2 Problem Statement 
The main goal of this dissertation is to develop a computer-aided image analysis and 
decision support system for bladder cancer using advanced computer vision and machine 
learning techniques. The development of this new system for CTU is built upon the knowledge 
and experiences in the development of CAD techniques for breast cancer, lung cancer, and other 
diseases in the CAD Research Laboratory. This system is useful for two major applications: (1) 
computer-aided diagnosis (CAD) system for detection of bladder lesion, and (2) computerized 
bladder cancer staging and monitoring of treatment response. 
The CAD system includes modules for bladder segmentation, prescreening of lesion 
candidates, lesion segmentation, feature extraction, and feature classification.  The CAD system 
is intended to provide a second opinion to radiologists in the detection of bladder lesions on 
multi-detector row CT urography (CTU). 
The decision support systems for bladder cancer staging and monitoring of treatment 
response share some of the image analysis and machine learning methods developed for the 
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CAD system. We modified the segmentation and feature extraction modules developed for the 
CAD system and adapted them to extract image-based biomarkers. The classification module 
was adapted to combine image-based biomarkers and non-image-based biomarkers to predict 
bladder cancer staging and treatment response assessment. 
We aim to build (1) a CAD system that may assist radiologists in detecting bladder 
lesions, and (2) a decision support system for computerized bladder cancer staging and 
monitoring of treatment response. 
 
1.3 Summary of Contributions 
The main contributions of this dissertation are summarized below: 
 Refining a previously developed bladder segmentation method using image 
processing techniques and a new method for propagating segmentation contours 
(Chapter 2)
1
. 
 Using deep-learning convolutional neural network (DL-CNN) to perform bladder 
segmentation, which improves the segmentation performance while reducing the 
number of user inputs required (Chapter 3)
2
. 
 Creating a system for the detection of bladder masses within the contrast-
enhanced region of the bladder, where the contrast between the contrast material 
and the bladder masses makes it easier to detect the masses (Chapter 4)
3
. 
 Creating a system for the detection of the bladder masses within the entire bladder, 
including the subtle lesions within the non-contrast-enhanced region of the 
bladder, while reducing the number of false positive findings resulting from the 
added detection task (Chapter 5)
6
. 
 Creating a system for detection of bladder wall thickening that may also be 
indicative of bladder cancer (Chapter 6). 
 Creating a system for automatic staging of bladder lesions, where muscle-invasive 
bladder cancers are distinguished from non-muscle-invasive bladder cancers 
(Chapter 7)
7
. 
 Creating a system to segment bladder lesions using DL-CNN and testing if such a 
system can predict whether a patient will completely respond to neoadjuvant 
chemotherapy using the change in gross tumor volume (Chapter 8)
4
. 
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 Creating a system for identifying lesions that completely respond to neoadjuvant 
chemotherapy using pre- and post-treatment CTU images (Chapter 9)
5
. 
 Conducting an observer performance study with 11 clinicians to demonstrate that 
the decision support system can identify cases that completely respond to 
treatment and improve the performance of the clinicians who use the CAD system 
as a second opinion (Chapter 10). 
 Performing a simulation study that shows that the performance of a trained 
classifier on a test data set with missing data replaced with the average value of 
the training set decreases on average compared to that without missing data, but 
the average performance is higher than retraining the classifier without the 
missing feature when the proportion of test cases with missing data is small 
(Chapter 11). 
 
1.3.1 Other contributions 
 Other contributions not detailed in this dissertation include the use of the developed 
methods for organs other than the bladder. One study estimated the tumor features of head and 
neck cancers on CT
8
, and another study examined using different biomarkers, including imaging 
biomarkers, for accurate detection of tumor progression of oropharyngeal cancers
9
. We also 
attempted to apply pre-trained networks and transferring the learned weights of the deep-learning 
network to the task of pre- and post-treatment response assessment
10
. 
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Chapter II 
CT Urography: Segmentation of Urinary Bladder using Conjoint Level Set Analysis 
and Segmentation System with Local Contour Refinement
 
2.1 Abstract 
We are developing a computerized system for bladder segmentation on CT urography (CTU), as 
a critical component for computer-aided detection of bladder cancer. The presence of regions 
filled with intravenous contrast and without contrast presents a challenge for bladder 
segmentation. Previously, we proposed a Conjoint Level set Analysis and Segmentation System 
(CLASS)
11
. In case the bladder is partially filled with contrast, CLASS segments the non-
contrast (NC) region and the contrast-filled (C) region separately and automatically conjoins the 
NC and C region contours; however, inaccuracies in the NC and C region contours may cause 
the conjoint contour to exclude portions of the bladder. To alleviate this problem, we 
implemented a local contour refinement (LCR) method that exploits model-guided refinement 
(MGR) and energy-driven wavefront propagation (EDWP). MGR propagates the C region 
contours if the level set propagation in the C region stops prematurely due to substantial non-
uniformity of the contrast. EDWP with regularized energies further propagates the conjoint 
contours to the correct bladder boundary. EDWP uses changes in energies, smoothness criteria of 
the contour, and previous slice contour to determine when to stop the propagation, following 
decision rules derived from training. A data set of 173 cases was collected for this study: 81 
cases in the training set (42 bladders with lesions, 21 bladders with wall thickenings, 18 normal 
bladders) and 92 cases in the test set (43 bladders with lesions, 36 bladders with wall 
thickenings, 13 normal bladders). For all cases, 3D hand segmented contours were obtained as 
reference standard and used for the evaluation of the computerized segmentation accuracy. For 
CLASS with LCR, the average volume intersection ratio, average volume error, absolute average 
volume error, average minimum distance and Jaccard index were 84.2±11.4%, 8.2±17.4%, 
13.0±14.1%, 3.5±1.9 mm, 78.8±11.6%, respectively, for the training set and 78.0±14.7%, 
16.4±16.9%, 18.2±15.0%, 3.8±2.3 mm, 73.8±13.4% respectively, for the test set. With CLASS 
only, the corresponding values were 75.1±13.2%, 18.7±19.5%, 22.5±14.9%, 4.3±2.2 mm, 
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71.0±12.6%, respectively, for the training set and 67.3±14.3%, 29.3±15.9%, 29.4±15.6%, 
4.9±2.6 mm, 65.0±13.3%, respectively, for the test set. The differences between the two methods 
for all five measures were statistically significant (p<0.001) for both the training and test sets. 
The results demonstrate the potential of CLASS with LCR for segmentation of the bladder. The 
results presented in this chapter have been published
1
. 
 
2.2 Introduction 
Bladder cancer is the fourth most common cancer diagnosed in men. The American Cancer 
Society estimates that bladder cancer will cause 16,870 deaths (12,240 in men, 4,630 in women) 
in the United States in 2017, with 76,030 new cases being diagnosed (60,490 in men, 18,540 in 
women)
12
. Early detection and treatment of bladder cancer increases patient survivability. If 
bladder cancers are detected and treated while the cancer is confined within the bladder’s inner 
lining but has not invaded the muscular bladder wall, the 5-year survival rate is 88%. If the 
cancer is detected after it has invaded the bladder wall but is still confined to the bladder, the 5-
year survival rate drops to 63%
12
. 
Multi-detector row CT (MDCT) urography has shown promise of detecting bladder lesions 
and has become the imaging modality of choice for evaluation of most urinary tract 
abnormalities, since a single exam can be used to evaluate the kidneys, intrarenal collecting 
systems, and ureters. CT urography (CTU), therefore, may spare the patients from having to 
undergo other imaging studies (intravenous pyelogram (IVP), ultrasound, conventional 
abdominal CT, and even MRI), thereby reducing health care costs
13-17
. 
Interpretation of a CTU study requires thorough image analysis, often requiring extensive 
time. On average, 400 slices are generated for each CTU scan at a slice interval of either 1.25 
mm or 0.625 mm (range: 200 to 600 slices). The radiologists interpreting the study have to 
visually determine whether or not lesions are present within the urinary tracts, frequently needing 
to adjust the brightness and contrast of the images and use zooming from a display workstation. 
The possibility that multiple lesions may be present requires that the radiologists pay close 
attention throughout the entire urinary tract. In addition, many different urinary anomalies may 
be found in a single CTU study. Not only do the radiologists have to identify these anomalies, 
they must also determine how likely each of them is to be a urothelial neoplasm. The challenges 
of analyzing a CTU study leads to a substantial variability among radiologists in detection of 
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bladder cancer, with reported sensitivities ranging from 59% to 92%
18, 19
. Due to the workload of 
interpreting CTU studies, the likelihood for the radiologists’ to miss a subtle lesion may not be 
negligible, thus any technique that may help radiologists with identification of urothelial 
neoplasms within the urinary tract will be useful. Computer-aided diagnosis (CAD) system, used 
as an adjunct may be the tool that reduces the chance of oversight by the radiologists. We are 
developing a CAD system that detects bladder cancer in CTU, and a critical part of this system is 
accurate bladder segmentation that isolates the bladder from the surrounding anatomical 
structures. 
Li et al.
20
 segmented the bladder wall from magnetic resonance (MR) cytoscopy in 6 
patients and analyzed it for suspected lesions using a partial volume segmentation algorithm. 
Duan et al.
21
 used two collaborative level set functions and clustering to segment the bladder, 
also in MR cytoscopy of 6 patients. In a different study, Duan et al.
22
 developed a 
segmentation method using MR images of 10 patients that used an adaptive window-setting 
scheme to detect tumor surfaces. Recently, Han et al.
23
 of the same group segmented the 
bladder wall in T1-weighted MR images using an adaptive Markov random field model and 
coupled level set information in 6 patients. Li et al.
20
 did not report quantitative results for the 
bladder segmentation. Duan et al.
21
 and Han et al.
23
 evaluated the segmentation performances 
using radiologists’ subjective ratings without reporting quantitative results. Chai et al .24 
presented a method for semiautomatic bladder segmentation on cone beam CT by using a 
population-based statistical bladder shape calculated using spherical harmonics description, 
then applying principal component analysis. They used 95 scans from 8 patients to train their 
method, and validated their method using 233 scans from 22 patients. Segmentation 
performance was measured using the Jaccard index comparing the segmentation with manual 
segmentation done slice-by-slice, which was 70.5% at the automatic stage and increased to 
77.7% at the following semiautomatic stage. Hadjiiski et al. developed preliminary bladder 
segmentation methods for CTU using active contour with 15 patients
25
 without quantitative 
results, and level sets with 70 patients, which was evaluated using quality ratings
26
. 
There are challenges to segmenting bladders in CTU. Bladders may be partially or fully 
filled with excreted intravenous (IV) contrast material that opacifies a portion of the bladder. 
The boundaries between the bladder wall and the surrounding soft tissue have very low 
contrast such that they are often difficult to delineate. In addition, bladders may exist in a 
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variety of shapes and sizes. To address these challenges, Hadjiiski et al.
27
 developed a 
segmentation package specifically designed based on the characteristics of the bladder in CTU 
images referred to as Conjoint Level set Analysis and Segmentation System (CLASS) 
(frequently used acronyms are listed in Table 2.1). The segmentation performance was 
qualitatively evaluated using 81 bladders and quantitatively evaluated using 30 bladders by 
comparing the computer-segmented contours to hand-segmented reference contours and 
obtained promising results. 
 
Table 2.1: Definitions of frequently used acronyms. 
AVDIST Average minimum distance between two contours 
C Contrast-filled 
CAD Computer-aided detection 
CCP Contour conjoint procedure 
CLASS Conjoint level set analysis and segmentation system 
CTU CT urography 
EDWP Energy-driven wavefront propagation 
IV Intravenous 
L Contour of the contrast-filled region of the bladder 
LCR Local contour refinement 
MDCT Multi-detector row CT 
MGR Model-guided refinement 
NC Non-contrast 
ROI Region of Interest 
CLASS C 
Contour 
CLASS contour of the contrast-filled region of the bladder 
CLASS NC 
Contour 
CLASS contour of the non-contrast-filled region of the bladder 
 
 
In this study, we further developed the CLASS method by incorporating a local contour 
refinement procedure to improve the segmentation accuracy and evaluated its performance 
using a moderately-sized data set, although it was the largest data set of independent subjects 
compared to those used in other reported studies. The improvement in the segmentation 
performance of CLASS with the new refinement technique compared to that of CLASS alone 
was quantified using manual segmentation as reference standard. 
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2.3 Materials and Methods 
2.3.1 Bladder segmentation using CLASS 
Our previous work on CLASS
27
 is described briefly as follows. An axial CTU scan of 
the bladder is shown in Figure 2.1. Figures 2.2 and 2.3 show two regions of interest (ROI) from 
different CTU slices that contain the bladder. The bladders shown are partially filled with IV 
contrast material, and malignant lesions of different sizes can be identified in the lower, 
contrast-enhanced portion of the bladder. The presence of the two distinct areas that have very 
different attenuation values, an area filled with excreted IV contrast material and an area 
without contrast material (Figures 2.2 and 2.3), poses a challenge for segmentation that needs to 
go across the strong boundary between the two areas. 
 
 
Figure 2.1: An axial slice of a CTU scan in which the bladder is partially filled with IV contrast material. A malignant lesion is 
present in the contrast-filled region of the bladder, indicated by the light blue arrow. 
 
Bladder 
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Figure 2.2: ROI of a bladder partially filled with IV contrast 
material, showing the two distinct areas. A malignant lesion 
is present in the contrast-filled region of the bladder (black 
arrow). 
 
Figure 2.3: A large malignant lesion is located in the contrast-
filled portion of the bladder (black arrow). 
 
We are developing a software package, referred to as the Conjoint Level set Analysis 
and Segmentation System (CLASS), for segmenting the bladder in CTU. We introduced 
CLASS previously
27
 with limited quantitative assessment of its performance including 
comparison of its segmentation accuracy to radiologist’s hand outlines in a small data set and 
their qualitative visual judgment on a larger data set. 
CLASS consists of four stages: (1) preprocessing and initial segmentation, (2) 3D level 
set segmentation, (3) 2D level set segmentation, and (4) post-processing. CLASS segments the 
non-contrast (NC) region and the contrast-filled (C) region by applying the level sets to each 
region separately, then automatically conjoins them during post-processing using a procedure 
called Contour Conjoint Procedure (CCP). More details of CLASS can be found in the 
literature
27
. 
 
2.3.2 Local Contour Refinement 
Although CLASS performs reasonably well in comparison to hand segmentations, 
achieving a large volume intersection ratio for more than 70% of bladders
27
, a number of cases 
failed because the level set propagation in the C region may stop prematurely due to either 
substantial non-uniformity of the contrast, or a lesion present in the region. In this study, we 
designed a new Local Contour Refinement (LCR) method to further improve the segmentation 
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accuracy, especially to improve the segmentation of the C region, and including lesions that 
may be present.  
Local contour refinement consists of two main processes: model-guided refinement 
(MGR) and energy-driven wavefront propagation (EDWP). MGR propagates the contour of the 
C region (L) (See Figure 2.4) using local moving windows if the level set segmentation stops 
prematurely. EDWP uses regularized local energies to propagate the occasionally imperfect 
conjoining contour segments that conjoin the contours of NC and C regions, to the correct 
bladder boundary. The block diagram of CLASS with LCR is presented in Figure 2.4. The 
parameter values for the proposed methods were determined experimentally using cases from 
the training set. By altering one parameter at a time, we studied the sensitivity of the parameters 
(i.e., the effect of the change of each parameter on the quality of the automatic 3D contour), both 
by visual inspection and by the performance measures. We fixed the less sensitive parameters 
first, and altered the parameters with higher sensitivity to achieve the best segmentation. Once 
the parameters were fixed based on the training set, the CLASS with LCR was applied to the test 
set with that fixed parameter set without further changes. 
12 
 
 
 
Figure 2.4: Block diagram of the CLASS with LCR.  MGR is performed on the CLASS contour of the contrast-filled region. 
The CLASS contour of the non-contrast region and the contour L of contrast-filled region after MGR are joined and refined by 
EDWP to obtain the final contour of the bladder. 
 
 
 
 
Final 
Segmentation 
CLASS 
C Contour (L) 
CLASS 
NC Contour 
 
Model-Guided 
Refinement (MGR) 
 
Energy-driven 
Wavefront 
Propagation (EDWP) 
 
CLASS 
 
Volume of interest 
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2.3.2.1 Model-guided refinement  
 The model-guided refinement (MGR) method was designed to improve the CLASS C 
contour in 2D for every slice. Inaccuracies in the NC and C contours may cause the Contour 
Conjoint Procedure (CCP) to exclude portions of the bladder. To alleviate this problem, we 
implemented an MGR method to propagate the C region contour, L, if the level set propagation 
in the C region stops prematurely due to substantial non-uniformity of the contrast. MGR uses 
the level set contour, the local gradient and contrast as input and incorporates adaptive 
thresholding to propagate the L contour in 2D for every slice to the correct bladder boundary. 
The parameters used for the MGR method was determined experimentally using the training set. 
MGR propagates the level set L contour by analysis of three moving windows, all of 3 X 
3 pixels, at each point Li along the L contour: one centered at the point Li, the other two 
positioned at an inner and outer neighborhood of the contour, respectively.  The center of the 
outer window (WO) is located outside the contour in the normal direction, two pixels away from 
Li. The center of the inner window (WI) is located inside the contour, also in the normal direction, 
two pixels away from Li (Figure 2.5). The average intensities of the three windows are calculated 
as follows: 
 
𝐼𝑊(𝐿𝑖) =
∑ 𝐼(𝑃)𝑃∈𝑊
𝑁𝑊
, (2.1) 
 
𝐼𝑊𝑂(𝐿𝑖) =
∑ 𝐼(𝑃)𝑃∈𝑊𝑂
𝑁𝑊𝑂
, (2.2) 
 
𝐼𝑊𝐼(𝐿𝑖) =
∑ 𝐼(𝑃)𝑃∈𝑊𝐼
𝑁𝑊𝐼
, (2.3) 
where IW(Li) is the average intensity of the window W centered at Li, obtained by taking the 
average of the intensity of the pixels I(P) within the window W. IWO(Li) and IWI(Li) are the 
average intensity of the WO and WI windows, respectively, calculated in a similar way as IW(Li). 
NW , NWO , and NWI are the areas of the W, WO, and WI windows, respectively, and NW = NWO = 
NWI =9 pixels. 
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Figure 2.5: Diagram of inner and outer window used for MGR. Li is the given point on contour L that may be propagated. Li+1 
and Li-1 are the next and previous points, respectively, on the contour neighboring the point Li. The inner and outer windows 
are located two pixels away from Li and centered along the normal. The inner window WI is located towards the centroid of the 
contour L. The outer window WO is located outside the contour. 
 
 The normal direction is determined by the normal angle 𝜃 defined as:  
 
𝜃 =
1
2
(tan−1 (
𝑦𝑖 − 𝑦𝑖−1
𝑥𝑖 − 𝑥𝑖−1
) + tan−1 (
𝑦𝑖+1 − 𝑦𝑖
𝑥𝑖+1 − 𝑥𝑖
)), (2.4) 
where (xi ,yi) is the coordinate of the given point Li on the contour, and (xi+1,yi+1) and (xi-1,yi-1) are 
the coordinates of the next Li+1  and previous Li-1  neighboring points on the contour to the point 
Li, respectively (Figure 2.5). 
The point Li is propagated if the condition in either Equation (2.5) or Equation (2.6) is 
satisfied: 
 𝐼𝑊𝑂(𝐿𝑖) − 𝐼𝑊𝐼(𝐿𝑖) > 200, 
(2.5) 
  
{
𝐼𝑊(𝐿𝑖) > 𝑇ℎ
𝐼𝑊𝑂(𝐿𝑖) − 𝐼𝑊𝐼(𝐿𝑖) > −400,
  
(2.6) 
where Th is the optimal threshold determined at the beginning of the MGR  by the process 
explained below. Th is kept constant during the propagation of all Li points for all contours in a 
case. Equation (2.5) propagates the contour while the contour is within the C region of the 
bladder, propagating the contour to areas with positive gradient. Equation (2.6) propagates the 
contour even if the non-uniformity of the contrast creates areas of negative gradient. Equation 
Li+
1 Li-1 
Inner window 
WI 
Outer window 
WO 
Li 
Normal 
direction 
Contour L 
15 
 
(2.6) also propagates the contour to encompass the bladder wall once the contour reaches the 
edge of the C region. If one of these conditions is met, point Li propagates to a point one pixel 
away in the normal direction, determined by Equation (2.4) in a single iteration. Multiple 
iterations are carried out to propagate the contour. The propagation of the contour stops when all 
points Li stop moving. Smoothness of the contour is maintained by automatically adding points 
to the contour if the distance between consecutive points on the contour exceeds 6 pixels where 
the contour becomes too sparse, and removing points from the contour that cause sharp angles, 
defined as angle less than 90 degrees. 
The optimal threshold Th for the MGR is selected based on an adaptive method and is 
specific for every case. The Th is selected at the beginning of MGR.  First, the mean (μ) and the 
standard deviation (σ) of the voxel intensities within the volume defined by the 3D level set 
CLASS contours of the C region are calculated. A set of candidate thresholds Thm are estimated 
by Thm = μ –nmσ, where nm = 0, 0.5, 1, …, 10. For every candidate threshold, the level set 
contours on the best slice b (the slice that best represents the bladder region, where the bladder is 
seen the largest, which was manually selected when the ROI was defined), the slice before (b-1), 
and the slice after (b+1), are propagated. A given point Li on the 2D contours of the three slices 
is propagated if it satisfies both Equation (2.5) and Equation (2.6):  
To further prevent leaking, a criterion is set to determine adaptively how much a 
subsequent contour can expand from the current contours.  We first calculated the average 
minimum distance between two contours (AVDIST) as: 
 
𝐴𝑉𝐷𝐼𝑆𝑇(𝐺, 𝑈) =
1
2
(
∑ min{𝑑(𝑥, 𝑦): 𝑦 ∈ 𝑈}𝑥∈𝐺
𝑁𝐺
+
∑ min{𝑑(𝑥, 𝑦): 𝑥 ∈ 𝐺}𝑦∈𝑈
𝑁𝑈
), (2.7) 
where G is the current contour, and U is the subsequent contour. NG and NU denote the number 
of voxels on G and U, respectively. The function d is the Euclidean distance. For a given voxel 
along the contour G, the minimum distance to a point along the contour U is determined. The 
minimum distances obtained for all points along G are averaged. This process is repeated by 
switching the roles of G and U.  AVDIST is then calculated as the average of the two average 
minimum distances.  
For every candidate threshold Thm, the relative contour propagation increase (RCPI) is 
defined as: 
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𝑅𝐶𝑃𝐼 =
1
2
(𝐴𝑉𝐷𝐼𝑆𝑇(𝑆(𝑏), 𝑆(𝑏−1)) + 𝐴𝑉𝐷𝐼𝑆𝑇(𝑆(𝑏), 𝑆(𝑏+1))), (2.8) 
where 𝑆(𝑏), 𝑆(𝑏−1), 𝑆(𝑏+1)are the contours obtained by propagating level set L contours on the 
best slice b, the slice before b-1, and the slice after b+1, respectfully, using the candidate 
threshold Thm  and Equations (2.5) and (2.6). The optimal threshold Th is selected to be the 
largest Thm that provides less than 40% increase in RCPI from the RCPI obtained from the 
previous threshold, Thm-1. Th is fixed for the entire case, and is used to obtain the L contours on 
other slices of the case by propagating their respective level set L contours using Equations (2.1) 
through (2.6), applying methods as mentioned above. Obtaining the optimal threshold by this 
method helps prevent MGR from leaking. Figure 2.6 shows an example comparing segmentation 
results with and without MGR. 
  
(a) (b) 
Figure 2.6: Bladder segmentation using CLASS with and without MGR. (a) CLASS excluded portions of the bladder due to a 
malignant lesion (black arrow) attached to the bladder wall, but MGR propagated the L contour through the lesion to the correct 
bladder boundary. (b) MGR resolved a similar problem with a malignant mass lesion preventing the L contour from correctly 
segmenting the bladder. The yellow contour represents CLASS with MGR. The light blue contour shows CLASS without MGR. 
 
2.3.2.2 Energy-driven wavefront propagation (EDWP) 
The EDWP method was designed to smooth the transition between the conjoint C and 
NC contours and further pushes the contour towards the true bladder boundary, as described in 
the following.  Inaccuracies in the contours of the NC and C regions may cause Contour 
Conjoint Procedure (CCP) to exclude portions of the bladder. In cases where a lesion is present 
in the C region, MGR may not propagate through the lesion due to the edge of the lesion having 
similar edge properties as the bladder wall. When the level set contour of the NC region and the 
contour L of C region after MGR are conjoined, CCP may create erroneous connection between 
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the two contours, as seen by the straight connections between the contours of NC and C regions 
in Figure 2.7. This conjoining segment may cut across a lesion or the bladder, excluding other 
portions of the bladder in the process. The EDWP method combines local energies with a priori 
knowledge on contrast-enhanced bladder on CT images to guide the contour to search for the 
true bladder boundary.  
  
(a) (b) 
Figure 2.7: Bladder segmentation using CLASS with MGR. Inaccuracies in the NC region contour and C region contour L may 
cause CCP to exclude portions of the bladder. MGR was unable to propagate past the lesions (black arrow) in the C region to the 
correct bladder wall in both (a) and (b). (a) The malignant lesion extends to the NC area, thus MGR did not propagate the L 
contour through the lesion. (b) The inhomogeneous nature of the boundary between the NC and C regions of the bladder 
prevented MGR from propagating the L contour fully, missing the malignant lesion. The light blue contour represents the CLASS 
NC region contour. The pink contour represents the L contour with MGR. The yellow outer contour is the result of conjoining the 
NC region contour and L contour without LCR. 
 
EDWP propagates the points on the conjoining contour segment to the bladder boundary 
by calculating the local energies 𝐸𝑅(𝑍𝑖), 𝐸𝑂𝑢𝑡𝑅(𝑍𝑖), and 𝐸𝑂𝑟𝑖𝑔𝑅(𝑍𝑖). The local energy 𝐸𝑅(𝑍𝑖) is 
the energy of a region Ri centered at a given point Zi along the conjoining segment. Ri includes Zi 
and the points on the conjoining segment that are a maximum of two points away from Zi, i.e. 
Zi±2, Zi±1, therefore Zi, Zi±1, Zi±2 ∈ Ri. The energy term 𝐸𝑅(𝑍𝑖) is defined as: 
 
𝐸𝑅(𝑍𝑖) =
∑ 𝛼𝐼𝑤(𝑃)𝑃∈𝑅𝑖
𝑇𝛼
, (2.9) 
where IW(P) is the average intensity of a window defined by Equation (2.1), but a window size of 
5 X 5 pixels is used here. α is the weight assigned to IW(P): α is 4 for the energy of Zi and 1 for 
the rest of the reference points in Ri. Tα is the total weight, which is 8. 
The local energy 𝐸𝑂𝑢𝑡𝑅(𝑍𝑖),  is the energy of the region 𝑅𝑖
𝑜𝑢𝑡 obtained by propagating all 
points in Ri one pixel outside of the contour in their respective normal direction, estimated by the 
normal angle (Equation (2.4)).  𝐸𝑂𝑢𝑡𝑅(𝑍𝑖) is defined as: 
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 𝐸𝑂𝑢𝑡𝑅(𝑍𝑖) =
∑  𝛼𝐼𝑤(𝑃)𝑃∈𝑅𝑖𝑜𝑢𝑡
𝑇𝛼
, (2.10) 
where IW(P), α , and Tα are defined as in Equation (2.9) above. 
𝐸𝑂𝑟𝑖𝑔𝑅(𝑍𝑖)  is the local energy of the region 𝑅𝑖
𝑜𝑟𝑖𝑔
 centered at the original Zi in the 
conjoint segment before propagation with EDWP. 𝐸𝑂𝑟𝑖𝑔𝑅(𝑍𝑖) is defined as: 
 
𝐸𝑂𝑟𝑖𝑔𝑅(𝑍𝑖) =
∑  𝛼𝐼𝑤(𝑃)𝑃∈𝑅𝑖
𝑜𝑟𝑖𝑔
𝑇𝛼
, (2.11) 
where IW(P), α , and Tα are defined as in Equation (2.9) above. Before the first iteration, 
𝐸𝑅(𝑍𝑖) = 𝐸𝑂𝑟𝑖𝑔𝑅(𝑍𝑖). 
The local energies 𝐸𝑅(𝑍𝑖), 𝐸𝑂𝑢𝑡𝑅(𝑍𝑖), and 𝐸𝑂𝑟𝑖𝑔𝑅(𝑍𝑖) are calculated for every iteration of 
the propagation.  The EDWP monitors the changes in the energy to determine when to stop the 
propagation. The point Zi is propagated if both the following conditions are satisfied: 
 
𝐸𝑂𝑢𝑡𝑅(𝑍𝑖) − 𝐸𝑅(𝑍𝑖) >  −20, (2.12) 
 
𝐸𝑂𝑢𝑡𝑅(𝑍𝑖) − 𝐸𝑂𝑟𝑖𝑔𝑅(𝑍𝑖) >  −20, (2.13) 
Equation (2.12) propagates the conjoining segment through lesions and C region of the bladder 
until the drop in 𝐸𝑂𝑢𝑡𝑅(𝑍𝑖) energy exceeds the criterion, usually the darker tissue background 
around the bladder wall. Equation (2.13) stops the propagation in cases where Equation (2.12) is 
still satisfied when the conjoint segment is at the bladder wall. Using these conditions allows the 
segment to propagate through regions of higher energy such as contrast material (Figure 2.8), 
and eventually stop at a region of low energy (the darker tissue background around the bladder 
wall (Figure 2.8)). If both criteria for propagation are satisfied, Zi propagates to the pixel located 
one pixel outside of the contour in the normal direction, estimated by Equation (2.4), to the 
conjoining segment. After propagating all points along the conjoint segment for a given iteration, 
smoothness of the contour is maintained by limiting the smoothing energy terms in 2D and 3D as 
follows. 
The 2D smoothness criterion is applied sequentially to all regions Ri, along the conjoint 
segment. The 2D smoothing energy is defined as: 
 𝐸𝑆𝑚𝑜𝑜𝑡ℎ 2𝐷 = max{𝛾(𝑍𝑖 , 𝑃): 𝑃 ∈ 𝑍𝑖±1, 𝑍𝑖±2}, (2.14) 
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where the function 𝛾 provides the number of iterations Zi propagated after a point P among Zi±1 
and Zi±2 stopped propagating. Within a region Ri, Zi stops propagating if ESmooth 2D is greater than 
4, even if the energy criteria is met. Using this method ensures that Zi does not over-propagate 
by accounting for the changes in energy at the reference points in Ri.  
3D smoothing energy is defined as: 
 E𝑆𝑚𝑜𝑜𝑡ℎ 3𝐷 =  min{𝑑(𝑍𝑖 , 𝑃): 𝑃 ∈ 𝑃𝑆}, (2.15) 
where the function d is the Euclidean distance. PS is the previous slice (j-1) located in the 
cephalic aspect of the current slice (j). ESmooth 3D measures the minimum distance between Zi on 
slice j and the points on the previous contour on slice j-1. If this value is greater than 5 voxels, Zi 
stops propagating. Additional steps to maintain smoothness include adding points to the contour 
if the contour becomes too sparse defined by the same criteria as MGR, and removing points 
from the contour that cause sharp angles, defined as angle less than 90 degrees. 
Once propagation stops the energy of the conjoining segment follows the relationships 
below: 
 
∑𝐸𝑂𝑢𝑡𝑅(𝑍𝑖)
𝑄
𝑖=1
<∑𝐸𝑅(𝑍𝑖)
𝑄
𝑖=1
 (2.16) 
 
∑𝐸𝑂𝑢𝑡𝑅(𝑍𝑖)
𝑄
𝑖=1
<∑𝐸𝑂𝑟𝑖𝑔𝑅(𝑍𝑖)
𝑄
𝑖=1
 (2.17) 
where Q is the number of points along the conjoining segment. Figure 2.8 shows examples after 
improvement by applying EDWP to the cases in Figure 2.7. 
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(a) (b) 
Figure 2.8: Bladder segmentation using CLASS with LCR. (a) Energy-driven wavefront propagation (EDWP) propagated the 
conjoint contour past the malignant lesion (black arrow) to the correct bladder boundary. (b) Inaccuracy with L contour after 
MGR caused CCP to exclude portions of the bladder, but EDWP propagated the contour to the correct bladder boundary. The 
light blue contour represents contour without EDWP. The yellow contour represents the contour with EDWP. 
 
2.3.4 Data set 
In this study, a data set of 173 patients undergoing CTU who subsequently underwent 
cystoscopy and biopsy was utilized. The cases were collected retrospectively from the 
Abdominal Imaging Division of the Department of Radiology at the University of Michigan with 
approval of the Institutional Review Board. We designated 81 of these cases as the training set, 
and the other 92 cases as the test set. The cases were assigned to the training or the test sets by 
balancing the difficulty of the cases between the two sets by researcher who was trained by an 
experienced abdominal radiologist. 
 Of the 81 training set bladders, 42 bladders contained focal mass-like lesions (40 
malignant and 2 benign), 21 bladders had wall thickening (16 malignant and 5 benign) and 18 
were normal. In these cases, 61 bladders were partially filled with IV contrast material, 8 were 
completely filled with contrast material, and 12 had no visible contrast material. Of the 92 test 
set bladders, 43 bladders contained focal mass-like lesions (42 malignant and 1 benign), 36 
bladders had wall thickening (23 malignant and 13 benign) and 13 were normal. In these cases, 
85 bladders were partially filled with IV contrast material, 4 were completely filled with contrast 
material, and 3 had no visible contrast material. The bladder conspicuity was medium to high.  
The MDCT urography scans used in this study were acquired with GE Healthcare 
LightSpeed MDCT scanners. Excretory phase images, obtained 12 minutes after the initiation of 
21 
 
intravenous contrast injection at a concentration of 300 mg iodine per ml, were utilized.  The 
images used were acquired at an interval and slice thickness of 1.25 mm or 0.625 mm using 120 
kVp and 120–280 mA. Since patients were not turned prior to image acquisition, dependently 
layering IV contrast material that had been excreted into the renal collecting systems partially 
filled the bladder on the CTU images. 
 
2.3.5 Evaluation methods 
Segmentation performance was evaluated by quantitative methods comparing the computer 
segmentation result to the reference standard.  The 3D hand-segmented contours for all 173 cases 
were obtained as reference standard in this study. An experienced radiologist provided manual 
outlines on the CT slices for all cases using an in-house developed graphic user interface (GUI). 
The radiologist outlined the bladder on every 2D CT slice on which the bladder was visible, 
resulting in a 3D surface contour. There were a total of 16,197 slices manually outlined by the 
radiologist for the 173 bladders.  Several performance metrics 
28
 that quantify the similarity of a 
pair of contours were used for evaluating the system, including the volume intersection ratio, the 
volume error, the average minimum distance, and the Jaccard index 
29
, between the hand-
segmented contours and computer segmented contours. 
The volume intersection ratio is the ratio of the intersection between the reference 
volume and the given volume to the reference volume: 
 
𝑅3𝐷 =
𝑉𝐺 ∩ 𝑉𝑈
𝑉𝐺
, (2.19) 
where VG is the volume enclosed by the reference standard contour G and VU is the volume 
enclosed by the contour U being evaluated. A value of 1 indicates that VU completely overlaps 
with VG, while a value of 0 means VU and VG do not overlap. 
The volume error is the ratio of the difference between the reference volume and the 
given volume to the reference volume: 
 
𝐸3𝐷 =
𝑉𝐺 − 𝑉𝑈
𝑉𝐺
, (2.20) 
where positive error indicates under-segmentation and negative error indicates over-
segmentation. Because the over- and under-segmentation tend to mask the actual deviations from 
the reference standard when the average is taken, the absolute error |E
3D
| is also calculated. 
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The average distance, AVDIST, is the average of the distances between the closest points 
of the two contours already defined in Section 2.2.1, Equation (8). For this calculation, G is the 
3D reference contour marked by the radiologist and U is the 3D contour being evaluated.  
The Jaccard index is defined as the ratio of the intersection between the reference volume 
and the segmented volume to the union of the reference volume and the segmented volume:  
 
𝐽𝐴𝐶𝐶𝐴𝑅𝐷3𝐷 =
𝑉𝐺 ∩ 𝑉𝑈
𝑉𝐺 ∪ 𝑉𝑈
, (2.21) 
A value of 1 indicates that VU completely overlaps with VG, whereas a value of 0 implies VU and 
VG are disjoint. 
 No single measure can completely describe the agreement between the two volumes; 
however, by combining two performance measures, different aspects of the performance can be 
assessed. For example, the  Jaccard index, the overlap and non-overlap fractions with the 
reference standard, can be derived from the volume intersection ratio and the volume error 
30
. 
 
2.4 Results 
Examples of CLASS NC and C region contours and CLASS with LCR segmentation are 
shown in Figure 2.9. The segmentation performance measures averaged over the cases in the 
training and test sets, respectively, are presented in Tables 2.2 and 2.3. 
  
(a) (b) 
  
(c) (d) 
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Figure 2.9: Bladder segmentation of test cases using CLASS with and without LCR. (a) CLASS missed portions of the malignant 
lesion and failed to segment the bladder boundary in the C region, whereas LCR segmented the bladder more accurately. (b) The 
large malignant lesion in the C region was mostly missed by CLASS; however, LCR fully segmented the lesion. (c) Benign wall 
thickening was missed by CLASS, but LCR segmented the bladder more accurately. (d) A difficult malignant lesion was missed 
with CLASS, but LCR propagated the contour through the lesion to the bladder boundary. The light blue contour represents 
segmentation results using CLASS. The yellow contour represents segmentation result from CLASS with LCR. 
 
Table 2.2: Segmentation results from CLASS with and without LCR, averaged over the 81 bladders in the training set. The value 
for the method that performed better is in bold. 
Segmentation 
Method (Training 
set) 
Volume 
intersection ratio 
 
Volume error 
Absolute volume 
error 
Average 
minimum 
distance 
Jaccard index 
R3D E3D |E3D| AVDIST JACCARD3D 
CLASS with LCR 84.2±11.4% 8.2±17.4% 13.0±14.1% 3.5±1.9 mm 78.8±11.6% 
CLASS without 
LCR 
75.1±13.2% 18.7±19.5% 22.5±14.9% 4.3±2.2 mm 71.0±12.6% 
 
 
Table 2.3: Segmentation results from CLASS with and without LCR, averaged over the 92 bladders in the test set. The value for 
the method that performed better is in bold. 
Segmentation 
Method 
(Test set) 
Volume 
intersection ratio 
 
Volume error 
Absolute volume 
error 
Average 
minimum 
distance 
Jaccard index 
R3D E3D |E3D| AVDIST JACCARD3D 
CLASS with LCR 78.0±14.7% 16.4±16.9% 18.2±15.0% 3.8±2.3 mm 73.8±13.4% 
CLASS without 
LCR 
67.3±14.3% 29.3±15.9% 29.4±15.6% 4.9±2.6 mm 65.0±13.3% 
 
 
CLASS with LCR consistently performed better than CLASS for the data set used. In 
comparison to CLASS only, CLASS with LCR resulted in larger volume intersection ratio, 
smaller volume error, smaller absolute volume error, smaller average distance error, and larger 
Jaccard index for both training and test sets. The standard deviations for all 5 measures were 
smaller with LCR than without LCR for the training set. For the test set, the standard deviations 
were smaller with LCR than without LCR for the absolute volume error and average distance 
error. The differences for all of the performance measures between the two methods were 
statistically significant for both the training and test sets (p<0.001 by two-tailed paired t-test) at 
alpha level of 0.01 after the Bonferroni correction for the 5 comparisons. 
The histograms for volume intersection ratio, volume error, and average distance for both 
the training and test sets are shown in Figures 2.10, 2.11, and 2.12, respectively. 
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Training Set Test Set 
  
(a) (b) 
Figure 2.10: Histogram of percent volume intersection ratio for (a) the training set and (b) the test set for CLASS and CLASS with 
LCR. The improvement by LCR was statistically significant (p<0.001) for both the training and test sets.  
 
 
 
Training Set Test Set 
  
(a) (b) 
Figure 2.11: Histogram of the volume error for (a) the training set and (b) the test set for CLASS and CLASS with LCR. The 
improvement by LCR was statistically significant (p<0.001) for both the training and test sets.  
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Training Set Test Set 
  
(a) (b) 
Figure 2.12: Histogram of the average minimum distance for (a) the training set and (b) the test set for CLASS and CLASS with LCR. 
The improvement by LCR was statistically significant (p<0.001) for both the training and test sets.  
 
Of the 81 cases in the training set, CLASS with LCR had 65 bladders with a volume 
intersection ratio greater than 80% whereas CLASS had 34 bladders (Figure 2.10(a)). There were 
63 bladders whose absolute volume error for the training set was less than 20% for CLASS with 
LCR, compared to 41 bladders for CLASS only (Figure 2.11(a)). Forty-seven bladders in the 
training set had an average distance less than 3 mm for CLASS with LCR, compared to 27 
bladders for CLASS only (Figure 2.12(a)).  
Of the 92 test cases, CLASS with LCR had 51 bladders with a volume intersection ratio 
greater than 80% whereas CLASS had only 18 bladders (Figure 2.10(b)). There were 60 bladders 
whose absolute volume error for the test set was less than 20% for CLASS with LCR, compared 
to 28 bladders for CLASS only (Figure 2.11(b)). Forty bladders in the test set had an average 
distance less than 3 mm for CLASS with LCR, compared to 20 bladders for CLASS only (Figure 
2.12(b)). 
 
2.5 Discussion 
In this study, CLASS with the new LCR method was applied to a data set containing 
bladders in CTUs having a wide range of image quality. Most of the bladders were partially 
filled with excreted contrast material; however, some bladders were entirely filled and others did 
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not contain any contrast-enhanced urine due to variation in the rate of excreted contrast material 
accumulation in the bladder. CLASS with LCR performed better than CLASS for every 
performance measure. The LCR more than doubled the number of bladders with volume 
intersection ratio greater than 80%, absolute volume error less than 20%, and average distance 
less than 3 mm for the test set.  The number of bladders with the above mentioned performance 
measures also increased for each measure in the training set. Figures 2.8 and 2.9 show examples 
of difficult bladder cases successfully improved by LCR. The bladders in Figure 2.8 and Figures 
2.9(a) and 2.9(b) contained large malignant lesions in the contrast-enhanced area that CLASS 
had missed. The benign wall thickening in Figure 2.9(c) was missed by CLASS. The case in 
Figure 2.9(d) contains an inhomogeneous malignant lesion that was also missed by CLASS. In 
each of these cases, CLASS could not accurately segment the C portion of the bladder due to the 
strong edge between the large abnormality and the contrast agent, resulting in segmentation 
excluding portions of the bladder and the lesion. LCR propagated the conjoint contour to the 
proper bladder boundary, enclosing the previously mentioned features, thus achieving a more 
accurate segmentation. 
It is difficult to perform direct comparison to the previous methods by other investigators 
summarized in the Introduction due to the differences in the data sets and their varying difficulty.  
A relative comparison was performed to only one of the studies
24
, in which quantitative results 
were reported. Chai et al.
24
 achieved Jaccard indices of 70.5% and 77.7% for their automatic 
and semiautomatic methods, respectively, using 95 scans of 8 patients for training, and using 
233 scans of 22 patients for testing. In comparison, the Jaccard indices of our CLASS with 
LCR method were 78.8% and 73.8% for the training (81 patients) and test set (92 patients), 
respectively. CLASS with LCR achieved accuracy comparable to that of Chai et al.
24
 while 
using a larger independent data set. CLASS with LCR also does not require initial manual 
delineation of the bladder, and also does not require manual correction of the contours, unlike 
the automatic and semiautomatic methods, respectively, of Chai et al.
24
. 
There are cases that LCR still could not segment the bladder accurately. LCR did not 
refine the non-contrast filled region contour from CLASS; therefore, the method was not able to 
reliably stop the NC region contour at the bladder boundary when a complex background is 
present, as shown in the upper boundary of the example in Figure 2.13(a). LCR did, however, 
propagate the C region contour L properly to the correct lower bladder boundary, compared to 
27 
 
CLASS. In addition, LCR does not solve the problem if errors in the NC region contour cause 
the initial conjoining segment used for EDWP to cut across the bone. As shown in Figure 
2.13(b), LCR propagated the contour L to include a lesion and portions of the contrast-filled 
region of the bladder that CLASS had missed; however, the inaccuracy in the NC region contour 
created an initial conjoint segment through the bone. LCR was not able to identify this error, and 
propagated the contour segment within the bone, due to the similar appearance of the bone and 
the bone marrow to a C region containing a lesion, causing leaking in the segmentation. Better 
criteria to prevent leakage into adjacent normal tissue and bone are needed. It may also be 
necessary to develop additional local refinement methods to improve segmentation accuracy.  
 
 
(a) (b) 
Figure 2.13: Bladder segmentation using CLASS with LCR. (a) shows leaking in the NC contour due to complex boundary. (b) 
shows segmentation leaking into the bone. The light blue contour represents segmentation results using CLASS. The yellow 
contour represents segmentation result from CLASS with LCR. 
 
2.6 Conclusion 
The results show that the LCR method can significantly improve the segmentation of 
bladders by CLASS on CTU scans. LCR propagates the CLASS contour of the contrast-filled 
region of the bladder and propagates the conjoint contour of the contrast and non-contrast filled 
region to the correct bladder boundaries using both 2D and 3D information. Further work to 
prevent over-segmentation into adjacent organs or bone edges is discussed in Chapter III. This 
study is a step toward the development of a reliable and efficient system for segmentation of 
bladders, which is a critical component of a CAD system for detection of urothelial lesions 
imaged with CT urography. 
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Chapter III 
Urinary Bladder Segmentation in CT Urography using Deep-Learning Convolutional 
Neural Network and Level Sets
 
 
3.1 Abstract 
 A Deep-Learning Convolutional Neural Network (DL-CNN) was trained to distinguish 
between the inside and the outside of the bladder using 160,000 regions of interest (ROI) from 
CTU images. The trained DL-CNN was used to estimate the likelihood of an ROI being inside 
the bladder for ROIs centered at each voxel in a CTU case, resulting in a likelihood map. 
Thresholding and hole-filling were applied to the map to generate the initial contour for the 
bladder, which was then refined by 3D and 2D level sets. The segmentation performance was 
evaluated using 173 cases: 81 cases in the training set (42 bladders with lesions, 21 bladders with 
wall thickenings, 18 normal bladders), and 92 cases in the test set: (43 bladders with lesions, 36 
bladders with wall thickenings, 13 normal bladders). The computerized segmentation accuracy 
using the DL likelihood map was compared to that using a likelihood map generated by Haar 
features and a random forest classifier, and that using our previous Conjoint Level set Analysis 
and Segmentation System (CLASS) without using a likelihood map. All methods were 
evaluated relative to the 3D hand-segmented reference contours. With DL-CNN-based likelihood 
map and level sets, the average volume intersection ratio, average percent volume error, average 
absolute volume error, average minimum distance, and the Jaccard index for the test set were 
81.9±12.1%, 10.2±16.2%, 14.0±13.0%, 3.6±2.0 mm, and 76.2±11.8%, respectively. With the 
Haar-feature-based likelihood map and level sets, the corresponding values were 74.3±12.7%, 
13.0±22.3%, 20.5±15.7%, 5.7±2.6 mm, and 66.7±12.6%, respectively. With our previous 
CLASS with LCR method, the corresponding values were 78.0±14.7%, 16.4±16.9%, 
18.2±15.0%, 3.8±2.3 mm, 73.8±13.4%, respectively. We demonstrated that the DL-CNN can 
overcome the strong boundary between two regions that have large difference in gray levels and 
provides a seamless mask to guide level set segmentation, which has been a problem for many 
gradient-based segmentation methods. Compared to our previous CLASS with LCR method that 
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required two user inputs to initialize the segmentation, DL-CNN with level sets achieved better 
segmentation performance while using a single user input. Compared to Haar-feature-based 
likelihood map, the DL-CNN-based likelihood map could guide the level sets to achieve better 
segmentation. The results demonstrate the feasibility of our new approach of using DL-CNN in 
combination with level sets for segmentation of the bladder. The results presented in this chapter 
have been published
2
. 
 
3.2 Introduction 
As there are still challenges to segmenting the bladders in CTU, we have studied new 
techniques for improved performance and reduced requisite user input. Bladders may be filled 
with excreted intravenous (IV) contrast material that partially or fully opacifies the bladder. 
The boundaries between the bladder wall and the surrounding soft tissue have very low 
contrast such that they are often difficult to delineate. In addition, imaged bladders may have a 
variety of shapes and sizes. To address these challenges, Hadjiiski et al.
25, 26
 developed 
preliminary bladder segmentation methods for CTU using active contour with 15 patients and 
level sets with 70 patients. Hadjiiski et al.
27
 also developed a segmentation package specifically 
designed based on the characteristics of the bladder in CTU images, referred to as Conjoint 
Level set Analysis and Segmentation System (CLASS), that segments the contrast-enhanced 
and non-contrast regions of the bladder separately, using two input bounding boxes, and then 
joins the regions together. They qualitatively evaluated the segmentation performance of 81 
bladders and performed quantitative evaluation of 30 bladders comparing the computer-
segmented contours to hand-segmented reference contours and obtained promising results. The 
CLASS method was further developed by Cha et al.
1
 as described in Chapter III to improve the 
segmentation accuracy. Model-guided refinement was used to propagate the contours of the 
contrast-enhanced region if the level set propagation stopped prematurely due to substantial 
non-uniformity of the contrast, as described in Chapter II, section 2.3.2.1. An energy-driven 
wavefront propagation that used changes in energies, smoothness criteria of the contour, and a 
stop criterion determined by the previous slice contour was designed to further propagate the 
conjoint contours to the correct bladder boundary. The segmentation performance was evaluated 
using 81 training cases and 92 independent test cases. 
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Convolutional neural networks (CNN) have been used previously to classify patterns in 
medical images for use with computer-aided detection and specifically for microcalcification 
detection in mammograms
31-38
. In these applications, the training sets were typically small, 
generally using less than 500 samples. As computational power grows, CNNs with very 
complex architectures that require training with massive data become practical. The deep-
learning CNN (DL-CNN) using graphics processing units (GPU) has been shown to be able to 
classify natural images using a large training set. Krizhevski et al.
39, 40
 have shown that by 
using DL-CNN, they are able to achieve relatively low error rates and good classification 
accuracy on the ImageNet ILSVRC-2010 and ILSVRC-2012 data sets
41
, and the CIFAR-10 
data set
42
. 
In this study, we explored the application of the DL-CNN to bladder segmentation. The 
DL-CNN was trained to recognize the patterns inside and outside the bladder and generated a 
bladder likelihood map to guide the level set segmentation. For comparison, we also generated 
a bladder likelihood map by using Haar features
43, 44
, to differentiate bladder region from the 
surrounding structures as classified by a random forest classifier. To evaluate the effectiveness 
of the template-based approach, their performances were compared to our CLASS with local 
contour refinement (LCR) method described in Chapter 2.  
The chapter is organized as follows. First, the data set used in the study is described. 
Second, the method of generating the bladder likelihood map using DL-CNN is presented. Third, 
the level set segmentation method using the likelihood map is described. Fourth, the method of 
generating the likelihood map using Haar features is designed as a comparison to the DL-CNN 
approach. Finally, the segmentation results are presented and discussed. 
 
3.3 Materials and Methods 
 A DL-CNN was trained to distinguish between regions of interest (ROI) that are inside 
and outside of the bladder. The DL-CNN outputs the likelihood that an input ROI is inside the 
bladder that is used to form the bladder likelihood map. The map is used to generate the initial 
contour for level-set-based bladder segmentation. A flowchart of the segmentation method is 
shown in Figure 3.1. 
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Figure 3.1: Flowchart of the template-based segmentation method. 
 
3.3.1 Data set 
In this study, a data set of 173 patients undergoing CTU who subsequently underwent 
cystoscopy and biopsy was utilized. The cases were collected retrospectively from the 
Abdominal Imaging Division of the Department of Radiology at the University of Michigan with 
approval of the Institutional Review Board. We designated 81 of these cases as the training set, 
and the other 92 cases as the test set. The cases were assigned to the training or the test sets by 
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balancing the difficulty of the cases between the two sets by researcher who was trained by an 
experienced abdominal radiologist. The data set used in this study was described in Chapter II, 
section 2.3.4. 
Three-dimensional (3D) hand-segmented contours for all 173 cases were obtained as 
reference standard (RS1) in this study. An experienced radiologist provided manual outlines on 
the CT slices for all cases using a graphical user interface. The bladder was outlined on every 2D 
CT slice on which the bladder was visible, resulting in a 3D surface contour. There were a total 
of 16,197 slices for the 173 bladders. A subset of cases that contained lesions (41 training set 
cases, 50 test set cases, a total of 8,420 slices) was outlined by a different reader experienced in 
bladder segmentation to provide a second reference standard (RS2). The two sets of independent 
manual outlines allowed us to study the inter-observer variability and to evaluate the difference 
in the computer segmentation performance relative to the two sets of hand outlines. 
 
3.3.2 Bladder likelihood map generation using deep-learning convolutional neural network 
(DL-CNN) 
 We applied the DL-CNN developed by Krizhevski et al. called cuda-convnet
39, 40
 to the 
classification of ROIs on 2D slices as being inside or outside of the bladder. The neural network 
is trained using labeled ROIs of the same size extracted from the CTU slices in the training cases. 
Each of the extracted ROIs is input into the DL-CNN that outputs the likelihood of the ROI to be 
inside the bladder. To use the trained DL-CNN to generate a bladder likelihood map, it is applied 
to ROIs centered at each pixel on an axial slice in a CTU scan that contains the bladder and the 
likelihood value for the ROI is assigned to the center pixel. The resulting output over all pixels 
on the slice forms a bladder likelihood map, and the 2D maps over the consecutive CT slices 
constitutes a 3D likelihood map.  
 
3.3.2.1 DL-CNN components 
 Components of the DL-CNN are briefly described in the following. More information 
about this network can be found in literature
39,40
. 
Neurons: A DL-CNN neuron consists of two functional parts: (1) summation of the 
weighted inputs to the neuron and (2) application of an activation function to the sum. The 
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activation function used in this DL-CNN is a non-saturation nonlinear function, defined by the 
following equation: 
 
𝑓(𝑥) =  max (0, 𝑥) (3.1) 
The output of a neuron generally is obtained by a sigmoid activation function; however, it was 
shown that networks trained with gradient descent can converge much faster when neurons with 
the activation function in Equation (3.1) are used, which were named Rectified Linear Units, 
following Nair et al.
40, 45
. 
 Convolution layer: In the convolution layer, the input ROI is convolved with the 
convolution kernels. The resulting values are collected into corresponding kernel maps in the 
convolution layer (Figure 3.2). The kernel maps are transformed by the activation function given 
by Equation (3.1), to give the output signal. 
 
Figure 3.2: Diagram of the convolution layer. An input ROI is convolved with multiple convolution kernels, and the resulting 
values are collected into corresponding neurons in the kernel maps. 
 
 Pooling layer: The pooling layers summarize the outputs of neighboring groups of 
neurons within the same kernel map. We compared two commonly used overlapping pooling 
layers for our application; one used the maximum values and the other used average values 
within 3 x 3 groups of pixels centered at the pooling unit, with the distance between pooling set 
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to two pixels. Previous study had found that using overlapping pooling was less prone to 
overtraining
40
. 
 Local Response Normalization layer: Using local normalization scheme aids in the 
generalization of the training. The activity of a neuron in the layer pervious to the normalization 
layer was normalized using the following equation
40
: 
 
𝑏𝑥,𝑦
𝑖 =
𝑎𝑥,𝑦
𝑖
(1 +
𝜏
𝑁
∑ (𝑎𝑥,𝑦
𝑗 )
2min(𝑛,𝑖+
𝑁
2)
𝑗=max(0,𝑖−
𝑁
2
)
)
𝜀 
(3.2) 
where 𝑏𝑥,𝑦
𝑖  is the response-normalized neuron activity, 𝑎𝑥,𝑦
𝑖  is the neuron activity computed by 
applying the kernel 𝑖 at the coordinates (x,y), 𝑛 is the number of kernel maps of the previous 
layer, and 𝑁, 𝜏, and 𝜀 are constants. For our implementation of the DL-CNN, we used 𝑁 = 9, 
𝜏 = 0.001, and 𝜀 = 0.75, following the study by Krizhevsky et al.40. 
 
3.3.2.2 DL-CNN architecture 
A block diagram of the network architecture used in this study is shown in Figure 3.3. 
The network consists of five main layers: two convolution layers, two locally-connected layers, 
and one fully-connected layer. The locally-connected layers perform the same operation as the 
convolution layer, except that instead of applying a single convolution kernel to every location of 
the input image to obtain a kernel map, different convolution kernels are applied at every 
location of the input image, and the resulting values are collected into the corresponding neurons 
within the corresponding kernel map. The fully-connected layer uses every kernel map element 
multiplied by a weight as input. All of the inputs are summed, and the activation function 
(Equation 3.1) is applied to generate output values. 
 The first convolution layer filters the input images with 64 kernels of size 5 x 5. The 
output of the layer is pooled and normalized using the pooling and local response normalization, 
and is input into the second convolution layer that filters the output with an additional 64 kernels 
of size 5 x 5. The first locally-connected layer takes as input the pooled and normalized output of 
the second convolution layer and filters it with 64 kernels of size 3 x 3. The second locally-
connected layer has 32 kernels of size 3 x 3 connected to the normalized, pooled output of the 
first locally-connected layer. The fully-connected layer outputs two values. The outputs from the 
fully-connected layer are input into a Softmax layer that computes the following function: 
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𝑓(𝑥𝑖) =
𝑒𝑥𝑖
∑ 𝑒𝑥𝑗𝑗
 (3.3) 
where 𝑥𝑖 is each input value to the layer. The output of this layer ranges from 0 to 1, which can 
be interpreted as the likelihood of the input ROI being classified into the one of the given 
categories. The negative log likelihood was used for the loss function. The network structure 
including the number of kernels and kernel sizes, and parameters were determined using the 
training set. For example, the kernel size combination of 5 x 5 and 3 x 3 for the convolution 
layers and the locally-connected layers, respectively, performed best on the training set 
compared to other kernel size combinations. 
 
Figure 3.3: Block diagram of the DL-CNN architecture used in this study. 
 
3.3.2.3 DL-CNN training 
 The DL-CNN was trained using the cases in the training set. A cropped CTU slice of a 
bladder case is shown in Figure 3.4(a). For each axial slice of the cases in the training set, ROIs 
Convolution 
Normalization 
Pooling 
Convolution 
Normalization 
Pooling 
Locally-connected 
Locally-connected 
Fully-connected Bladder 
Likelihood 
Input 
ROI 
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of N x N-pixels inside and outside the bladder were extracted using hand-outlines provided by an 
experienced radiologist (Figure 3.4(b)). Three ROI sizes, N = 16, 32, 64 were studied but the size 
of 32 x 32 pixels was used in the following discussion. Each bladder ROI was labeled as being 
inside or outside of the bladder as follows. If over 90% of an ROI was within the hand-outlined 
bladder, the ROI was labeled as being inside the bladder. A value of 90% was chosen to ensure a 
sufficient number of ROIs was identified as being inside the bladder. If less than 5% of an ROI 
was within the hand-outlined bladder, the ROI was labeled as being outside the bladder to avoid 
most of the bladder and the bladder wall while including the background regions that surround 
the bladder. ROIs not labeled as being inside or outside of the bladder were excluded. Figure 
3.4(c) shows examples of ROIs that were extracted from a slice. 
 
  
(a) (b) 
37 
 
 Approximately 160,000 ROIs were generated from the cases in the training set after 
balancing the number of ROIs that were inside and outside of the bladders. Figure 3.5(a) and 
3.5(b) show examples of the ROIs inside and outside the bladder, respectively, used to train the 
DL-CNN.  
 
(a) 
 
(c) 
Figure 3.4: Images of a CTU slice from a training case. (a) Cropped CTU slice centered at the bladder. (b) The CTU slice shown 
with radiologist’s hand outline of the bladder. (c) Example of ROIs that were extracted from the CTU slice to train the DL-CNN. 
The yellow ROI at the top of the bladder shows the size of a 32x32-pixel ROI. The ROIs are partially overlapping. The pink 
ROIs are ones marked as outside of the bladder. The light blue ROIs are ones marked as inside of the bladder. 
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(b) 
Figure 3.5: Images of the 160,000 ROIs used to train the DL-CNN using the cases in the training set. Each ROI is 32x32 pixels. (a) 
ROIs that are labeled as inside the bladders. (b) ROIs that are labeled as outside the bladders. A small subset of the ROIs in each 
class is zoomed in to illustrate the content of typical ROIs. 
 
The neural network was trained for 1500 iterations, but the DL-CNN trained for 1000 
iterations was selected to generate the bladder likelihood maps. We observed that a network 
trained with up to 1000 iterations had similar training classification error rates as a network 
trained with up to 1500 iterations. Classification error rate is defined as the ratio of the number of 
incorrectly identified ROIs to the total number of ROIs. Figure 3.6 shows the classification error 
rate of the DL-CNN training for the entire training set as the number of iterations increased. In 
addition, we observed that bladder likelihood maps generated using DL-CNN trained for 1000 
iterations were better or comparable to maps generated using network trained for 1500 iterations 
for representative cases from a range of difficulties in the training set, thus 1000 iterations was 
used to generate the likelihood maps. Training the network using 160,000 ROIs and 1000 
iterations took approximately 5.5 hours using a Tesla C2075 GPU. 
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3.3.2.4 Bladder likelihood map generation with DL-CNN 
 For every axial slice in a CTU scan that contains the bladder, a bladder likelihood map 
was generated. Our current segmentation system uses a single box, or volume of interest (VOI) 
that approximately encloses the bladder as input. The bladder likelihood map is therefore 
generated within this VOI. The trained DL-CNN is applied to each voxel within the VOI. At 
each voxel, a 32 x 32-pixel ROI on the axial slice is extracted and input to the DL-CNN that 
outputs the likelihood that the input ROI is inside the bladder. The likelihood score for the ROI is 
assigned to the center pixel of the ROI. The collection of voxel-wise likelihood scores forms a 
bladder likelihood map. Figure 3.7 shows the bladder likelihood map of the CTU slice shown in 
Figure 3.4. 
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Figure 3.6: Plot of the classification error rate of DL-CNN training for the entire training set as the number of iterations increase. 
The error rates at iterations 1000 and 1500 were very similar. The training results from iteration 1000 were used to generate the 
bladder likelihood maps. 
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3.3.3 Bladder segmentation using DL-CNN bladder likelihood map 
We have developed a software package that uses the DL-CNN bladder likelihood map 
and level sets to segment the bladder from the surrounding tissue. The system was initialized by 
the same VOI that encloses the bladder within which the bladder likelihood map was generated. 
The system consisted of four stages: (1) preprocessing (2) initial segmentation, (3) 3D level set 
segmentation, and (4) 2D level set segmentation.  
In the first stage, preprocessing techniques were applied in 3D to the VOI. Smoothing, 
anisotropic diffusion, gradient filters and the rank transform of the gradient magnitude were 
applied to the slices within the VOI to obtain a set of gradient magnitude images and a set of 
gradient vector images that were used during level set propagation in the third stage. 
In the second stage, the initial segmentation surface was generated using the DL-CNN 
bladder likelihood maps. First, a binary bladder mask, 𝐷𝐿𝑀𝑎𝑠𝑘, was generated by applying the 
following criterion to every pixel on all slices of the bladder likelihood map: 
 
𝐷𝐿𝑀𝑎𝑠𝑘(𝑥, 𝑦) = {
1, 𝐷𝐿𝑆𝑐𝑜𝑟𝑒(𝑥, 𝑦) ≥ 𝜃
0, 𝐷𝐿𝑆𝑐𝑜𝑟𝑒(𝑥, 𝑦) < 𝜃
 (3.4) 
where 𝐷𝐿𝑀𝑎𝑠𝑘(𝑥, 𝑦)  is the pixel value on the bladder mask at the coordinates (𝑥, 𝑦) , 
𝐷𝐿𝑆𝑐𝑜𝑟𝑒(𝑥, 𝑦) is the bladder likelihood score at the coordinates (𝑥, 𝑦), and 𝜃 is the threshold 
 
 
Figure 3.7: Bladder likelihood map of the CTU slice shown in Figure 3.4. High intensity represents high likelihood of the voxel 
being inside the bladder. In this example, for demonstration purposes, the bladder likelihood map was generated for an area larger 
than the VOI. The VOI is shown by the box around the bladder. 
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imposed on the bladder likelihood score. The value for 𝜃 was determined by histogram analysis. 
A histogram of the DL-CNN likelihood score for the pixels inside and outside of the bladder 
within the VOIs in the training cases was generated (Figure 3.8). We observed that the likelihood 
score of 0.85 provided a good separation of the two classes (e.g. inside the bladder and outside 
the bladder), with a large number of pixels correctly identified as being inside the bladder. 
Thresholding the likelihood maps at the score of 0.85 gave the best contour that did not leak to 
the outside of the bladder while closely approaching the hand segmentation for cases in the 
training set. For these reasons, 0.85 was chosen as the threshold. 
Second, an ellipsoid whose minor and major axes are 1.5 of the width and height of the 
VOI, respectively, centered at the centroid of the bladder mask, is placed on the 𝐷𝐿𝑀𝑎𝑠𝑘. The 
intersection of the bladder mask and the ellipsoid is labeled as the object region. The ellipsoid is 
used to prevent the object region from leaking into the organs above the bladder and the pelvic 
bones, as these structures can also obtain high likelihood scores from the DL-CNN. Finally, a 
morphological dilation filter with a spherical structuring element of 2 voxels in radius, 3D flood 
fill algorithm, and a morphological erosion filter with a spherical structuring element of 2 voxels 
in radius are applied to the object region to connect neighboring components and extract an 
initial segmentation surface, 𝜙0(𝑥). 
 
In the third stage, the initial segmentation surface is propagated towards the bladder 
boundary using cascading level sets. Our chosen level set implementation evolves according to 
the equation: 
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Figure 3.8: Histogram of the DL-CNN likelihood score for the pixels in the training set. Higher likelihood score indicates that the 
pixel is more likely to be inside the bladder. 
42 
 
 
{
𝜕
𝜕𝑡
𝛹(𝑥) = −𝛼𝐴(𝑥)𝛻𝛹(𝑥) − 𝛽𝑃(𝑥)|𝛻𝛹(𝑥)| + 𝛾𝜅(𝑥)|𝛻𝛹(𝑥)|
𝛹(𝑥, 𝑛 = 0) = 𝜙0(𝑥)
 (3.5) 
where 𝛼, 𝛽, and 𝛾  are the coefficients for the advection, propagation, and curvature terms, 
respectively, 𝐴(𝑥) is a vector field image (assigning a vector to each voxel in the image) that 
drives the contour to move towards regions of high gradient, 𝑃(𝑥) is a scalar speed term between 
0 and 1 causing the contour to expand at the local rate, and 𝜅(𝑥) = 𝑑𝑖𝑣 (
𝛻𝛹(𝑥)
|𝛻𝛹(𝑥)|
) is the mean 
curvature of the level set at point x. The symbol 𝛻 denotes the gradient operator and 𝑑𝑖𝑣 is the 
divergence operator
28
. 𝜙0(𝑥) is the initial segmentation surface, and 𝑛 is the number of iterations. 
Three 3D level sets with predefined sets of parameters are applied in series to the initial 
segmentation surface. The corresponding parameters of the 3 level sets are presented in Table 3.1. 
Table 3.1: Parameters for the level sets. 
Level set: α β γ n 
First 1 2 1 10 
Second 1 0.6 q 150 
Third 0 1.0 0 10 
2D slices 4.0 0.2 0.5 100 
 
 
The first 3D level set slightly expands and smoothes the initial contour. The second 3D level set 
brings the contour towards the sharp edges, but also expands it slightly in regions of low gradient. 
The parameter “q” in Table 3.1 is defined to be a linear function 𝜎𝑀 + 𝜙 of the 2D diagonal 
distance M of the VOI box in millimeters (mm), where 𝜎 = 0.06, 𝜙 = −0.11  as shown 
previously
28
. The third 3D level set further draws the contour towards sharp edges. As a final 
step, a 2D level set is applied to every slice of the segmented object to refine the 3D contours 
using the 3D level set contours as the initial contour. Further details on the level sets used can be 
found in the literature
28
. An example of the segmented bladder for CTU slice shown in Figure 
3.4 using the DL-CNN bladder likelihood map with level sets (DL-CNN with level sets) is 
shown in Figure 3.9. 
43 
 
 
3.3.4 Bladder likelihood map generation using Haar features and random forest classifier 
 To compare the performance of DL-CNN for bladder likelihood map generation, the 
maps were also generated using Haar features and random forest classifier. Fifty-nine Haar 
features were extracted from the 32 x 32-pixel ROIs used to train the DL-CNN. A large number 
of Haar features can be extracted from a 32 x 32-pixel ROI. Using every possible Haar feature 
would be difficult due to the enormous number of features that would be generated; therefore, we 
considered the representative shapes for the bladder boundaries, and after experimenting on the 
training cases, we selected 59 different Haar features to generate the bladder likelihood maps, 
which are described in Table 3.2. 
Table 3.2: Number of features extracted for different Haar filter sizes and filter types as described by Viola et al.43 and 
Lienhart et al.
43
. 
 
 8 x 8-pixel 
16 x 16-
pixel 
16 x 18-
pixel 
18 x 16-
pixel 
16 x 32-
pixel 
32 x 16-
pixel 
32 x 32-
pixel 
Edge Features 10 8 0 0 2 2 2 
Line Features 10 0 4 4 0 0 2 
Four-Rectangle 
Features* 
9 5 0 0 0 0 1 
*A single filter of this Four-Rectangle feature filter consists of 4 smaller, equal-sized rectangles arranged in a checkerboard 
pattern. 
 
 
 
 
Figure 3.9: Bladder segmentation of the CTU slice shown in Figure 3.4 using the DL-CNN bladder likelihood map with level 
sets. 
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 The extracted features were used to train a random forest classifier that combined the 
features together to generate a score that corresponds to an ROI’s likelihood of being inside the 
bladder. The random forest classifier with 100 trees was trained using the same set of 160,000 
training ROIs as described above for training the DL-CNN. The bladder likelihood map was 
generated by extracting the 59 Haar features values from each ROI. The feature values were 
input into the trained random forest classifier that output the likelihood that the input ROI was 
inside the bladder. The likelihood score for the ROI was assigned to the center pixel of the ROI. 
The collection of likelihood scores over the voxels in the VOI formed the bladder likelihood map. 
The distribution of the Haar-feature-based bladder likelihood scores was different than 
that from the DL-CNN scores, thus a different threshold of 0.56 was chosen experimentally 
using the training cases and used to generate the binary bladder mask for initialization of the 
level sets. After the Haar-feature-based bladder binary mask was generated, the bladder 
segmentation process was identical to that described in Section 3.3.3.  
 
3.3.5 Evaluation Methods 
Segmentation performance was evaluated by comparing the automatic segmentation results 
to the 3D hand-segmented contours. The volume intersection ratio, the volume error, the average 
minimum distance, and the Jaccard index
29
 between the hand-segmented contours and computer-
segmented contours were calculated. The performance metrics are described in Chapter II, 
section 2.3.5. 
 
3.4 Results 
3.4.1 Segmentation performance using DL-CNN bladder likelihood map with level sets 
 The trained DL-CNN obtained a classification error rate of 0.054 for the training set. The 
error rate for the classification of the ROIs was not measured, as the classification of the ROI is 
not the final goal of this study. Examples of the segmentation from cases in the test set are shown 
in Figure 3.10. Figure 3.11 shows the bladder likelihood maps used to generate the bladder 
boundaries in Figure 3.10. The segmentation performance measures averaged over the cases in 
the training and test sets are presented in Table 3.3. 
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(a) (b) 
Figure 3.10: Examples of bladder segmentations using DL-CNN with level sets for two cases in the test set. (a) Malignant 
bladder wall thickening was fully enclosed within the segmentation. (b) The bladder segmentation enclosed the lesion present in 
the bladder; however, the bottom of the contrast-enhanced region was slightly under-segmented. Arrows point to the wall 
thickening and lesion in (a) and (b), respectively. The light blue contour represents segmentation result from DL-CNN with 
level sets. The dark blue contour represents the radiologist’s hand outline. 
 
 
 
(a) (b) 
Figure 3.11: Bladder likelihood maps and the corresponding bladder segmentation for cases shown in Figure 3.10. (a) Refining 
the initial contour generated from the likelihood map by level sets results in accurate bladder segmentation. (b) Regions within 
the non-contrast region of the bladder had low likelihood of being within the bladder. The level sets propagated the initial 
contour to enclose the lesion and the non-contrast region. The light blue contour represents segmentation result from DL-CNN 
with level sets. The dark blue contour represents the radiologist’s hand outline. 
 
Table 3.3: Segmentation evaluation results using DL-CNN-based likelihood map with level sets averaged over the 81 training 
cases and 92 test cases. 
 
 
Volume 
intersection ratio Volume error 
Absolute volume 
error 
Average minimum 
distance Jaccard index 
R3D E3D |E3D| AVDIST JACCARD3D 
Training Set 87.2±6.1% 6.0±9.1% 8.8±6.4% 3.0±1.2 mm 81.9±7.6% 
Test Set  81.9±12.1% 10.2±16.2% 14.0±13.0% 3.6±2.0 mm 76.2±11.8% 
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 The histograms for volume intersection ratio, volume error, average distance, and the 
Jaccard index for both the training set and the test set are shown in Figures 3.12, 3.13, 3.14, and 
3.15, respectively. 
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Figure 3.12: Histogram of the percent volume intersection ratio for the training and test sets. The mean volume intersection 
was 87.2% for the 81 training cases, and 81.9% for the 92 test cases. 
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Figure 3.13: Histogram of the volume error for the training and test sets. The mean volume error was 6.0% for the 81 training 
cases, and 10.2% for the 92 test cases. 
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Of the 81 cases in the training set, 70 bladders (86.4%) had a volume intersection ratio 
greater than 80% (Figure 3.12). There were 79 bladders (97.5%) whose absolute volume error 
for the training set was less than 20% (Figure 3.13). Forty-six bladders (56.8%) in the training 
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Figure 3.14: Histogram of the average distance for the training and test sets. The mean average distance was 3.0 mm for the 81 
training cases, and 3.6 mm for the 92 test cases. 
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Figure 3.15: Histogram of the Jaccard index for the training and test sets. The mean Jaccard index was 81.9% for the 81 training 
cases, and 76.2% for the 92 test cases. 
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set had an average distance less than 3 mm (Figure 3.14), and 50 bladders (61.7%) had Jaccard 
indices of over 80% (Figure 3.15).  
Of the 92 test cases, 61 bladders (66.3%) had a volume intersection ratio greater than 80% 
(Figure 3.12). There were 73 bladders (79.3%) whose absolute volume error for the test set was 
less than 20% (Figure 3.13). Forty-six bladders (50.0%) in the test set had an average distance 
less than 3 mm (Figure 3.14), and 42 bladders (45.7%) had Jaccard indices of over 80% (Figure 
3.15). 
 
3.4.2 Dependence of segmentation performance on input ROI size and DL-CNN pooling 
 Table 3.4 summarizes the segmentation performance on the test cases for the conditions: 
(1) the maximum pooling layers were replaced by average pooling layers while keeping the input 
ROI size at 32 x 32 pixels and other parameters the same as those in Section 3.1, (2) the input 
ROI size was changed to 16 x 16 pixels and 64 x 64 pixels while all other parameters the same as 
those in Section 3.1. The training set results showed similar trends. Figure 3.16 shows examples 
of the bladder likelihood map for 16x16-pixel ROI and the 64x64-pixel ROI for the CTU slice 
shown in Figure 3.4. 
Table 3.4: Segmentation evaluation results for DL-CNN with level sets using average pooling with 32x32-pixel ROI, and 
maximum pooling using 16x16-pixel ROI, and 64x64-pixel ROI averaged over the 92 test cases. Training set results showed 
similar trends. 
 
Volume intersection 
ratio 
Volume error 
Absolute volume 
error 
Average 
minimum 
distance 
Jaccard index 
R3D E3D |E3D| AVDIST JACCARD3D 
Average Pooling 
32x32-pixel ROI 
81.0±12.1% 5.3±21.5% 16.2±14.9% 4.5±2.9 mm 72.1±13.3% 
Maximum Pooling 
16x16-pixel ROI 
79.2±14.2% 11.0±20.1% 17.4±14.8% 4.4±2.5 mm 72.6±14.0% 
Maximum Pooling 
64x64-pizel ROI 
67.1±12.7% 24.9±19.8% 27.9±15.1% 6.4±2.8 mm 62.8±13.1% 
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3.4.3 Variability of reference standards 
Table 3.5 shows the segmentation results using DL-CNN likelihood map with level sets 
compared against the two reference standards, as well as the results comparing the two hand-
outlines with each other.  
  
  
(a) (b) 
Figure 3.16: Bladder likelihood map of the CTU slice shown in Figure 3.4 using different ROI sizes. (a) Likelihood map 
generated using 16x16-pixel ROIs. (b) Likelihood map generated using 64x64-pixel ROIs. 
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Table 3.5: Segmentation evaluation results in a subset of test cases with lesions (41 training cases, 50 test cases) between hand-
segmented reference standards (RS1, RS2) by two different readers and DL-CNN with level sets. Segmentation evaluation of 
RS2 using RS1 as the reference is included to show inter-observer variations. 
 Volume 
intersection 
ratio 
Volume error 
Absolute 
volume error 
Average 
minimum 
distance 
Jaccard index 
R3D E3D |E3D| AVDIST JACCARD3D 
DL-CNN vs 
RS1 
Training Set 85.9±6.6% 6.9±9.6% 9.3±7.1% 3.2±1.3 mm 80.4±8.4% 
Test Set 81.2±11.5% 12.5±13.5% 13.4±12.5% 3.6±1.9 mm 76.4±11.5% 
DL-CNN vs 
RS2 
Training Set 84.3±7.1% 9.7±10.0% 11.4±7.9% 3.4±1.3 mm 79.8±8.2% 
Test Set 78.2±10.9% 17.5±12.0% 17.7±11.6% 4.0±2.1 mm 75.1±11.0% 
RS2 vs RS1 
Training Set 96.2±2.8% -3.0±4.8% 4.2±3.8% 1.4±0.5 mm 90.2±4.8% 
Test Set 95.0±8.1% -6.2±15.3% 10.3±12.8% 1.7±1.0 mm 86.1±9.5% 
 
 
3.4.4 Comparison of segmentation performance using DL-CNN-based and Haar-feature-
based bladder likelihood maps 
 Table 3.6 summarizes the segmentation performance measures using the Haar-feature-
based likelihood map to guide the level sets, averaged over the cases in the training and test sets. 
An example comparing the segmented bladder using the Haar-feature-based likelihood map with 
that using the DL-CNN-based likelihood map is shown in Figure 3.17.  
   
(a) (b) (c) 
Figure 3.17: Comparison of bladder segmentations using DL-CNN-based likelihood map and Haar-feature-based likelihood 
map. (a) DL-CNN-based segmentation (light blue contour) encloses the bladder lesion within the segmentation, while the Haar-
feature-based segmentation (pink contour) does not fully enclose the lesion and leaks into the prostate. The arrow points to the 
lesion. The dark blue contour represents the radiologist’s hand outline. (b) Bladder likelihood map generated using DL-CNN. 
(c) Bladder likelihood map generated using Haar features and random forest classifier. 
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Table 3.6: Segmentation evaluation results using Haar-feature-based likelihood map with level sets averaged over 81 training 
cases and 92 test cases. 
 
Volume 
intersection ratio 
Volume error 
Absolute volume 
error 
Average 
minimum 
distance 
Jaccard index 
R3D E3D |E3D| AVDIST JACCARD3D 
Training Set 76.2±10.4% 15.5±15.0% 18.1±11.6% 5.2±1.7 mm 70.7±10.0% 
Test Set  74.3±12.7% 13.0±22.3% 20.5±15.7% 5.7±2.6 mm 66.7±12.6% 
 
 
 Table 3.7 shows the initial segmentation surface (𝜙0(𝑥)) generated from the DL-CNN-
based and Haar feature-based bladder likelihood maps in comparison to the hand outlines (RS1). 
The results show the segmentation performance without the refinement by the level sets and the 
differences between the DL-CNN-based likelihood maps and the Haar-feature-based likelihood 
maps. We observer better segmentation performance when DL-CNN is used. 
Table 3.7: Segmentation evaluation results using initial contours (no level sets) generated using bladder likelihood maps with 
DL-CNN and Haar Features averaged over the 92 test cases. Training cases showed similar trends. 
 
Volume 
intersection ratio 
Volume error 
Absolute volume 
error 
Average minimum 
distance 
Jaccard index 
R3D E3D |E3D| AVDIST JACCARD3D 
DL-CNN 68.7±12.0% 27.3±13.7% 27.4±13.6% 5.7±2.2 mm 66.2±11.8% 
Haar Features  59.8±12.1% 32.3±18.6% 34.0±15.2% 8.1±2.6 mm 55.6±11.4% 
 
 
3.4.5 Comparison of segmentation performance using DL-CNN bladder likelihood map 
with level sets and CLASS with LCR 
Segmentation results of several test cases for both CLASS with LCR and DL-CNN with 
level sets are shown in Figure 3.18. The segmentation performance measures for CLASS with 
LCR method are shown in Table 3.8. These results should be compared to those in Table 3.3 
that were obtained with the DL-CNN with level sets method for the same training and test sets 
and the reference standards. 
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(a) (b) 
   
(c) (d) 
Figure 3.18: Comparison of bladder segmentation using DL-CNN with level sets and CLASS with LCR. The pink contour 
represents segmentation using CLASS with LCR. The dark blue contour represents the radiologist’s hand outline. (a) DL-CNN 
slightly under-segments the upper region of the non-contrast region, but encloses more of the large, malignant lesion and does 
not leak towards the bones. (b) The two segmentation methods perform similarly, but DL-CNN with level sets encloses the 
lesion, whereas CLASS does not. (c) DL-CNN with level sets does not leak into the surrounding organs in the non-contrast 
region, unlike CLASS. (d) CLASS performs better than DL-CNN with level sets in the non-contrast enhanced region. Both 
methods over-segment the contrast-enhanced region. The light blue contour represents segmentation using DL-CNN with level 
sets. 
 
Table 3.8: CLASS with LCR segmentation evaluation results averaged over the 81 training cases and 92 test cases. 
 
Volume 
intersection ratio 
Volume error 
Absolute volume 
error 
Average minimum 
distance 
Jaccard index 
R3D E3D |E3D| AVDIST JACCARD3D 
Training Set 84.2±11.4% 8.2±17.4% 13.0±14.1% 3.5±1.9 mm 78.8±11.6% 
Test Set  78.0±14.7% 16.5±16.8% 18.2±15.0% 3.8±2.3 mm 73.9±13.5% 
 
 
3.5. Discussion 
 In this study, a new segmentation method that combines a likelihood map generated by 
DL-CNN with cascading level sets was developed and applied to a data set containing bladders 
in CTUs having a wide range of image quality. Most of the bladders were partially filled with 
excreted contrast material; however, some bladders were entirely filled with excreted contrast 
material and others did not contain any contrast-enhanced urine due to variation in timing for 
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image acquisition. The presence of the two distinct areas that have very different attenuation 
values: an area filled with contrast material and an area without contrast material, poses a 
challenge for segmentation that needs to go across the strong boundary between the two areas. 
To alleviate this problem, we previously required two manually input VOIs: one for the non-
contrast region and the other for the contrast-enhanced region using our CLASS segmentation 
method
1, 27
 and an LCR method was needed to refine and connect the two contours. However, 
by combining the DL-CNN bladder likelihood maps with the level set methods, we no longer 
needed the separate input user inputs for the two different regions. A major contribution of this 
work is that it demonstrates the DL-CNN can overcome the strong boundary between two 
regions that have large difference in gray levels and provides a seamless mask to guide level set 
segmentation. This has been a problem for many gradient-based segmentation methods. As a 
result, this new method requires only one user input bounding box for the entire bladder to start 
the segmentation procedure compared to the two user input bounding boxes for the previous 
method. 
Compared to our CLASS with LCR method using the same data set, segmentation 
using DL-CNN performed better. All performance measures were improved using DL-CNN 
with level sets (Table 3.3) compared to CLASS with LCR (Table 3.8) for both the training and 
test sets. The differences in the volume intersection ratio, absolute volume error, average 
minimum distance, and the Jaccard index for the training set were statistically significant, with 
p-values of 0.01, 0.007, 0.01, and 0.002, respectively, by two-tailed paired t-test at an alpha 
level of 0.01 after the Bonferroni correction for the 5 comparisons. For the test set, the 
differences in the volume intersection ratio, volume error, and the absolute volume error were 
statistically significant with p-values of 0.004, 0.001, and 0.005 by two-tailed paired t-test at 
the alpha level of 0.01. For the training set, the percentages of cases obtaining improvements in 
the 5 performance measures ranged from 54% to 64%. For the test set, the improvements 
ranged from 54% to 67%. More importantly, DL-CNN with level sets better included lesions 
within its segmented region; 50 out of 59 (84.7%) lesions in the training set, and 64 out of 78 
(82.1%) lesions in the test set were included better than or similar to the bladder segmented 
with CLASS with LCR. These improvements were obtained while reducing the number of user 
inputs (one box vs. two boxes). 
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DL-CNN with level sets generally enclosed more of the lesions within the segmented 
regions compared to CLASS with LCR (Figure 3.18(a, b)), which is important because further 
steps of the CAD system for lesion detection and characterization will be performed within the 
segmented bladder. The non-contrast enhanced region was segmented more accurately, 
without leaking into the adjacent organs using the DL-CNN (Figure 3.18(a, c)). However, 
there were cases that performed worse than our previous method (Figure 3.18(d)). These were 
caused by either the network giving low likelihood scores for portions of the bladder, causing 
under-segmentation, or the network giving relatively high likelihood scores for other organs, 
such as the bone, causing over-segmentation. Organs that were given relatively high bladder 
likelihood scores, such as the femoral heads, can be seen in the regions outside the VOI in 
Figure 3.7. 
For a few test set cases, DL-CNN with level sets performed well below the average 
performance of the test data set. Some of these cases had poor image quality due to noise caused 
by the large patient size or the presence of hip prosthesis. Other large segmentation mistakes 
were due to the patient having advanced bladder cancer spreading into the neighboring organs 
and causing the segmentation to leak into those areas. In the future, we will improve our method 
to reduce the errors caused by these types of cases. 
When average pooling was used instead of maximum pooling in the network structure, 
the segmentation performance measures deteriorated in general. The differences between the 
two methods were statistically significant for the volume error, average minimum distance, 
and the Jaccard index for the test set. 
The graphics processing units (GPUs) used for DL-CNN are designed such that they 
perform efficiently when the inputs are multiples of 16. Therefore, we studied 16x16, 32x32, 
and 64x64-pixel ROI sizes as input to the network. Using the 16x16-pixel ROIs as input to the 
network resulted in bladder likelihood maps with finer details, such as lesion boundaries and 
the boundary between the non-contrast and the contrast-enhanced regions of the bladder. 
However, these maps did not lead to better segmentation than the likelihood maps obtained 
from 32x32-pixel ROIs likely due to the fine details hindering the generation of the initial 
contour for the entire bladder. On the other hand, the bladder likelihood maps obtained from 
64x64-pixel ROIs contained fewer details from the structures surrounding the bladder. 
However, the shapes of the bladder might have lost too much details compared to those in the 
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likelihood maps generated using 32x32-pixel ROIs. It also had the tendency of misclassifying 
large lesions as outside of the bladder. As shown in Table 3.4, both the smaller 16x16-pixel 
ROI and the larger 64x64-pixel ROI were inferior to the 32x32-pixel ROI for generating the 
bladder likelihood maps to guide bladder segmentation. 
The bladder segmentation using DL-CNN with level sets performed comparably 
regardless of which of the two hand outlines was used as the reference standard. The agreement 
between the computer and the hand outlines are slightly lower than the agreement between the 
two observers (approximately 10% for the volume intersection ratio and the Jaccard index), but 
the computer segmentation in this range of accuracy is acceptable and still useful for defining 
the search region for bladder lesion detection, as shown in our previous work on bladder lesion 
detection
3
. 
Comparing Table 3.3 and Table 3.6, it is seen that the bladder likelihood maps obtained 
from the Haar features and the random forest classifier were not as effective as those from the 
DL-CNN, resulting in lower bladder segmentation performance. The differences in all 
performance measures but the volume error for the test set were statistically significant.  
The comparison of the initial segmentation surfaces generated from the bladder 
likelihood maps with the reference standards show that the DL-CNN-based maps are closer to 
the hand outlines than the Haar-feature-based maps (Table 3.7). The result also shows that 
segmentation using the DL-CNN alone cannot reach the high performance level achieved by 
DL-CNN with refinement by level sets. The DL-CNN bladder likelihood maps are generally 
under-segmenting the bladder, often catching the edge of the inner bladder wall for cases with 
circumferential bladder wall thickening while lowering the threshold for the DL-CNN bladder 
likelihood map would lead to leaking. Applying the level sets to the slightly under-segmented 
contours allows better control of the balance between under- and over-segmentation.  
We chose the network structure size and level sets parameters by experimentation where 
each parameter was varied over a reasonable range, and the best parameter within the studied 
range was chosen based on the evaluation of the training set results. Our sensitivity analysis of 
the level sets can be found in the literature
28
. We have performed a sensitivity analysis of the 
network structure size. The number of kernels within the first two convolution layers was varied 
between 32, 64, and 96. The network was trained on the training set, and the bladders were 
segmented using DL-CNN likelihood maps with level sets. The change in the volume 
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intersection ratio was in the range of 0.5-1.9%, absolute volume error 0.2-9.3%, average 
minimum distance 0.6-10.1%, and the Jaccard index 0.1-2.2%. These results demonstrate that 
our DL-CNN based segmentation system is robust within a reasonable range of parameters.  
A limitation to the new method is the long training time for the DL-CNN. The DL-
CNN requires training, which takes approximately 5.5 hours for 160,000 ROIs and 1500 
iterations. However, the processes involving the DL-CNN have not been optimized, and a 
slower GPU was used for compatibility reasons for this study. Optimizing the process and 
using faster hardware will reduce the runtime for training the DL-CNN. Once the DL-CNN has 
been trained, it takes approximately 4 minutes to generate the bladder likelihood maps within 
the VOI of a case. It takes 2 – 5 minutes to mark the VOI and run the level set segmentation, 
depending on the bladder size. On the other hand, CLASS with LCR takes approximately 4 – 
10 minutes per case to mark the VOI and run the segmentation. Therefore, for an unknown 
case, it may require up to 10 minutes for DL-CNN with level sets, which is comparable to the 
CLASS with LCR method. 
It is difficult to perform direct comparison of segmentation performance to the previous 
methods used by other investigators, as summarized in the Introduction due to the differences in 
the data sets and in their degrees of difficulty. A rough comparison can be made to only one of 
the studies
24
 that reported quantitative results. Chai et al.
24
 achieved Jaccard indices of 70.5% 
and 77.7% for their automatic and semi-automatic methods, respectively, using 95 scans of 8 
patients for training, and 233 scans of 22 patients for testing. Our segmentation method using 
DL-CNN achieved higher accuracy than the automatic method from Chai et al.
24
, and achieved 
comparable results to their semi-automatic method, while using a larger independent test set.  
 
3.6 Conclusion 
Our results show that the proposed segmentation method using DL-CNN can accurately 
segment the bladders on CTU scans. While only using a single bounding box for the entire 
bladder as the input to the system, the new method performed comparably to or better than our 
previous CLASS with LCR method for all performance measures that required two bounding 
boxes as input. However, the cost of this improvement is the increased runtime for training the 
DL-CNN. Once the DL-CNN is trained and implemented as a part of the segmentation package, 
the runtime for an unknown case becomes comparable. The agreement of the segmentations 
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between DL-CNN and the two hand outlines were comparable, but the agreement was lower 
than the agreement between the two hand outlines. We observed that DL-CNN can differentiate 
the inside and outside of the bladder regions better than the Haar features with random forest 
classifier, resulting in a more accurate bladder likelihood map and segmentation after refinement 
by level sets. Further work is underway to optimize the segmentation process and to improve the 
segmentation accuracy. It is especially important to include bladder lesions inside the segmented 
bladder boundaries. This study is a step toward the development of a reliable system for 
segmentation of bladders, which is a critical component of a CAD system for detection of 
urothelial lesions imaged with CT urography. 
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Chapter IV 
Detection of Urinary Bladder Mass in CT Urography (CTU) with SPAN
 
4.1 Abstract 
In this chapter, we focused on developing a system for detecting masses fully or partially 
within the contrast-enhanced (C) region of the bladder. With IRB approval, a data set of 70 
patients with 98 biopsy-proven bladder lesions fully or partially immersed within the contrast-
enhanced region (C region) of the bladder was collected for this study: 35 patients for the 
training set (38 malignant, 7 benign lesions), and 35 patients for the test set (49 malignant, 4 
benign lesions). The bladder in the CTU images was automatically segmented using our 
Conjoint Level set Analysis and Segmentation System (CLASS) that we developed specifically 
to segment the bladder. A closed contour of the C region of the bladder was generated by 
maximum intensity projection using the property that the dependently layering contrast 
material in the bladder will be filled consistently to the same level along all CTU slices due to 
gravity.  Potential lesion candidates within the C region contour were found using our 
Straightened Periphery ANalysis (SPAN) method. SPAN transforms a bladder wall to a 
straightened thickness profile, marks suspicious pixels on the profile, and clusters them into 
regions of interest to identify potential lesion candidates. The candidate regions were 
automatically segmented using our Auto-Initialized Cascaded Level Set (AI-CALS) 
segmentation method. Twenty-three morphological features were automatically extracted from 
the segmented lesions. The training set was used to determine the best subset of these features 
using simplex optimization with the leave-one-out case method. A linear discriminant classifier 
(LDA) was designed for the classification of bladder lesions and false positives. The detection 
performance was evaluated on the independent test set by free-response receiver operating 
characteristic (FROC) analysis. At the prescreening step, our system achieved 84.4% sensitivity 
with an average of 4.3 false positives per case (FPs/case) for the training set, and 84.9% 
sensitivity with 5.4 FPs/case for the test set. After LDA classification with the selected features, 
the FP rate improved to 2.5 FPs/case for the training set, and 4.3 FPs/case for the test set without 
59 
 
missing additional true lesions.  By varying the threshold for the LDA scores, at 2.5 FPs/case, the 
sensitivities were 84.4% and 81.1% for the training and test sets, respectively. At 1.7 FPs/case, 
the sensitivities decreased to 77.8% and 75.5%, respectively. The results demonstrate the 
feasibility of our method for detection of bladder lesions fully or partially immersed in the 
contrast-enhanced region of CTU. The results presented in this chapter have been published
3
, 
before the methods for bladder segmentation presented in Chapter III were published. 
 
4.2 Introduction 
Interpretation of a CTU study requires thorough image analysis, often requiring extensive 
time. The radiologist interpreting the study must visually determine the presence of lesions 
within the urinary tracts on a display workstation, frequently adjusting the brightness, contrast, 
and zoom levels. The radiologist must pay close attention throughout the entire urinary tract, as 
multiple lesions may be present. In addition, many different urinary anomalies may be found in a 
single CTU study. Not only do the radiologists have to identify these anomalies, they must also 
determine their likelihood each of these of being a urothelial neoplasm. The challenges of 
interpreting a CTU leads to a substantial variability among radiologists in detection of bladder 
cancer, with reported sensitivities ranging from 59% to 92%
18, 19
. The chance that the radiologist 
misses a subtle lesion may not be negligible due to overall workload, and the need to maintain 
rapid case throughput. Thus, any technique that helps radiologists identify urothelial neoplasms 
will be useful. Computer-aided detection (CAD), used as an adjunct, may reduce the chance of 
oversight by the radiologists. We are developing a CAD system that detects bladder cancer in 
CTU to be used for such purposes. 
Few investigators have worked on CAD for bladder cancer to-date. Duan et al.
22
 used an 
adaptive window setting to segment bladder tumor surfaces for magnetic resonance (MR) 
cystography. They generated multiple windows that covered the inner wall of the bladder and 
from which features were extracted. Using quadratic discriminant analysis, they determined if a 
window contained a true positive or false positive in a data set of 10 patients. Jaume et al.
46
 
detected bladder tumors in abdominal CT images by estimating the bladder wall thickness using 
inner and outer bladder surface meshes generated using the Marching Cubes algorithm. They 
separated each of the 26 bladders in their data set into 6 regions and created an atlas to 
distinguish between normal and diseased regions. Hadjiiski et al.
25
 performed a pilot study in 
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detecting lesions within the contrast-enhanced region of the bladder in 15 patients in CTU. They 
used a rule-based system based on shape measures and uniformity measures to identify lesion 
candidates. 
Automatic detection of bladder lesions in CTU is challenging. The imaged bladders, 
along with their lesions, can assume a variety of shapes and sizes. Bladders may also be 
partially or fully filled and may or may not contain excreted intravenous (IV) contrast material, 
resulting in variations in the degree of bladder opacification. The lesions in the bladder region 
that is filled with contrast material have much different contrast relative to those in the bladder 
region not filled with contrast material. This requires different strategies for the detection of 
lesions in the contrast enhanced (C) and non-contrast enhanced (NC) regions of the bladder. 
In this study, we focused on developing a system for detection of bladder lesions fully or 
partially immersed in the C region of the bladder. We designed the system and evaluated its 
performance using free-response receiver operating characteristic (FROC) analysis using a data 
set of 70 cases.  Although the data set was still small, to our knowledge it was the largest data set 
compared to those used in other reported studies.  
 
4.3 Materials and Methods 
The bladder as seen on the CTU images was automatically segmented within a manually 
marked bounding box, then as part of the prescreening step, the C region was delineated from the 
segmented bladders. The bladder wall of the C region was transformed into a wall thickness 
profile that was analyzed to determine lesion candidates. These candidates were automatically 
segmented, and morphological features were extracted. The best subset of these features was 
determined and a linear discriminant classifier was designed with a training set for classification 
of the bladder lesions and false positives. The block diagram of the detection system is presented 
in Figure 4.1. The detection performance was evaluated in an independent test set by FROC 
analysis.  
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Figure 4.1: Block diagram of the detection system.  
 
4.3.1 Data set 
With approval of the Institutional Review Board, a data set of 70 patients undergoing CTU 
who subsequently underwent cystoscopy and biopsy was collected retrospectively from the 
Department of Radiology at the University of Michigan. The CTU scans were acquired with GE 
Healthcare LightSpeed MDCT scanners at a slice interval of 1.25 mm or 0.625 mm using 120 
kVp and 160-560 mAs, and reconstructed with filtered back projection using the standard 
reconstruction kernel. The excretory phase images used were obtained 12 minutes after the 
initiation of intravenous injection of 125-175 mL of iodinated contrast material (at a 
concentration of 300 mg iodine per ml).  Since patients were not moved prior to image 
acquisition, dependently layering IV contrast material that had been excreted into the renal 
collecting systems partially or fully filled the bladder on the excretory phase CTU images.  
All lesions were marked by experienced radiologists on the CTU volumes as reference 
standard. Two radiologists (26 years of experience, 16 years of experience) marked the lesion by 
placing an ROI over the lesion, indicating the starting and ending slice of the lesion, measuring 
the longest diameter of the lesion, and giving a subtlety rating. Consensus was obtained if the 
lesion locations were different, and the final radiologist impression was correlated with radiology 
and pathology reports. The size and subtlety of the lesions given by the single, more experienced 
radiologist were reported to illustrate the detection performance of the system for lesions of 
different degrees of difficulty as seen by an experienced radiologist. 
A total of 98 biopsy-proven bladder lesions was identified in the fully or partially contrast-
enhanced region of the bladder. The cases were split evenly into independent training and test 
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sets. The training set contained 35 subjects having 38 malignant and 7 benign lesions with an 
average size of 20.1 mm (range: 4.2–61.7 mm), measured as the longest diameter on an axial 
slice (Figure 4.2(a)). The test set contained 35 subjects having 49 malignant and 4 benign lesions 
with an average size of 18.8 mm (range: 1.4–61.1 mm) (Figure 4.2(a)). The average lesion 
subtlety ratings in both sets were 2.2 (scale 1 to 5, 5 very subtle) (Figure 4.2(b)). 
 
For image processing purposes, all CT voxel values in terms of Hounsfield Units (HU) are 
linearly shifted into gray level, where gray level = HU + 1024 so that all image voxel values are 
positive. 
 
4.3.2 Bladder segmentation using CLASS 
A critical component of CAD system that detects bladder cancer is accurate bladder 
segmentation that isolates the bladder from the surrounding anatomical structures. An axial CTU 
scan of the bladder is shown in Figure 4.3. The bladder shown is partially filled with IV 
contrast material and a malignant lesion can be identified in the posterior, contrast-enhanced 
portion of the bladder. The presence of the two distinct regions in the bladder lumen that have 
very different attenuation values: a region filled with IV contrast material and a region without 
contrast material, poses a challenge for segmentation algorithm that needs to go across the 
strong boundary.  
  
(a) (b) 
Figure 4.2: Histograms of lesion size (a) and lesion subtlety (b) for lesions in the training and test set. The average lesion size 
was 20.1 mm (range: 4.2–61.7 mm) for the training set, and 18.8 mm (range: 1.4–61.1 mm) for the test set.  The average lesion 
subtlety ratings in both sets were 2.2 (scale 1 to 5, 5 very subtle). 
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Figure 4.3: An axial slice of a CTU scan in which the bladder is partially filled with IV contrast material. A malignant lesion is 
present in the contrast-enhanced region of the bladder, indicated by the bold arrow. 
 
We have applied our methods described in Chapter II, called Conjoint Level set 
Analysis and Segmentation System (CLASS)
1, 11
 in order to segment the bladder in CTU. An 
example of a bladder and its segmentation is shown in Figures 4.4(a) and 4.4(b), respectively. 
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Figure 4.4: Bladder lesion candidate prescreening and segmentation – example of true positive. (a) ROI of the CTU slice that 
includes the lesion. (b) Bladder segmentation of the slice encompassing the bladder wall. (c) Maximum Intensity Projection (MIP) 
of the bladder used to determine the boundary between the contrast-enhanced and non-contrast regions. (d) Segmentation of the 
contrast-enhanced region of the bladder (L contour). The horizontal line on top of the contour is the boundary between the NC 
and C regions of the bladder, B1. The arrow on the left side of the bladder indicates the starting point for the wall thickness 
profile. The arrow on the right points to a true lesion. (e) Magnified C region image after adaptive thresholding. (f) Bladder wall 
profile. The pixels marked in green were removed during the false positive reduction of voxel candidate. The left section of the 
profile was removed using location-based rules as described in section 2.3.3. (g) Bladder wall profile used for candidate detection. 
The line is the threshold used to determine lesion candidates. The arrow points to a lesion candidate that is mapped onto the 
bladder in (h). (i) Magnified image of the region around the lesion candidate. The windowing of the image was adjusted to better 
visualize the bladder wall. (j) Lesion candidate segmentation. The segmentation refines the initial region (in pink), resulting in a 
better representation of the lesion. 
 
4.3.3 Bladder wall profile generation and lesion candidate identification with SPAN 
 Bladder lesion candidates are identified by first isolating the contrast-enhanced region of 
the bladder, and then by using our newly developed method, referred to as Straightened 
Periphery ANalysis (SPAN). SPAN consists of three stages: (1) wall thickness profile generation, 
(2) false positive reduction of voxel candidate, and (3) lesion candidate identification. 
 
4.3.3.1 Isolating the contrast-enhanced region of the bladder 
 The contrast-enhanced region of the bladder is separated from the non-contrast region 
using the property that the dependently layering excreted contrast material in the bladder will 
be filled to the same level consistently along all CTU slices due to gravity. We use maximum 
intensity projection (MIP) along the slices of the bladder to estimate the upper boundary of the 
contrast enhanced region. The ROIs initializing the segmentation of the C and NC regions of 
the bladder are used to determine the range of the CTU slices for the MIP. As the bladder is 
located anterior to the larger pelvic bones when the patient lies in a supine position, it is 
common for the bones intrude into the bladder’s ROI towards the bladder neck. If the high 
attenuation bones show up on the MIP image, their interference makes it difficult to accurately 
determine the upper level of the contrast material. Therefore, only a portion of the slices 
included in the ROI is used. We experimentally determined that 30% of the slices towards 
caudal aspect of the bladder (towards the patient’s feet) from the best slice (to avoid the pelvic 
bones) and 90% of the slices towards the cephalic aspect of the bladder (towards the patient’s 
head) from the best slice (to avoid other organs above the bladder) worked the best. The best 
slice is the slice that best represents the bladder region, e.g., where the bladder to be the largest. 
It was selected manually when the ROIs were defined. An MIP image is shown in Figure 4.4(c). 
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 From the MIP image, a gray level profile is generated as described below. The two ROI 
boxes marked for the NC and C region segmentations are combined to create a rectangular box 
such that the width of the box is the width of intersection of the NC and C boxes and the height 
is the union of the heights of the NC and C boxes. Then the box’s width is reduced by 50% while 
keeping the same center (Figure 4.5(a)) to minimize the negative effects of the peripheries of the 
irregularly shaped bladders on the estimation of the transition point between the contrast and 
non-contrast regions. For every row of the box, the gray levels of the pixels belonging to the row 
are averaged and recorded into a profile (Figure 4.5(b)). The profile is analyzed to find the first 
row R1 whose average gray level is greater than a gray level threshold Thp. By using the training 
data set the Thp was determined experimentally as 1330, which provided adequate separation of 
the NC and C regions for the training cases. A horizontal line B1 at row R1 that intersects with 
the bladder boundary is determined as the boundary between the NC and C regions of the 
bladder (Figure 4.4(d)).  The portion of the C region of the bladder contour and the B1 boundary 
then form a new closed contour, referred to as the L contour, that encloses the C region (Figure 
4.4(d)). The image pixels that are within the L contour, i.e., the C region of the bladder, are 
analyzed in the subsequent steps. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
Figure 4.5: Estimation of boundary (row R1) between the NC and C regions. (a) The box used to calculate the average bladder 
GL profile shown in (b). The arrow points to the row that the y-coordinate was determined to be that of R1. (b) Profile of the 
average GL values for each row of the box in (a). The arrow indicates the average GL of the first row that has value above the 
1330 threshold and therefore identified as R1. 
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 4.3.3.2 Wall thickness profile generation with SPAN 
 Generating the bladder wall thickness profile using the previously obtained C region 
image and L contour involves two steps: (1) adaptive thresholding of the contrast material, and 
(2) transformation of the L contour to a straightened wall profile. 
 Adaptive thresholding. The contrast material within the C region is removed by adaptive 
thresholding. Using a constant threshold for the contrast material may result in missing lesions 
that have relatively high gray levels in some cases, and may also lead to portions of the contrast 
material not being eliminated that may become false positives in other cases. Using adaptive 
thresholding method resolves these potential issues. 
 For each slice within the C region, the mean and the standard deviation of the pixel gray 
levels are calculated. For pixels whose gray level was greater than 1800, their gray level was set 
to 1800 for calculating the average. The average gray level, GLAvg, is stratified into four different 
groups that are used to determine the initial threshold, Thinit, using the following decision rules, 
which were determined using the training set:  
 
𝑇ℎ𝑖𝑛𝑖𝑡 =
{
 
 
 
 
𝑇ℎ𝐼
𝐻      𝐺𝐿𝐴𝑣𝑔 ≥ 𝑇ℎ𝐼
𝐻
𝑇ℎ𝐼
𝑀𝐻      𝑇ℎ𝐼
𝑀𝐻 ≤ 𝐺𝐿𝐴𝑣𝑔 < 𝑇ℎ𝐼
𝐻
𝑇ℎ𝐼
𝑀𝐿      𝑇ℎ𝐼
𝑀𝐿 ≤ 𝐺𝐿𝐴𝑣𝑔 < 𝑇ℎ𝐼
𝑀𝐻
𝑇ℎ𝐼
𝐿      𝐺𝐿𝐴𝑣𝑔 < 𝑇ℎ𝐼
𝑀𝐿
 (4.1) 
where 𝑇ℎ𝐼
𝐻 , 𝑇ℎ𝐼
𝑀𝐻, 𝑇ℎ𝐼
𝑀𝐿, and 𝑇ℎ𝐼
𝐿 are the high, medium high, medium low, and low gray level 
thresholds, respectively. The thresholds were determined after analyzing the histogram of pixel 
gray levels within the C region using the training set. The histograms of pixel gray levels within 
the C region for both the training and test sets are shown in Figure 4.6. Assuming a Gaussian 
mixture distribution, multiple Gaussians were fit to the histogram for the training set (Figure 
4.6(a)), and the peaks of the Gaussians, (𝑇ℎ𝐼
𝑀𝐻, 𝑇ℎ𝐼
𝐿) along with intersections of the Gaussians 
that corresponded to a sharp drop in the histogram (𝑇ℎ𝐼
𝐻, 𝑇ℎ𝐼
𝑀𝐿) were used as the thresholds 
after adjusting for outlier cases (Table 4.1). The peak of the Gaussian whose gray level was 
above 1330 was not used as a threshold, as our analysis during the isolation of the C region 
showed that these pixels are generally part of the contrast material and not the bladder wall. For 
slices with high GLAvg, 𝑇ℎ𝑖𝑛𝑖𝑡  is set to be 𝑇ℎ𝐼
𝐻 to ensure most of the contrast material is removed 
after thresholding. For slices with average contrast enhancement between 𝑇ℎ𝐼
𝐻  and 𝑇ℎ𝐼
𝑀𝐻 , 
setting 𝑇ℎ𝑖𝑛𝑖𝑡 to be 𝑇ℎ𝐼
𝑀𝐻  will remove the majority of the contrast material in the slice (Table 
4.1 and Figure 4.6).  𝑇ℎ𝑖𝑛𝑖𝑡 is set to be 𝑇ℎ𝐼
𝑀𝐿 for slices with GLAvg within the range of 𝑇ℎ𝐼
𝑀𝐻  to 
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𝑇ℎ𝐼
𝑀𝐿, which are usually near the end of the bladder. The amount of contrast material in these 
slices is generally less than the amount in slices near the center of the bladder, resulting in lower 
intensity of the contrast region. The slices whose GLAvg is less than 𝑇ℎ𝐼
𝑀𝐿 typically are those 
with C regions that were not well-enhanced by the contrast material. These slices require a 
smaller gray level threshold or the contrast material would not be removed, thus their 𝑇ℎ𝑖𝑛𝑖𝑡  is 
set to be 𝑇ℎ𝐼
𝐿.   
 
Table 4.1: Parameter values for adaptive thresholding in wall thickness profile generation. 
𝑇ℎ𝐼
𝐻 𝑇ℎ𝐼
𝑀𝐻 𝑇ℎ𝐼
𝑀𝐿 𝑇ℎ𝐼
𝐿 ε λ τ 𝑇ℎ𝐺𝐿
𝐻  𝑇ℎ𝐺𝐿
𝐿  
1400 1300 1200 1150 15 -60 20 100 80 
 
 
 The gray level threshold for the contrast material, ThC, is then refined adaptively by both 
Thinit and the standard deviation of the pixel gray levels, GLStDev, within the C region as follows: 
 
𝑇ℎ𝐶 =
{
 
 𝑇ℎ𝑖𝑛𝑖𝑡 −
𝐺𝐿𝑆𝑡𝐷𝑒𝑣
𝜀
𝐺𝐿𝑆𝑡𝐷𝑒𝑣 ≥ 𝑇ℎ𝐺𝐿
𝐻
𝑇ℎ𝑖𝑛𝑖𝑡 − 𝜆 𝑇ℎ𝐺𝐿
𝐿 ≤ 𝐺𝐿𝑆𝑡𝐷𝑒𝑣 < 𝑇ℎ𝐺𝐿
𝐻
𝑇ℎ𝑖𝑛𝑖𝑡 + 𝜏 𝐺𝐿𝑆𝑡𝐷𝑒𝑣 < 𝑇ℎ𝐺𝐿
𝐿
 (4.2) 
where ε, λ, and τ are constants, and 𝑇ℎ𝐺𝐿
𝐻 , and 𝑇ℎ𝐺𝐿
𝐿  are the high and low thresholds for GLStDev, 
respectively. Using the training set, the constants were determined experimentally, while the 
thresholds were determined by analyzing the histogram of the GLStDev. The histogram of GLStDev 
 
 
 
 
 
(a) (b) 
Figure 4.6: Histogram of gray level values of pixels within the C region of the (a) training set and (b) test set. The multiple 
Gaussians that were fitted to the training set to determine threshold values are shown with dotted lines in (a). 
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for both the training and test set are shown in Figure 4.7. After fitting two Gaussians to the 
histogram of the training set 𝐺𝐿𝑆𝑡𝐷𝑒𝑣 (Figure 4.7(a)), the peak of one of the Gaussians, 𝑇ℎ𝐺𝐿
𝐿 , 
and the intersection of the Gaussians corresponding to a sharp drop, 𝑇ℎ𝐺𝐿
𝐻 , on the histogram 
were used as the thresholds, leading to three different categories. For slices with GLStDev greater 
than 𝑇ℎ𝐺𝐿
𝐻 , the C region is usually very inhomogeneous and requires a lower threshold to ensure 
most of the contrast material is removed. For slices with GLStDev values in the range of 𝑇ℎ𝐺𝐿
𝐿  to 
ℎ𝐺𝐿
𝐻 , they generally also contain pixels with high gray levels so that the Thinit is also lowered to 
ensure that sufficient contrast material is removed for the subsequent stages. Slices with GLStDev 
values lower than 𝑇ℎ𝐺𝐿
𝐿   usually contain fairly homogenous C region. The dependent layering of 
the contrast material on these slices is not as prevalent as other slices with higher GLStDev, thus 
their gray level are lower. These cases need a higher threshold to ensure that lesions are not 
removed along with the contrast material. The values of the chosen constants and thresholds are 
shown in Table 4.1. 
 
 Once 𝑇ℎ𝐶 is determined, the contrast material is eliminated from within the C region by 
setting the gray level to 0 for all pixels whose gray level is greater than 𝑇ℎ𝐶. Examples of C 
region images after adaptive thresholding are shown in Figures 4.4(e), 4.8(b), and 4.9(b). 
 
. 
 
 
 
 
 
 
 
(a) (b) 
Figure 4.7: Histogram of standard deviation values of pixel gray level within the C region of a CTU slice, GLStDev for the (a) 
training set and (b) test set.  The multiple Gaussians that were fitted to the training set to determine threshold values are 
shown with dotted lines in (a). 
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Comparison of the C region with and without the adaptive thresholding for cases in the three 
different GLStDev categories is shown in Figure 4.10. Notice that without the adaptive 
thresholding (Figure 4.10(d-f)), much of the contrast material remains within the C region image, 
which would lead to incorrect wall thickness profiles and thus missing lesion candidates and 
false positive detections. With adaptive thresholding, well-defined bladder wall can be obtained 
(Figure 4.10(g-i)). 
 Wall profile generation. Once the contrast material is removed from the slice, a 
straightened profile of wall thickness is generated by mapping all of the points along the L 
contour, Li, i=1, …, n, sequentially to the X-axis of a new coordinate system such that Li(xi ,yi) 
has the coordinate  (Xi,0). The origin of this new coordinate system is defined at the top left of 
the profile, with Y-values increasing in the downward direction. For a given pixel Li(xi ,yi), the 
path normal to the point towards the interior of the L contour is calculated using the normal 
angle 𝜃 defined as: 
 
𝜃 = 90˚ +
1
2
(tan−1 (
𝑦𝑖 − 𝑦𝑖−1
𝑥𝑖 − 𝑥𝑖−1
) + tan−1 (
𝑦𝑖+1 − 𝑦𝑖
𝑥𝑖+1 − 𝑥𝑖
)), (4.3) 
where (xi+1,yi+1) and (xi-1,yi-1), respectively, are the coordinates of the next Li+1  and previous Li-1  
neighboring points of Li,. The pixels along the normal path are sequentially mapped onto the 
profile at increasing Y-values such that the new coordinates of the pixels are given by (Xi,Yj)  
j=1,…im, while Xi is fixed.  The path along the normal ends when four black pixels are 
encountered consecutively, indicating that the path reaches the lumen of the C-region where the 
pixel gray level has been set to 0. The number of pixels along the normal path at Li is denoted by 
im.  Figures 4.4(f), 4.8(c), and 4.9(c) show examples of the transformation. Pixels that will be 
removed by the following false reduction step are also marked on the figures. 
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Figure 4.8: Bladder lesion candidate prescreening and segmentation at a slice near the end of the bladder – example of false 
positives. (a) Segmentation of the C region of the bladder (L contour). (b) C region image after adaptive thresholding. (c) Bladder 
wall profile. The pixels marked in green were removed during the false positive reduction of voxel candidate. (d) Bladder wall 
profile used for candidate detection. The line is the threshold used to determine lesion candidates. The arrows point to lesion 
candidates. (e) Lesion candidates projected onto the bladder. Arrows point to lesion candidates. (f,g) Magnified image of the 
region around the lesion candidate. (h,i) Lesion candidate segmentation. Two single pixel lesion candidates shown in (e) and (g) 
were discarded during the lesion candidate determining stage using the size criteria. The two remaining candidates were both 
false positive lesions and were removed by the LDA classifier. 
 
(c) 
(a) (d) 
(e) 
(f) (g) 
(h) (i) 
(b) 
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Figure 4.9: Bladder lesion candidate prescreening and segmentation for a lesion along B1 – example of true positive. (a) 
Segmentation of the C region of the bladder (L contour). (b) C region image after adaptive thresholding. (c) Bladder wall profile. 
The pixels marked in green were removed during the false positive reduction of voxel candidate. (d) Bladder wall profile used for 
candidate detection. The line is the threshold used to determine lesion candidates. The arrows point to lesion candidates. (e) 
Lesion candidates projected onto the bladder. Arrows point to lesion candidates. (f) Magnified image of the region around the 
lesion candidate. The windowing of the image was adjusted to better visualize the lesion. (g) Lesion candidate segmentation. The 
three candidate pixel regions at the bottom of the bladder were discarded during the lesion candidate determining stage using the 
size criteria. 
(b) 
(f) 
(g) 
(d) 
(e) 
(c) 
(a) 
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4.3.3.3 False positive reduction of voxel candidate with SPAN  
 False positive reduction is applied to the straightened bladder wall profile. One step for 
reducing false positives is to remove pixels with gray level values above 1100 on the profile in 
the section corresponding to B1 of the L contour. Columns on the profile in the section whose 
starting points, (Xi,0), has a gray level value above 1100 are also removed. Because the B1 
section is the border separating the C region and the NC region of the bladder, the gray level of 
the region along B1 is often lower than other regions within the C region of the bladder. This 
may cause many false positive findings, as the darker regions transformed onto the profile may 
be marked as lesion candidates. After studying lesions in the training set that are located near B1, 
we found that the pixels of lesions within the B1 region typically have gray level values less than 
   
(a) (b) (c) 
   
(d) (e) (f) 
 
 
 
(g) (h) (i) 
Figure 4.10: C region images with and without adaptive thresholding for cases that fall within the different categories of 
𝐺𝐿𝑆𝑡𝐷𝑒𝑣. (a-c) Bladder slices with L contour with different standard deviations, 𝐺𝐿𝑆𝑡𝐷𝑒𝑣: (a) 𝐺𝐿𝑆𝑡𝐷𝑒𝑣 = 133, (b) 𝐺𝐿𝑆𝑡𝐷𝑒𝑣 = 89, 
(c) 𝐺𝐿𝑆𝑡𝐷𝑒𝑣 = 77. (d-f) C region after hard thresholding slices in (a-c) using ThC of 1330 without adaptive thresholding.  (g-i) C 
region after adaptive thresholding with rules in Equation (4.3) for slices in (a-c). (g) ThC = 1191, (𝐺𝐿𝑆𝑡𝐷𝑒𝑣 ≥ 𝑇ℎ𝐺𝐿
𝐻 ), (h) ThC = 
1140, (𝑇ℎ𝐺𝐿
𝐿 ≤ 𝐺𝐿𝑆𝑡𝐷𝑒𝑣 < 𝑇ℎ𝐺𝐿
𝐻 ),  (i) ThC = 1220, (𝐺𝐿𝑆𝑡𝐷𝑒𝑣 < 𝑇ℎ𝐺𝐿
𝐿 ). 
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1100. By applying this criterion, we can reduce false positive findings that may be caused by the 
lower pixel gray levels of the profile along the B1 boundary neighboring the non-contrast region. 
 Sharp peaks along the bladder wall profile that are likely caused by noise are also 
removed. Since noise is random and forms small peaks, we set a criterion to exclude peaks less 
than three pixels in width and greater than five pixels in height relative to its surroundings. 
Examples of SPAN for a true lesion, false positive lesions, and a lesion located along B1 are 
shown in Figures 4.4(f), 4.8(c) and 4.9(c), respectively. 
 
4.3.3.4 Lesion candidate identification with SPAN 
Lesion candidates are found by analyzing the bladder wall profile. For a given bladder 
profile, the average height of the profile (μ) is calculated, excluding the pixels from the B1 
section (the border between the NC and C regions) and locations whose height is greater than 10 
pixels. The standard deviation (σ) of the pixels used is also calculated, and a height threshold (H), 
in pixels, is set using the following equation that was determined experimentally to maximize the 
number of true positives found while keeping the false positive findings low: 
 
𝐻 = 𝑓𝑙𝑜𝑜𝑟 (𝜇 −
𝜎
2
+ 0.8) + 2 (4.4) 
where the floor function represents the rounding down operation. On the profile, pixels with 
heights larger than H are considered to be lesion candidate pixels (Figure 4.4(g), Figure 4.8(d), 
Figure 4.9(d)). After the lesion candidate pixels are identified, they are mapped back to the 
original bladder slices as lesion candidate voxels (Figure 4.4(h, i), Figure 4.8(e-g), Figure 4.9(e-
f)).  
 The lesion candidate voxels are then grouped into regions. Candidate voxels that are one 
slice apart, and within five voxels apart in 3D space are clustered into the same region. A 
candidate voxel is ignored if there are no other candidate voxels that are within five voxels on 
the same slice. Regions that contain less than five candidate voxels or greater than 50,000 
candidate voxels are ignored. This size range was determined by analyzing the training cases. 
Each of the regions retained is enclosed with a 3D bounding box to indicate an ROI for a lesion 
candidate. 
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4.3.4 Lesion candidate segmentation, feature extraction, and classification 
4.3.4.1 Lesion segmentation with Auto-Initialized Cascaded Level Set (AI-CALS) 
 Using the ROI obtained for a lesion candidate, the lesion is segmented from the 
surrounding tissue using the AI-CALS segmentation system
47
. The AI-CALS system consists of 
three stages: preprocessing, initial segmentation, and level set segmentation. While this process 
seems similar to the CLASS system used for bladder segmentation, AI-CALS uses a different 
method for initial segmentation, and different sets of parameters that were specifically developed 
for segmentation of bladder lesions. In the first stage, preprocessing techniques are applied in 3D 
to the ROI obtained from the candidate prescreening process above. Smoothing, anisotropic 
diffusion, gradient filters and the rank transform of the gradient magnitude are applied to the 
slices within the ROI to obtain a set of smoothed images, a set of gradient magnitude images, 
and a set of gradient vector images. The set of smoothed images is used in the second stage, 
while the other two sets are used during level set propagation in the third stage. 
We modified the AI-CALS method in the second stage to improve the lesion 
segmentation performance for this study. In the second stage, the system automatically labels a 
subset of voxels in the ROI for analysis based on the attenuation, gradient, and location of the 
voxels. First, voxels with gray level value below 600 are removed. The voxels with gradient 
values in the top 50 percentile of all voxels in the ROI are identified using the gradient 
magnitude image and removed from the ROI. In order to distinguish between the contrast 
material and the lesion candidate that may be present within the ROI, a step that uses Otsu’s 
method
48
 is added that is not part of the original AI-CALS. The region with voxel gray level 
values between 1024 and the threshold gray level determined by the Otsu’s method is marked by 
a binary mask. An elliptical cylinder whose radius is 0.8 of the width and height of the ROI, 
centered at the centroid of the binary mask, is placed within the binary mask. The intersection of 
the binary mask and the elliptical cylinder is labeled as the object region. In the original AI-
CALS, an ellipsoid centered at the ROI is to determine the object region; however, we found that 
using an ellipsoid causes the lesions to be under-segmented towards the first and last slices of the 
ROI, while using an elliptical cylinder, as described above, alleviate this problem. A 
morphological dilation filter with a spherical structuring element of 2 voxels in radius, 3D flood 
fill algorithm, and a morphological erosion filter with a spherical structuring element of 2 voxels 
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in radius are applied to the object region to connect neighboring components and extract an 
initial segmentation surface.  
In the third stage, the initial segmentation surface is propagated towards the lesion 
boundary using cascading level sets. Our chosen level set implementation evolves according to 
the equation: 
 𝜕
𝜕𝑡
𝛹(𝑥) = −𝛼𝐴(𝑥) ∙ 𝛻𝛹(𝑥) − 𝛽𝑃(𝑥)|𝛻𝛹(𝑥)| + 𝛾𝜅(𝑥)|𝛻𝛹(𝑥)| (4.5) 
where  ,  , and   are the coefficients for the advection, propagation, and curvature terms, 
respectively, A(x) is a vector field image (assigning a vector to each voxel in the image) that 
drives the contour to move towards regions of high gradient, P(x) is a scalar speed term between 
0 and 1 causing the contour to expand at the local rate, and 𝜅(𝑥) = 𝑑𝑖𝑣 (
𝛻𝛹(𝑥)
|𝛻𝛹(𝑥)|
) is the mean 
curvature of the level set at point x. The symbol 𝛻 denotes the gradient operator and div is the 
divergence operator
28
.  
Three 3D level sets with predefined sets of parameters are applied in series to the initial 
segmentation surface. The corresponding parameters of the 3 level sets are presented in Table 4.2. 
Table 4.2: Parameters for the AI-CALS level sets 
Level set: α β γ n 
First 1 2 1 10 
Second 1 0.4 q 100 
Third 0 1.0 0 20 
2D slices 4.0 0.3 0.5 100 
 
The first 3D level set slightly expands and smoothes the initial contour. The second 3D 
level set brings the contour towards the sharp edges, but also expands it slightly in regions of low 
gradient. The parameter “q” in Table 4.2 is defined to be a linear function 𝜎𝑀 + 𝜙 of the 2D 
diagonal distance M of the ROI box in millimeters (mm), where 11.0  ,06.0    as shown 
previously
28
. The third 3D level set further draws the contour towards sharp edges. As a final 
step, a 2D level set is applied to every slice of the segmented object to refine the 3D contours 
using the 3D level set contours as the initial contour. Further details on the AI-CALS method can 
be found in the literature
47
. Examples of true and false segmented bladder lesion candidates are 
shown in Figures 4.4(j), 4.8(h, i), and 4.9(g). 
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4.3.4.2 Feature extraction and classification  
For each segmented lesion candidate, 23 morphological features are automatically 
extracted from the central slice of the segmented lesion. Five of the morphological features are 
based on the normalized radial length that is defined as the Euclidean distance from the object’s 
centroid to each of its edge pixels, i.e., the radial length, normalized relative to the maximum 
radial length of the object
49
. Table 4.3 lists the features that were used. The definitions of these 
features can be found in the literature
50
. These features are studied because we found that these 
features are useful for lesion classification from our previous experience with breast masses. 
Table 4.3: Table of morphological features used. 
NRL Shape-based Gray level-based 
NRL Mean Perimeter 10 Contrast Features 
NRL Standard Deviation Area Gray Level Average 
NRL Entropy Circularity Gray Level Standard Deviation 
NRL Area Ratio Rectangularity  
NRL Zero Crossing Count Perimeter-to-area Ratio  
 
Fourier Descriptor  
 
Using the training set, stepwise feature selection is used to select the best feature subset. 
Using simplex optimization with leave-one-out case method, the best combination of values for 
the feature selection parameters, Fin, Fout, and tolerance, is determined from the training set. 
Features for classification are then selected from the entire training set with the best thresholds. 
The six features selected were normalized radial length area, rectangularity, area, average gray 
level, and two contrast features. More details about these features and the feature selection can 
be found in the literature
51
. A linear discriminant (LDA) classifier was then designed with the 
training set for classification of the bladder lesions and false positives using the selected features 
as input predictor variables. The trained LDA classifier was applied to the test set for 
independent testing.  
 
4.3.5 Evaluation Methods 
 The performance of the lesion candidate prescreening steps was evaluated by 
determining the sensitivity and specificity. The overall performance of the bladder lesion 
detection CAD system with feature extraction and FP reduction by the LDA classifier was 
evaluated using free-response receiver operator characteristics (FROC) analysis using our in-
house developed package that calculated the sensitivity and specificity at specific operating 
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points. The FROC curve was generated by varying the decision threshold for the LDA 
discriminant scores. 
 
4.4 Results 
At the prescreening step, our system achieved 84.4% (38/45) sensitivity with an average 
of 4.3 false positives per case (FPs/case) for the training set, and 84.9% (45/53) sensitivity with 
5.4 FPs/case for the test set. The prescreening step generated 215 lesion candidates for the 
training set, (66 true lesion candidates, 149 false positive lesion candidates) that were used to 
train the LDA classifier. 
Tables 4.4 and 4.5 summarize the detected lesions during prescreening by size and 
subtlety, respectively. For both the training and test sets, most of the lesions that were missed 
had subtlety ratings of greater than 3 and were smaller than 10 mm; however, the detection 
system was able to find the majority of the lesions that fit into these categories. For lesions 
smaller than 10 mm, 66.7% (10/15) and 71.4% (15/21) were found by the system in the training 
and test sets, respectively (Table 4.4). For lesions with subtlety ratings greater than 2, 64.3% 
(9/14) of them were detected in the training set, while 78.9% (15/19) of them were detected in 
the test set (Table 4.5). The system detected 86.8% (33/38) and 85.7% (42/49) of the malignant 
lesions in the training and test sets. 
 
Table 4.5: Detected lesions at the prescreening stage for lesions of different subtleties. 
 
Lesion Subtlety (1-5, 5 very subtle) 
1 2 3 4 5 
Training set 
100% 
(18/18) 
84.6% 
(11/13) 
100% 
(5/5) 
50.0% 
(4/8) 
0% 
(0/1) 
Test set  
90.0% 
(18/20) 
85.7% 
(12/14) 
90.0% 
(9/10) 
83.3% 
(5/6) 
33.3% 
(1/3) 
 
Table 4.4:  Detected lesions at the prescreening stage for lesions of different sizes. 
 
Lesion Size (mm) 
0-10 10-20 20-30 30-40 40-50 50-60 60-70 
Training 
set 
66.7% 
(10/15) 
100% 
(14/14) 
50.0% 
(2/4) 
100% 
(6/6) 
100% 
(3/3) 
100% 
(1/1) 
100% 
(2/2) 
Test 
set 
71.4% 
(15/21) 
100% 
(11/11) 
85.7% 
(7/8) 
85.7% 
(6/7) 
100% 
(3/3) 
100% 
 (2/2) 
100% 
(1/1) 
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Using feature extraction and LDA classifier, the false positive (FP) rate improved to 2.5 
FPs/case for the training set and 4.3 FPs/case for the test set without missing additional true 
lesions. By varying the threshold for the LDA scores, the FROC curve was generated as shown 
in Figure 4.11. At 2.5 FPs/case, the training set achieved a sensitivity of 84.4%, while the test set 
achieved 81.1%. At 1.7 FPs/case, the sensitivities were 77.8% and 75.5% for the training and test 
sets, respectively. Table 4.6 shows the sensitivities of the system at different false positive rates 
for the training and test sets. 
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Figure 4.11: FROC curves for automatic computer detection after feature classification with LDA. After prescreening, the system 
achieved 84.4% sensitivity with 4.3 FPs/case for the training set, and 84.9% sensitivity with 5.4 FPs/case for the test set.  After 
LDA classification, at 1.7 FPs/case the sensitivities were 77.8% and 75.5% for the training and test sets, respectively. 
 
 
Table 4.6: Sensitivity at a given FP rate after using LDA classifier. 
 
False positive rate (FPs/case) 
0.5 1.0 1.5 2.0 2.5 3.0 
Training 
set 
48.9% 64.4% 70.0% 77.8% 84.4% 84.4% 
Test 
set 
36.6% 54.7% 70.6% 80.0% 81.1% 83.0% 
 
80 
 
Examples of true positive lesions detected are shown in Figure 4.12. Figure 4.13 shows 
examples of false positive detections, while Figure 4.14 shows lesions that were missed. 
 
We have performed a sensitivity analysis of our CAD system by changing the ROI box 
size, ROI centroid and best slice locations. The size of the ROI box was changed in the range 
from -5% up to 20% in the X-Y direction. The centroid of the ROI box was randomly shifted by 
5% in the X or Y direction. The best slice of the ROI box was randomly moved by -5% or 5%. 
  
 
(a) (b) (c) 
Figure 4.12: Examples of detected bladder lesion. Lesions of varying sizes and shapes were correctly identified by the CAD 
system. (a) Small lesion located along the posterior aspect of the bladder. (b) Large lesion partially obstructing the left 
ureterovesical junction. (c) Lesion covering large amount of the bladder wall. All three lesions were malignant. 
  
(a) (b) 
Figure 4.13: Examples of false positives. (a) Prostate protruding onto the bladder was detected as a lesion candidate. (b) 
Ureterovesical junction detected as a lesion candidate. Neither was removed by the LDA classifier. 
  
(a) (b) 
Figure 4.14: Examples of lesions missed by prescreening. The inhomogeneous contrast material in both (a) and (b) prevented 
the prescreening steps from identifying these lesion candidates. Both were malignant lesions. 
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The sensitivity of each ROI box change was estimated at the operating points used for the 
original box for the training (2.5 FP/case) and test (4.3 FP/case) sets, and shown in Tables 4.7 
and 8. Overall, we observed stable performance for lesion detection within the ranges of ROI 
box sizes and locations studied. 
Table 4.7: Detection sensitivity at 2.5 FP/case for training set. 
ROI Change Original 
XY 
-5% 
XY +5% XY +10% XY +15% XY +20% 
Best Slice 
±5% 
XY 
Centroid 
±5% 
Sensitivity 84.4% 77.8% 82.2% 82.2% 86.7% 86.7% 82.2% 84.4% 
 
 
Table 4.8: Detection sensitivity at 4.3 FP/case for test set. 
ROI Change Original 
XY 
-5% 
XY +5% XY +10% XY +15% XY +20% 
Best Slice 
±5% 
XY 
Centroid 
±5% 
Sensitivity 84.9% 84.9% 83.0% 81.1% 84.9% 73.6% 86.8% 84.9% 
 
 
4.5 Discussion 
 In this study, we developed a system that can automatically detect bladder lesions of a 
wide range of sizes and subtleties within the contrast-enhanced region of the bladders in CTU 
that only requires two ROI boxes as inputs. At the pre-processing stage, the system detected over 
80% of the lesions in both the training and test sets, while having about 5 false positives per case.  
Our system was able to detect lesions of various shapes and sizes at different locations 
within the contrast-enhanced region of the bladder. Small lesions protruding out from the bladder 
wall, large lesions that occupy a large portion of the contrast-enhanced region, and bladder 
masses that look like an extension of the bladder wall were all detected by the system (Figure 
4.12). 
During the prescreening stage, a relative large number of false positive lesions appeared 
close to the cephalic or caudal most aspects of the bladder. This may be caused by the fact that 
the CT slices at these locations are close to or even intersect the bladder wall in some regions; 
the partial volume effects may contribute to the inhomogeneous and low contrast appearance of 
the bladder region (Figure 4.7(e)). However, the LDA classifier was able to correctly remove the 
two false positives shown in that example. A common false positive finding that the LDA 
classifier has difficulty differentiating from true lesions is the prostate in male patients. For some 
cases, the prostate protruding into the bladder has a similar appearance to an intrinsic bladder 
lesion (Figure 4.13(a)). The bladder segmentation may also leak into the prostate due to the 
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interface between the bladder and the prostate being difficult to distinguish. The detection system, 
therefore, often identifies the portions of the prostate that are segmented as lesion candidates. 
Another common cause of false positive findings not removed by the LDA classifier is the 
ureterovesical junction (UVJ). When the location near the UVJ is imaged, the ureter wall at the 
junction between the ureter and the bladder may appear as a protrusion of tissue from the bladder 
wall, similar to a lesion (Figure 4.13(b)) that the system detects as a lesion candidate. Other 
causes of false positives include the inhomogeneous contrast material in the urine that did not get 
fully removed by the adaptive thresholding and folding of the bladder wall for cases with bladder 
diverticula. A common cause for false negatives is the non-uniformity of the contrast material 
that camouflages the lesions as a part of the bladder wall (Figure 4.14). 
Our system detected the majority of both malignant and benign lesions. For both the 
training and the test sets, more malignant lesions were detected than benign lesions. However, 
the number of benign lesions was much smaller than the number of malignant lesions in our data 
set. Therefore, we cannot draw a conclusion on whether the system detection performance is 
related to lesion malignancy. 
With feature extraction and FP reduction by LDA, our system achieved 84.4% sensitivity 
with an average of 2.5 FPs/case for the training set, and 84.9% sensitivity with 4.3 FPs/case for 
the test set. Our radiologist and urologist co-investigators expect that a CAD system with 85-90% 
sensitivity with 2 FP/case for the entire bladder would be useful in their practice. We were close 
to reaching this goal for our training set, but the system needs to be improved to meet our 
performance goals for unknown cases. Further improvement of the system is reported in Chapter 
V. 
Our system takes approximately 2 to 5 minutes to run for a case on a system with an Intel 
Xeon 5160 processor at 3 GHz, depending on the bladder size. It takes approximately 2 minutes 
per case for manual input, which includes loading the case and marking the two ROIs. 
It is difficult to make a direct comparison with the previous methods by other 
investigators described in the Introduction due to the differences in the data sets, lesion sizes and 
subtlety, and the performance evaluation methods. In the study by Jaume et. al
46
, they delineated 
each bladder in their data set into 6 different zones, and measured the performance by 
determining whether or not a zone was diseased or not. Duan et. al
22
 measured their performance 
by determining the percentage in which the lesions in their data set was covered by windows 
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marking a region representing a part of a lesion. In comparison to our pilot study
25
, in which 83% 
of bladder lesions were detected with 1.4 FPs/case using a data set of 15 cases, the current 
system had sensitivities of 84.4% and 84.9% at an FP rate of 2.5 FPs/case and 4.3 FPs/case for 
the training and test sets, respectively. When the system from our pilot study was applied to the 
larger data set used in this study, it had sensitivities of 77.8% and 50.9% at an FP rate of 2.6 
FPs/case and 2.7 FPs/case for the training and test sets, respectively. Our current system 
achieved a higher sensitivity when using a data set of 70 patients compared to the system in our 
pilot study. 
 This study has several limitations. First, the detection method was designed for detection 
in the contrast-enhanced region of the bladder. As the contrast between the lesion and its 
surroundings is much smaller in the non-contrast region, a different method will have to be 
developed for detection in the non-contrast region. Second, this study was directed towards 
detection of bladder masses, but not bladder wall thickening. Wall thickening that was found by 
the system (153 candidates in the training set, and 197 candidates in the test set that involve any 
portion of a thickening bladder wall) was not considered to be a true lesion and was excluded as 
a false positive in this study. A different method may need to be developed to detect wall 
thickenings accurately, as wall thickenings possess different characteristics than masses. We will 
present methods to detect bladder lesions in the entire bladder, and bladder wall thickenings in 
Chapters V and VI, respectively. 
  
4.6 Conclusion 
This study demonstrates the feasibility of our method for detection of bladder lesions 
located fully or partially in the contrast-enhanced region of the CTU scans for lesions of a variety 
of shapes and sizes. The prescreening stage detected most of the true lesions, but also many false 
positive lesions. Using feature extraction and a trained classifier, the number of false positive 
findings was reduced while keeping the sensitivity high. The results indicate the usefulness of 
the methods for bladder lesion detection for lesions partially or fully within the contrast-
enhanced region of CTU. Further work is underway to increase the sensitivity, detect lesions 
within the non-contrast enhanced region and detect lesions manifested as bladder wall thickening. 
This study is a step towards the development of a CAD system for detection of urothelial lesions 
in the bladder that are imaged with CT urography. 
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Chapter V 
Automatic Detection of Urinary Bladder Mass on CT Urography within the Whole Bladder
 
5.1 Abstract 
We have continued the development of the computer-aided detection system for bladder 
cancer in CT urography (CTU). We have previously developed methods for detection of bladder 
masses within the contrast-enhanced regions of the bladder individually as reported in Chapter 
IV. In this study, we investigated methods for detection of bladder masses within the entire 
bladder. The bladder was segmented using our method that was described in Chapter III that 
combined deep-learning convolutional neural network with level sets. The non-contrast-
enhanced region was separated from the contrast-enhanced region with a maximum-intensity-
projection-based method. The non-contrast region was smoothed and gray level threshold was 
applied to the contrast and non-contrast regions separately to extract the bladder wall and 
potential masses. The bladder wall was transformed into a straightened thickness profile that was 
analyzed to identify lesion candidates as a prescreening step. The candidates were segmented 
using our auto-initialized cascaded level set (AI-CALS) segmentation method, and 91 features 
were extracted for each candidate. A data set of 87 patients with 114 biopsy-proven bladder 
lesions was used, which was split into independent training and test sets: 47 training cases with 
61 lesions, and 40 test cases with 53 lesions. Using the training set, feature selection was 
performed and a linear discriminant (LDA) classifier was designed to merge the selected features 
for classification of bladder lesions and false positives. The trained classifier was evaluated with 
the test set. FROC analysis showed that the system achieved a sensitivity of 96.7% at 4.4 
FPs/case for the training set, and 90.6% at 4.9 FPs/case for the test set. At 2.0 FPs/case, the 
sensitivities were 88.5% and 84.9% for the training and test sets, respectively. The preliminary 
results using methods presented in this chapter have been published as conference proceedings
6
. 
Preparation for submission as a journal article is underway. 
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5.2 Introduction 
This chapter describes a system for detection of bladder lesions within the whole bladder 
on CT urogram. When we started looking into designing a system for detection of lesions within 
the bladder, we observed that the segmentation of the non-contrast enhanced (NC) region using 
the CLASS with LCR method had many errors. We noticed that the NC segmentation would 
either over-segment the bladder, enclosing non-bladder structures, or under-segment the bladder, 
resulting in missed bladder lesions within the NC region. Therefore, we first focused on 
performing bladder lesion detection within the contrast-enhanced (C) region of the bladder, as 
demonstrated in Chapter IV. Afterwards, we developed a new method for bladder segmentation 
using DL-CNN with level sets, as described in Chapter III that improved the performance of the 
segmentations. 
In this study, we developed a system for detection of bladder lesions within the entire 
bladder, using the bladder segmentation method described in Chapter III. We designed the 
system and evaluated its performance using free-response receiver operating characteristic 
(FROC) analysis using a data set of 87 cases.  
 
5.3 Materials and Methods 
5.3.1 Data set 
 The data set used in this retrospective study was collected using protocols approved by 
the Institutional Review Board. A total of 87 patients who had undergone CTU with subsequent 
cystoscopy and biopsy was collected from our institution. The CTU scans were acquired with 
the parameters described in Chapter II, section 2.3.5. 
 All locations of lesions were identified by experienced radiologists in CTU volume as 
reference standard. Two experienced radiologists marked the lesion location by drawing a 
bounding box around the lesion, including the starting (most cephalad) and the ending (most 
caudal) slice of the lesion. They also measured the longest diameter of the lesion and gave a 
subtlety rating. Consensus was obtained if the lesion locations were different between the 
radiologists, and findings were correlated with radiology, pathology, and biopsy reports. The size 
and subtlety of the lesions given by the more experienced radiologist were reported to illustrate 
the detection performance of the system for lesions of different degrees of difficulty as seen by 
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an experienced radiologist. Manual hand outlines of the lesions were performed by the more 
experienced radiologist as a reference standard to evaluate the automatic detection system’s 
performance. 
 Within the data set, 114 biopsy-proven bladder lesions were identified from 87 cases. The 
cases were split into independent training and test sets. All bladder lesions were found to be 
malignant according to biopsy reports. The training set consisted of 61 lesions from 47 cases 
with an average size of 22.4 mm (range: 1.4-61.7 mm) (Figure 5.1(a)), while the test set 
contained 53 lesions from 40 cases with an average size of 31.4 mm (range: 5.7-96.4 mm) 
(Figure 5.1(a)). The average lesion subtlety ratings were 2.3 for the training set, and 1.8 for the 
test set (scale 1 to 5, 5 very subtle) (Figure 5.1(b)). 
 
 
5.3.2 Bladder segmentation using DL-CLASS 
 A critical component of CAD system that detects bladder cancer is accurate bladder 
segmentation that isolates the bladder from the surrounding anatomical structures, as it 
determines the search region for the detection process. Bladder segmentation determines the 
search region for the detection process. Accurate bladder segmentation will help ensure high 
accuracy with low number of false positive findings. We have previously developed 
computerized methods and a software package for segmenting the bladder in CTU that we 
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(a) (b) 
Figure 5.1: Histograms of lesion size (a) and lesion subtlety (b) for lesions in the training and test set. The average lesion size 
was 22.4 mm (range: 1.4–61.7 mm) for the training set, and 31.4 mm (range: 5.7–96.4 mm) for the test set.  The average lesion 
subtlety ratings in both sets were 2.3 for the training set and 1.8 for the test set (scale 1 to 5, 5 very subtle). 
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refer to as the deep-learning cascaded level set analysis and segmentation system (DL-CLASS) 
that was described in Chapter III
2
. Briefly, the DL-CLASS method uses a deep-learning 
convolutional neural network (DL-CNN) trained with 160,000 regions of interests (ROI) to 
distinguish between the area inside the bladder and the surrounding area containing other 
organs within the CTU slice. The trained DL-CNN is applied to each voxel of a volume of 
interest containing the bladder in the CTU to generate a bladder likelihood score, resulting in a 
bladder likelihood map for each slice. A threshold is applied to the likelihood maps that are 
smoothed using a morphological dilation filter and a hole-filling algorithm to generate an 
initial contour. The CTU slices are then pre-processed, which apply smoothing, anisotropic 
diffusion, gradient filters, and the rank transform of the gradient magnitude. 3D level sets, 
followed by 2D level sets are applied to the initial contour to obtain the final bladder 
segmentation. Example of a segmented bladder can be seen in Figures 5.2(a) and 5.3(a). 
 
5.3.3 Bladder wall profile generation and lesion candidate identification with A-SPAN 
Bladder lesion candidates are identified by first isolating the contrast-enhanced region of 
the bladder, and then by using our newly developed method, referred to as Adaptive-
Straightened Periphery ANalysis (SPAN). A-SPAN consists of three stages: (1) wall thickness 
profile generation, (2) false positive reduction of voxel candidate, and (3) lesion candidate 
identification. 
 
5.3.3.1 Finding the boundary line between the contrast-enhanced and the no-contrast regions of 
the bladder 
 The steps for distinguishing the contrast-enhanced (C) and the non-contrast enhanced 
(NC) regions of the bladder were previously described in Chapter IV, section 4.3.3.1 which 
described our work of detecting lesions within the C region of the bladder
3
, and adapted to use 
with the DL-CLASS segmentations. Briefly, the contrast-enhanced region of the bladder is 
separated from the non-contrast region using the property that the dependently layering IV 
contrast material in the bladder will be filled to the same level consistently along all CTU 
slices due to gravity. We use maximum intensity projection (MIP) along the slices of the 
bladder to estimate the upper boundary of the contrast enhanced region. The ROIs initializing 
the segmentation of the C and NC regions of the bladder are used to determine the range of the 
CTU slices for the MIP. As the bladder is located on top of the pelvic bones when the patient 
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lies in a supine position, it is common that the bones intrude into the bladder’s ROI towards the 
bottom of the bladder. If the bright bones show up on the MIP image, its interference makes it 
difficult to accurately determine the upper level of the contrast material. Therefore, only a 
portion of the slices included in the ROI is used. We experimentally determined that 10% of the 
slices towards the bottom of the bladder from the best slice (to avoid the pelvic bones) and 90% 
of the slices towards the top of the bladder from the best slice (to avoid other organs above the 
bladder) worked the best. The best slice is the slice that best represents the bladder region, e.g., 
where the bladder is seen the largest. It was selected manually when the ROIs were defined.  
 From the MIP image, a gray level profile is generated. The width of the input bounding 
box of the bladder used for the DL-CLASS segmentations is reduced by 50% while keeping the 
same center to minimize the negative effects of the peripheries of the irregularly shaped bladders 
on the estimation of the transition point between the contrast and non-contrast regions. For every 
row of the box, the gray levels of the pixels belonging to the row are averaged and recorded into 
a profile. The profile is analyzed to find the first row R1 whose average gray level is greater than 
a gray level threshold Thp. By using the training data set the Thp was determined experimentally 
as 1330, which provided adequate separation of the NC and C regions for the training cases. The 
horizontal value B1 at row R1 that intersects with the bladder boundary is determined as the 
boundary between the NC and C regions of the bladder. The region above the horizontal value 
B1 is assigned as the NC region, and the region above the line is assigned as the C region. The 
two regions will be analyzed with different techniques as their properties vastly differ. 
 
5.3.3.2 Wall thickness profile generation with A-SPAN 
 Generating the bladder wall thickness profile involves two steps: (1) refining the bladder 
segmentation in the C region of the bladder, (2) adaptive thresholding of the urine to isolate the 
bladder wall and masses, and (3) transformation of the bladder segmentation to a straightened 
wall profile.  
 Refining the C region contour. The DL-CNN contour may under-segment the bladder in 
the C region, resulting in portions of lesions being outside of the bladder segmentation. To 
alleviate this issue, our previously developed Model-Guided Refinement (MGR) method
1
 that 
was described in Chapter II, section 2.3.2.1, was applied to the segmentation contour points 
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whose Y-value is greater than the horizontal value B1. The new, refined resulting contour will be 
referred as the L contour. 
 Adaptive thresholding of urine. Different strategies are used for the adaptive thresholding 
of the NC and C regions of the bladder to isolate the bladder wall from the urine within the 
bladder. The methods used for the C region adaptive thresholding is described in chapter IV, 
section 4.3.3.2
3
. For the NC region, the region is first blurred using a 7-pixel by 7-pixel average 
filter. As the contrast material is denser towards the bottom of the bladder, a threshold that is 
based on the horizontal location is implemented. The threshold value, 𝑇ℎ𝑁𝐶
𝑗
 is given by the 
following equation: 
 
𝑇ℎ𝑁𝐶
𝑗
= 𝜀 − 𝜏 ∗  (
𝑗 − 𝑌𝑁𝐶
𝐵1 − 𝑌𝑁𝐶
) (5.2) 
where 𝑗  is the Y-value of a given pixel within the NC region, 𝐵1  is the horizontal value 
mentioned in section 2.3.1, and 𝑌𝑁𝐶  is the Y-value of the upper most point (point with the 
smallest Y-value) of the bladder segmentation. 𝜀 and 𝜏 are constants experimentally determined 
to be 1210 and 410, respectively. Once 𝑇ℎ𝑁𝐶
𝑗
 is determined, the urine is eliminated from the NC 
region by setting the gray level to 0 for all pixels whose gray level is greater than 𝑇ℎ𝑁𝐶
𝑗
. 
 Wall profile generation. Once the urine is removed from the CTU slice, a straightened 
profile of wall thickness is generated by mapping all of the points along the L contour, Li, i=1, 
…, n, sequentially to the X-axis of a new coordinate system such that Li(xi ,yi) has the coordinate  
(Xi,0). The origin of this new coordinate system is defined at the top left of the profile, with Y-
values increasing in the downward direction. For a given pixel Li(xi ,yi), the path normal to the 
point towards the interior of the L contour is calculated using the normal angle 𝜃 defined as: 
 
𝜃 = 90˚ +
1
2
(tan−1 (
𝑦𝑖 − 𝑦𝑖−1
𝑥𝑖 − 𝑥𝑖−1
) + tan−1 (
𝑦𝑖+1 − 𝑦𝑖
𝑥𝑖+1 − 𝑥𝑖
)), (5.3) 
where (xi+1,yi+1) and (xi-1,yi-1), respectively, are the coordinates of the next Li+1  and previous Li-1  
neighboring points of Li,. The pixels along the normal path are sequentially mapped onto the 
profile at increasing Y-values such that the new coordinates of the pixels are given by (Xi,Yj)  
j=1,…im, while Xi is fixed.  The path along the normal ends when 16 black pixels are 
encountered consecutively, indicating that the path reaches the lumen of the bladder where the 
pixel gray level has been set to 0. The number of pixels along the normal path at Li is denoted by 
im. 
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(a) (b) (c) 
Figure 5.2: Detection of bladder mass: example of mass in NC region. (a) Bladder segmentation. (b) Wall profile after 
thresholding to remove the urine within the entire bladder. The arrows indicate bladder lesion candidates. (c) Detected bladder 
mass candidates mapped back to CTU image. 
 
 
  
 
 
 
(a) (b) (c) 
Figure 5.3: Detection of bladder mass: example of mass in C region. (a) Bladder segmentation. (b) Wall profile after 
thresholding to remove the urine within the entire bladder. The arrows indicate bladder lesion candidates. The Orange arrow 
points to false positives, while the blue arrow points to a bladder lesion. (c) Detected bladder mass candidates mapped back 
to CTU image. 
 
5.3.3.3 False positive reduction of voxel candidate with A-SPAN  
 Sharp peaks along the bladder wall profile that are likely caused by noise are removed. 
Since noise is random and forms small peaks, we set a criterion to exclude peaks less than three 
pixels in width and greater than five pixels in height relative to its surroundings. 
 One of the main false positive (FP) findings is organs situated just below the bladder, 
which include the prostate and the uterus. These possible false positive candidate pixels are 
removed based on their location mapped back to the original CTU slices, and the presence of 
other candidates near their locations. As the prostate and the uterus is generally located near the 
horizontal center of the CTU slice, candidate pixels whose x-value on the original CTU slice is 
within 30 pixels of the center of the CTU slice is studied as possible FP. If there are at least 15 
other candidate pixels within a 3-pixel by 3-pixel region centered on the studied candidate pixel 
location from all the CTU slices below in the axial direction, towards the caudal aspect of the 
bladder, the studied candidate pixel is considered as an FP, and is removed. As true positive 
lesions can be present on the center of the bladder as well, and these parameters were selected 
using the training set to remove the false positive findings while retaining the true positive pixel 
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candidates. Examples of A-SPAN for a true lesion in the NC region, and a lesion in the C region 
are shown in Figures 5.2 and 5.3, respectively. 
 
5.3.3.4 Lesion candidate identification with SPAN 
Lesion candidates are found by analyzing the bladder wall profile. After the FP removal 
step, all remaining pixels for a given bladder profile are considered to be lesion candidate pixels 
(Figure 5.2(b), 5.3(b)). After the lesion candidate pixels are identified, they are mapped back to 
the original bladder slices as lesion candidate voxels (Figure 5.2(c), 5.3(c)).  
 The lesion candidate voxels are then grouped into regions. Candidate voxels that are one 
slice apart, and within two voxels apart in 3D space are clustered into the same region. A 
candidate voxel is ignored if there are no other candidate voxels within two voxels on the same 
slice. Regions that contain less than five candidate voxels or greater than 50,000 candidate 
voxels are ignored. This size range was determined by analyzing the training cases. Each of the 
regions retained is enclosed with a 3D bounding box to indicate an ROI for a lesion candidate. 
Additional possible FP candidate regions are removed based on size and gray level of the regions, 
determined using the training set. 
 
5.3.4 Lesion candidate segmentation, feature extraction, and classification 
5.3.4.1 Lesion segmentation with Auto-Initialized Cascaded Level Set (AI-CALS) 
Using the ROI obtained for a lesion candidate, the lesion is segmented from the 
surrounding tissue using the AI-CALS segmentation system, described in Chapter IV, section 
4.3.4.1
3
. The AI-CALS segmentation system is briefly described in the following. The AI-CALS 
consists of three stages: preprocessing, initial segmentation, and level set segmentation. In the 
first stage, preprocessing techniques are applied in 3D to the ROI obtained from the candidate 
prescreening process above. In the second stage, the system generates an initial segmentation 
based on the attenuation, gradient, and location of the voxels. In the third stage, the initial 
segmentation surface is propagated towards the lesion boundary using cascading level sets. 
Further details on the AI-CALS method can be found in the literature
3, 47
. 
 
5.3.4.2 Feature extraction and classification  
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For each segmented lesion candidate, 91 features are automatically extracted from the 
central slice of the segmented lesion. The definitions of these features can be found in the 
literature
30, 50, 51
. These features, which include: morphological features, such as volume, 
circularity, rectangularity, and Fourier descriptor; (2) gray level features, such as the average 
gray level and contrast features; (3) texture features, such as run length statistics, and (4) gradient 
field features, such as the gradient magnitudes statistics for all voxels on the surface of the 
segmented lesion; are studied because we found that these features are useful for lesion 
classification from our previous experience with breast masses and lung nodules. 
Using the training set, stepwise feature selection is used to select the best feature subset. 
Using leave-one-out case method on the training set, a combination of four features is selected. 
The four features consist of two run-length statistics feature (texture feature), an average radial 
length feature (morphological feature), and a contrast feature (gray level feature). A linear 
discriminant (LDA) classifier was then designed with the training set for classification of the 
bladder lesions and false positives using the selected features as input predictor variables. The 
trained LDA classifier was applied to the test set for independent testing.  
 
5.3.5 Evaluation Methods 
 The performance of the lesion candidate prescreening steps was evaluated by 
determining the sensitivity and specificity. The overall performance of the bladder lesion 
detection CAD system with feature extraction and FP reduction by the LDA classifier was 
evaluated using free-response receiver operator characteristics (FROC) analysis. The FROC 
curve was generated by varying the decision threshold for the LDA discriminant scores. 
 
5.4 Results 
At the prescreening step, our system achieved 96.7% (59/61) sensitivity with an average 
of 4.4 false positives per case (FPs/case) for the training set, and 90.6% (48/53) sensitivity with 
4.9 FPs/case for the test set. The prescreening step generated 325 lesion candidates for the 
training set (118 true lesion candidates, 207 false positive lesion candidates) that were used to 
train the LDA classifier. 
Tables 5.1 and 5.2 summarize the detected lesions during prescreening by size and 
subtlety, respectively. For lesions smaller than 10 mm, 94.4% (17/18) and 85.7% (6/7) were 
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found by the system in the training and test sets, respectively (Table 5.1). For lesions with 
subtlety ratings greater than 2, 94.4% (17/18) of them were detected in the training set, while 
90.9% (10/11) of them were detected in the test set (Table 5.2). 
 
 
Table 5.2: Detected lesions at the prescreening stage for lesions of different subtleties. 
 
Lesion Subtlety (1-5, 5 very subtle) 
1 2 3 4 5 
Training set 
95% 
(19/20) 
100% 
(14/14) 
85.7% 
(6/7) 
100% 
(8/8) 
100% 
(3/3) 
Test set  
88.9% 
(16/18) 
80% 
(8/10) 
100% 
(4/4) 
83.3% 
(5/6) 
100% 
(1/1) 
 
 
Using feature extraction, LDA classifier, and by varying the threshold for the LDA scores, 
the FROC curve was generated as shown in Figure 5.4. At 4 FPs/case, the training set achieved a 
sensitivity of 95.0%, while the test set achieved 86.8%. At 2 FPs/case, the sensitivities were 88.5% 
and 84.9% for the training and test sets, respectively. Table 5.3 shows the sensitivities of the 
system at different false positive rates for the training and test sets. 
 
Table 5.1: Detected lesions at the prescreening stage for lesions of different sizes. 
 
Lesion Size (mm) 
0-10 10-20 20-30 30-40 40-50 50-60 60-70 
Training 
set 
94.4% 
(17/18) 
100% 
(11/11) 
87.5% 
(7/8) 
100% 
(6/6) 
100% 
(4/4) 
100% 
(2/2) 
100% 
(3/3) 
Test 
set 
85.7% 
(6/7) 
91.7% 
(11/12) 
77.8% 
(7/9) 
100% 
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Figure 5.4: FROC curves for automatic computer detection after feature classification with LDA. After prescreening, the system 
achieved 91.8% sensitivity with 4.4 FPs/case for the training set, and 90.6% sensitivity with 4.9 FPs/case for the test set.  After 
LDA classification, at 2 FPs/case the sensitivities were 90.2% and 84.9% for the training and test sets, respectively. 
 
 
 
Examples of true positive lesions detected are shown in Figure 5.5. Figure 5.6 shows 
examples of false positive detections, while Figure 5.7 shows a lesion that was missed. 
Table 5.3: Sensitivity at a given FP rate after using LDA classifier. 
 
False positive rate (FPs/case) 
0.5 1.0 1.5 2.0 2.5 3.0 
Training 
set 
57.4% 78.7% 82.0% 88.5% 90.2% 91.8% 
Test 
set 
49.1% 73.6% 83.0% 84.9% 84.9% 86.8% 
 
 
  
(a) (b) 
Figure 5.5: Examples of detected bladder lesions (true positives). Lesions within both the contrast-enhanced and non-
contrast regions of the bladder were correctly identified by the CAD system. (a) Lesion located in the non-contrast region. 
(b) Detected lesion within the contrast-enhanced bladder.  
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5.5 Discussion 
In this study, we developed a system that can automatically detect bladder lesions of a 
wide range of sizes and subtleties in CTU that only uses an ROI box as manual input. At the pre-
processing stage, the system detected over 90% of the lesions in both the training and test sets, 
while having about 4 to 5 false positives per case. Our radiologist and urologist co-investigators 
expect that a CAD system with 85-90% sensitivity with 2 FP/case for the entire bladder would be 
useful in their practice. We were able to reach this goal with the methods proposed in this study. 
A common false positive finding that the LDA classifier has difficulty to differentiate 
from true lesions is the prostate in male patients. For some cases, the portion of an enlarged 
prostate that protrudes into the bladder has a similar appearance to an intrinsic bladder lesion 
(Figure 5.6(a)). The bladder segmentation may also leak into the prostate due to the interface 
between the bladder and the prostate being difficult to distinguish. The detection system, 
therefore, identifies the portions of the prostate that are segmented as lesion candidates. We 
attempted to remove possible candidate pixels to try and remove some of the FPs, but we were 
not able to remove all of them. Another common cause of false positive findings not removed by 
the LDA classifier is the ureterovesical junction (UVJ). When the location near the UVJ is 
 
 
(a) (b) 
Figure 5.6: Examples of false positives. (a) Prostate protruding onto the bladder was detected as a lesion candidate. (b) 
Ureterovesical junction detected as a lesion candidate. Neither was removed by the LDA classifier. 
 
Figure 5.7: Example of lesion missed by prescreening (false negative). The relatively flat lesion near other focal lesions 
prevented the prescreening steps from identifying this lesion candidate, which was a malignant lesion. 
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imaged, the ureteral wall at the junction between the ureter and the bladder may appear as a 
protrusion from the bladder wall, similar to a lesion (Figure 5.6(b)) that the system detects as a 
lesion candidate. Other causes of false positives include the inhomogeneous contrast material in 
the urine that did not get fully removed by the adaptive thresholding and folding of the bladder 
wall for cases with bladder diverticula. 
Compared to the methods used in Chapter IV for the detection of bladder masses only 
within the contrast-enhanced region of the bladder, we expect that the new method performs 
better, as the bladder segmentation using DL-CNN performs better than the segmentation using 
CLASS with LCR. We observe this trend when looking at the test set pre-screening 
performances (90.6% at 4.9 FPs/case for whole bladder, and 84.9% at 5.4 FPs/case for C region 
only); however, it is difficult to make a direct comparison, as the data set between the two 
studies are slightly different. 
Using other machine-learning classifiers with the selected features performed similarly as 
the LDA classifier in the removal of false positive detections. The LDA, support vector machine, 
back-propagation neural network, and the random forest classifiers all performed similarly, with 
minor differences at some operating points, ranging from 87% to 89% sensitivity at 4 FPs/case, 
and 85% to 83% at 2 FPs/case. 
This study has several limitations. First, the data set consists of 87 cases and it is 
relatively small, with 40 cases being used as the test set. Our method should be evaluated on a 
much larger data set to study the feasibility of our method. Second, this study was directed 
towards detection of bladder masses, but not bladder wall thickening. Wall thickening that was 
found by the system (290 candidates in the training set, and 221 candidates in the test set that 
involve any portion of a thickening bladder wall) was not considered to be a true lesion and was 
excluded as a false positive in this study. A different method may need to be developed to detect 
wall thickening accurately, as wall thickening possesses different characteristics than masses. 
We develop methods to detect bladder wall thickenings that will be introduced in the next 
chapter, Chapter VI.  
 
5.6 Conclusion 
This study demonstrates the feasibility of our method for detection of bladder lesions on 
CTU for bladder lesions of a variety of shapes and sizes, in both the contrast-enhanced and non-
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contrast-enhanced regions of the bladder. The prescreening stage detected most of the true 
lesions, but also many false positive lesions. Using feature extraction and a trained classifier, the 
false positives were reduced while keeping the sensitivity high. The results indicate the 
usefulness of the methods for bladder lesion detection in CTU. Further work is underway to 
increase the sensitivity. This study is a step towards the development of a CAD system for 
detection of urothelial lesions imaged with CT urography. 
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Chapter VI 
Bladder Wall Thickening Detection in CTU
 
6.1 Abstract 
We are developing a computer-aided detection system for bladder cancer in CT 
urography (CTU). We have described developed methods for detection of focal bladder masses 
in Chapters IV and V. Bladder wall thickening is another manifestation of bladder cancer. In this 
study, we investigate methods for detection of bladder wall thickenings. The inner and outer 
bladder walls were segmented using our method that combined deep-learning convolutional 
neural network with level sets. The non-contrast-enhanced region was separated from the 
contrast-enhanced region with a maximum-intensity-projection-based method. The non-contrast 
region was smoothed and gray level threshold was applied to the contrast and non-contrast 
regions separately to extract the bladder wall and potential masses. The bladder wall was 
transformed into a straightened thickness profile that was analyzed to identify regions of wall 
thickenings. A data set of 112 patients, 87 with wall thickening, and 25 with normal bladders 
was used that was split into independent training and test sets: 57 training cases, of which 44 had 
bladder wall thickening, and 13 of which had normal bladders, and 55 test cases of which 43 had 
wall thickening and 12 had normal bladders. The volume of the wall thickening candidate was 
used as a feature to build an LDA classifier for the classification of bladder wall thickenings and 
false positives. The trained classifier was evaluated with the test set. FROC analysis showed that 
the system achieved a sensitivity of 93.2% at 2 FPs/case for the training set, and 88.4% at 2 
FPs/case for the test set. Preparation for submission as a journal article is underway at the time of 
this dissertation. 
 
6.2 Introduction 
CT urography can detect cancers that produce only thickening of the urothelium without 
any associated abnormality of the urinary tract lumen. This phenomenon was not widely known 
to exist until CT urography began to appear. CT urography may also detect bladder lesions that 
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were missed by cystoscopy. We have described developed methods for detection of bladder 
masses in Chapters IV and V. Bladder wall thickening is another indication for the presence of 
bladder cancer. In this study, we investigated methods for detection of bladder wall thickenings. 
We designed the system and evaluated its performance using free-response receiver operating 
characteristic (FROC) analysis. 
 
6.3 Materials and Methods 
6.3.1 Data set 
 The data set used in this retrospective study was collected using protocols approved by 
the Institutional Review Board. A total of 112 patients who had undergone CTU with 
subsequent cystoscopy and biopsy was collected from our institution. The CTU scans were 
acquired the protocol described in Chapter II, section 2.3.4.  
 All locations of the wall thickening were identified by experienced radiologists in a CTU 
volume and this was used as a reference standard. Two experienced radiologists marked the 
thickening location by drawing a bounding box around the thickening, including the starting 
(most cephalad) and the ending (most caudal) slice of the lesion. Manual hand outlines of inner 
and outer bladder walls were performed by the more experienced radiologist as a reference 
standard to evaluate the automatic detection system’s performance. 
 Within the data set, 87 patients who had bladder wall thickenings were identified from 
112 a total of cases, which also included 25 patients with normal bladders. The cases were split 
into independent training and test sets. The training set consisted of 44 cases with bladder wall 
thickenings and 13 normal bladder cases, while the test set contained 43 cases with bladder wall 
thickenings and 12 normal bladder cases. 
 
6.3.2 Bladder inner and outer wall segmentation using DL-CNN 
 We have previously developed computerized methods and a software package for 
segmenting the inner and outer bladder wall in CTU
52
. The method uses a deep-learning 
convolutional neural network (DL-CNN) trained with 240,000 regions of interests (ROI) to 
distinguish between the area inside the bladder wall and the surrounding areas including the 
bladder lumen and other organs within the CTU slice. The trained DL-CNN is applied to each 
voxel of a volume of interest containing the bladder in the CTU to generate a bladder 
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likelihood score, resulting in a bladder wall likelihood map for each slice. A threshold is 
applied to the likelihood maps, which are smoothed using a morphological dilation filter and a 
hole-filling algorithm to generate an initial contour. The CTU slices are then pre-processed, 
which apply smoothing, anisotropic diffusion, gradient filters, and the rank transform of the 
gradient magnitude. 3D level sets, followed by 2D level sets, with two separate parameters for 
the inner and outer wall segmentations, are applied to the initial contour to obtain the final 
bladder inner and outer wall segmentation. Example of a segmented bladder wall can be seen 
in Figure 6.1(a). More details about our method can be found in literature
52
. 
 
6.3.3 Bladder wall profile generation and wall thickening candidate identification 
Bladder wall thickening candidates are identified by first isolating the contrast-enhanced region 
of the bladder, and analyzing the bladder wall, which consists of the following steps: (1) wall 
thickness profile generation, (2) false positive reduction of voxel candidate, and (3) wall 
thickening candidate identification. 
 
6.3.3.1 Finding the boundary line between the contrast-enhanced and the no-contrast regions of 
the bladder 
 The contrast-enhanced (C) or opacified, and the non-contrast-enhanced (NC) regions, 
or unopacified, of the bladder were separated using methods described in Chapter V, section 
5.3.3.1 to obtain the horizontal value B1 that is the boundary between the NC and C regions of 
the bladder. The region above the horizontal value B1 is assigned as the NC region, and the 
region above the line is assigned as the C region. The two regions will be analyzed with 
different techniques as their properties vastly differ. 
 
6.3.3.2 Wall thickness profile generation 
 Generating the bladder wall thickness profile involves two steps: (1) refining the bladder 
segmentation in the C region of the bladder, (2) adaptive thresholding of the urine to isolate the 
bladder wall and masses, and (3) transformation of the bladder segmentation to a straightened 
wall profile.  
 Refining the C region contour. The DL-CNN contour may under-segment the bladder in 
the C region, resulting in portions of lesions being outside of the bladder segmentation. To 
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alleviate this issue, our previously developed Model-Guided Refinement (MGR) methods that is 
described in Chapter II, section 2.3.2.1
1
, was applied to the segmentation contour points whose 
Y-value is greater than the horizontal value B1. The new, refined resulting contour will be 
referred as the L contour. 
 Adaptive thresholding of urine. Different strategies are used for the adaptive thresholding 
of the NC and C regions of the bladder to isolate the bladder wall from the urine within the 
bladder. The methods were previously described in Chapter V, section 5.3.3.2. In brief, the C 
region uses the gray level information for setting the threshold, while the NC region uses a 
location-based method to set the threshold for removing the urine within the bladder. Once the 
threshold is determined, the urine is eliminated from the NC and C regions by setting the gray 
level to 0 for all pixels whose gray level is greater than 𝑇ℎ𝑁𝐶
𝑗
. Additionally, any pixels that are 
contained within the inner bladder wall segmentation also had their gray level set to 0. 
 Wall profile generation. Once the urine is removed from the CTU slice, a straightened 
profile of wall thickness is generated by mapping all of the points along the L contour, Li, i=1, 
…, n, sequentially to the X-axis of a new coordinate system such that Li(xi ,yi) has the coordinate  
(Xi,0). The origin of this new coordinate system is defined at the top left of the profile, with Y-
values increasing in the downward direction. For a given pixel Li(xi ,yi), the path normal to the 
point towards the interior of the L contour is calculated using the normal angle 𝜃 defined as: 
 
𝜃 = 90˚ +
1
2
(tan−1 (
𝑦𝑖 − 𝑦𝑖−1
𝑥𝑖 − 𝑥𝑖−1
) + tan−1 (
𝑦𝑖+1 − 𝑦𝑖
𝑥𝑖+1 − 𝑥𝑖
)), 
(6.3) 
where (xi+1,yi+1) and (xi-1,yi-1), respectively, are the coordinates of the next Li+1  and previous Li-1  
neighboring points of Li,. The pixels along the normal path are sequentially mapped onto the 
profile at increasing Y-values such that the new coordinates of the pixels are given by (Xi,Yj)  
j=1,…im, while Xi is fixed.  The path along the normal ends when 16 black pixels are 
encountered consecutively, indicating that the path reaches the lumen of the bladder where the 
pixel gray level has been set to 0. The number of pixels along the normal path at Li is denoted by 
im.  Pixels that will be removed by the following false reduction step are also marked on the 
figures.  
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(a) (b) (c) 
Figure 6.1: Detection of bladder wall thickening. (a) Bladder wall segmentation. The light blue contour represents the outer 
bladder wall segmentation, while the dark blue contour represents the inner bladder wall segmentation. (b) Wall profile after 
thresholding to remove the urine within the entire bladder. The arrows indicate location where candidate points are mapped 
back to the CTU image. (c) Detected bladder wall thickening candidates mapped back to CTU image after region growing. 
 
6.3.3.3 False positive reduction of voxel candidate 
 Sharp peaks along the bladder wall profile that are likely caused by noise are removed. 
Since noise is random and forms small peaks, we set a criterion to exclude peaks less than three 
pixels in width and greater than five pixels in height relative to its surroundings. 
  
6.3.3.4 Thickening candidate identification 
Wall thickening candidates are found by analyzing the bladder wall profile. For a given 
bladder profile, the histogram of the height of the profile is calculated, using a binning of 8 
pixels for the height. A height threshold in pixels is set by taking the binning value of the two 
bins greater than the peak of the histogram. Figure 6.2 shows the histogram for the wall profile 
shown in Figure 6.1(b). 
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Figure 6.2: Histogram of the wall profile shown in Figure 6.1(a). The peak of the histogram is located at a pixel height of 0 for 
this slice; therefore, the height threshold was set to 16 pixels, which is two bins greater than the peak.  
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 After the wall thickening candidate pixels are identified, they are mapped back to the 
original bladder slices as lesion candidate voxels. Region growing is performed on the candidates 
such that they will grow into a target touching region within the image if the target region is 
within the bladder wall segmentation. Figure 6.1(c) shows an example of candidates that were 
found and were grown. 
 The thickening candidate voxels are then grouped into regions. Candidate voxels that are 
one slice apart, and within two voxels apart in 3D space are clustered into the same region. A 
candidate voxel is ignored if there are no other candidate voxels that are within two voxels on the 
same slice. Regions that contain less than five candidate voxels or greater than 50,000 candidate 
voxels are ignored. This size range was determined by analyzing the training cases.  
 
6.3.4 Thickening feature extraction and classification 
The volumes of each of the regions were calculated in cubic millimeters to use as features 
for classification purposes. A linear discriminant analysis (LDA) classifier was then designed 
with the training set for classification of the bladder lesions and false positives using the volume 
features as input predictor variables. The trained LDA classifier was applied to the test set for 
independent testing.  
 
6.3.5 Evaluation methods 
 The performance of the lesion candidate prescreening steps was evaluated by 
determining the sensitivity and specificity. The overall performance of the bladder wall 
thickening detection CAD system with feature extraction and FP reduction by the LDA classifier 
was evaluated using free-response receiver operator characteristics (FROC) analysis. The FROC 
curve was generated by varying the decision threshold for the LDA discriminant scores. 
 
6.4 Results 
At the prescreening step, our system achieved 93.2% (41/44) sensitivity with an average 
of 2.6 false positives per case (FPs/case) for the training set, and 88.4% (38/43) sensitivity with 
3.4 FPs/case for the test set. Using feature extraction, LDA classifier and by varying the 
threshold for the LDA scores, the FROC curve was generated as shown in Figure 6.3. At 2 
FPs/case, the sensitivity of both training and testing set did not change. At 1 FPs/case, the 
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sensitivities were 93.2% and 88.4% for the training and test sets, respectively. Table 6.6 shows 
the sensitivities of the system at different false positive rates for the training and test sets. 
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Figure 6.3: FROC curves for automatic computer detection after feature classification with LDA. After prescreening, the system 
achieved 93.2% sensitivity with 2.6 FPs/case for the training set, and 88.4% sensitivity with 3.4 FPs/case for the test set.  After 
LDA classification, at 1 FPs/case the sensitivities were 93.2% and 88.4% for the training and test sets, respectively. 
 
 
Examples of true positive lesions detected are shown in Figure 6.4. Figure 6.5 shows 
examples of false positive detections, while Figure 6.6 shows a thickening that was missed. 
Table 6.1: Sensitivity at a given FP rate after using LDA classifier. 
 
False positive rate (FPs/case) 
0.5 1.0 1.5 2.0 
Training set 90.9% 93.2% 93.2% 93.2% 
Test set 88.4% 88.4% 88.4% 88.4% 
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6.5 Discussion 
In this study, we developed a system that can automatically detect bladder wall 
thickenings using only an ROI box as input. At the pre-processing stage, the system detected 
most of the thickenings in both the training and test sets, while having about 3 false positives per 
case.  
 
  
(a) (b) 
Figure 6.4: Examples of detected areas of bladder wall thickening (true positives). (a) Wall thickening located in the non-
contrast region. (b) Detected wall thickening partially within the contrast-enhanced region of the bladder.  
 
 
 
(a) (b) 
Figure 6.5: Examples of false positives. (a) Slightly thicker wall compared to the remainder of the bladder wall is present in a 
normal bladder. (b) Bladder wall looks thicker due to volume averaging. Neither was removed by the LDA classifier. 
 
 
Figure 6.6: Example of bladder wall thickening missed by prescreening (false negative). The relatively flat wall thickening on 
the bottom of the bladder prevented the prescreening steps from identifying this lesion candidate, which was malignant. 
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Common false positive findings were due to the slightly thicker-looking bladder walls 
that the radiologists did not marked as an abnormality, which was sometimes produced by 
volume averaging with adjacent structures (Figure 6.5). A common cause of false negative 
finding was due to only minimally increased wall thickening along the posterior aspect of the 
bladder (Figure 6.6). 
This study has several limitations. First, the reference standard used for this study was the 
radiologists marking the locations of bladder wall thickening, which may include regions that do 
not represent true bladder cancers. In the future, the system should be tuned to detect only 
bladder wall thickening with true pathology. Second, while the data set consists of 112 cases, it 
is relatively small. The method should be evaluated on a much larger data set to study the 
feasibility of our method. Third, this study was directed towards detection of bladder wall 
thickenings, but not focal bladder masses. As we have developed a system for detection of 
bladder masses, we plan on combining our two methods and developing a system for full 
detection of bladder abnormalities as components of a complete CAD system for detection of 
bladder cancer. 
 
6.6 Conclusion 
This study demonstrates the feasibility of our method for detection of areas of bladder 
wall thickenings in CT urogram studies. The prescreening stage detected most of the suspicious 
areas of thickening, but there were some false positive results. Using a trained classifier with 
volume of the detected region as the input feature, the false positives were reduced while keeping 
the sensitivity high. The results indicate the usefulness of the methods for bladder wall 
thickening detection in CTU. This study is a step towards the development of a CAD system for 
detection of urothelial wall thickenings imaged with CT urography. 
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Chapter VII 
Urinary Bladder Cancer Staging in CT Urography using Machine Learning 
 
7.1 Abstract 
We are evaluating the feasibility of using an objective computer aided system to assess 
bladder cancer stage in CT Urography (CTU). A data set consisting of 84 bladder cancer lesions 
from 76 CTU cases was used to develop the computerized system for bladder cancer staging 
based on machine learning approaches. The cases were grouped into two classes based on 
pathological stage ≥T2 or below T2, which is the decision threshold for neoadjuvant 
chemotherapy treatment clinically. There were 43 cancers below stage T2 and 41 cancers at 
stage T2 or above. All 84 lesions were automatically segmented using our previously developed 
auto-initialized cascaded level sets (AI-CALS) method. Morphological and texture features were 
extracted. The features were divided into subspaces of morphological features only, texture 
features only, and a combined set of both morphological and texture features. The data set was 
split into Set 1 and Set 2 for two-fold cross validation. Stepwise feature selection was used to 
select the most effective features. A linear discriminant analysis (LDA), a neural network (NN), 
a support vector machine (SVM), and a random forest (RAF) classifier were used to combine the 
features into a single score.  The classification accuracy of the four classifiers was compared 
using the area under the receiver operating characteristic (ROC) curve (Az). Based on the texture 
features only, the LDA classifier achieved a test Az of 0.91 on Set 1 and a test Az of 0.88 on Set 2. 
The test Az of the NN classifier for Set 1 and Set 2 were 0.89 and 0.92, respectively. The SVM 
classifier achieved test Az of 0.91 on Set 1 and test Az of 0.89 on Set 2. The test Az of the RAF 
classifier for Set 1 and Set 2 was 0.89 and 0.97, respectively. The morphological features alone, 
the texture features alone, and the combined feature set achieved comparable classification 
performance. The predictive model developed in this study shows promise as a classification tool 
for stratifying bladder cancer into two staging categories: greater than or equal to stage T2 and 
below stage T2. The preliminary results using methods presented in this chapter have been 
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published as conference proceedings
7
. A journal article has been submitted and is under revision 
at the time of this dissertation. 
 
7.2 Introduction 
The initial treatment for bladder cancer is transurethral resection of the bladder tumor 
(TURBT) that removes the tumor from the bladder and also helps provide information regarding 
the stage of the cancer
53-55
. Bladder cancer is staged in order to determine treatment options and 
estimate a prognosis for the patient. Accurate staging provides the physician with information 
about the extent of the cancer. The tumor stages T refer to the depth of the penetration of the 
tumor into the layers of the bladder. T0 indicates no primary tumor, T1 indicates that the tumor 
has invaded the connective tissue under the epithelium, T2 indicates that the tumor has invaded 
the bladder muscle, T3 indicates that the tumor has invaded the fatty tissue around the bladder, 
and T4 indicates that the tumor has spread beyond the fatty tissue into other areas such as the 
pelvic wall, uterus, prostate or abdominal wall
12
 (Figure 7.1). An example of bladder cancer 
stage T2 is presented in Figure 7.2.  
Accurate staging of bladder cancer is crucial to providing proper treatment to the patient. 
Superficial diseases (under stage T2) can be managed with less aggressive treatment than 
invasive diseases (stage T2 and above)
53-55
. There are two types of staging for bladder cancer - 
clinical and pathological. The clinical stage is the physicians’ best estimate for the extent of the 
cancer based on physical exams and imaging. The pathological stage is determined by analysis 
of the tissue collected from the cancer after biopsy, tumor resection or bladder cystectomy. The 
accuracy of the staging depends on the complete resection of the tumor. Incomplete resection of 
the tumor may reduce the reliability of the staging at the beginning of the tumor management 
process
56
. Cystectomy ensures that the entire bladder tumor is present for pathological review; 
therefore, the pathological staging is based on the histological review of the cystectomy 
specimen
57
. Adjuvant chemotherapy is used in patients with locally advanced bladder cancer in 
order to reduce the chances of cancer recurrence following radical cystectomy
58
. Neoadjuvant 
chemotherapy is used prior to radical cystectomy in order to reduce the tumor size before 
surgical removal; for example, a cisplatin-based regimen has been shown to decrease the 
probability of finding extravesical disease and improves survival when compared to radical 
cystectomy alone
58-60
.  
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Figure 7.1:  Bladder cancer stage grading scale definition.  
 
Correct staging of bladder cancer is crucial for the decision of neoadjuvant chemotherapy 
treatment and minimizing the risk of under-treatment or over-treatment. Many patients with 
stage T2 to T4 carcinomas of the bladder are often referred for neoadjuvant chemotherapy. 
Studies found that up to 50% of the patients who are estimated to have a T1 disease at 
clinical staging are under-staged and later upstaged after radical cystectomy
61-64
. This inaccuracy 
in staging can partly be attributed, in part, to the possibility that invasive portions of a bladder 
tumor may not be sampled during TURBT. Additionally, limitations in the ability of CT and 
MRI in detecting perivescial spread of tumor are well known.  
The purpose of this study is to develop an objective decision support system that can 
potentially reduce the risk of under-treatment or over-treatment by merging radiomic information 
in a predictive model using statistical outcomes and machine learning. 
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No primary tumor in the 
bladder  
Tumor invasion of 
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into muscular layer 
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Tumor has spread to 
other nearby organs 
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Figure 7.2:  Urinary Bladder CT. The bladder cancer is marked and clearly visible. The cancer stage is T2.  
 
 
7.3 Materials and Methods 
7.3.1 Data set 
The data collection protocol was approved by our institutional review board and is 
HIPAA compliant. Patient informed consent was waived for this retrospective study. Our data 
set consisted of 84 bladder cancer lesions from 76 bladder cancer CTU cases collected from 
patient files without additional imaging for research purpose.  The CTU scans in this data set 
were acquired using the protocol described in Chapter II, section 2.3.4. The data set consisted of 
22 non-contrast cases (22 lesions), 22 early phase contrast-enhanced cases (22 lesions), and 32 
delayed-phase contrast-enhanced cases (40 lesions). Per imaging protocol, the early phase 
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contrast-enhanced images are obtained 60-70 seconds following the initiation of a contrast 
injection.  The delayed-phase contrast-enhanced images are obtained 12 min after the initiation 
of contrast injection. The type of scan a patient receives is determined by the protocol of the 
hospital performing the scan. Our data set includes patients referred to our hospital for treatment 
so that some scans were performed at outside hospitals and followed different scanning protocols, 
resulting in scans with inconsistent contrast-enhancement phase. A patient may also get a non-
contrast scan due to risk factors, such as allergy to the contrast media, asthma or renal 
insufficiency
65
. 
For all cases, clinical and pathological staging were performed during the patient’s 
clinical care.  Cystectomy was performed after completing the course of neoadjuvant 
chemotherapy.  The primary chemotherapy regimen used for the patients in our data set was 
MVAC, which is a combination of four medications: Methotrexate, Vinblastine, Doxorubicin, 
and Cisplatin. Stage T2 is identified to be clinically important as a decision threshold for 
neoadjuvant chemotherapy treatment. The stage at the beginning of the tumor management 
process, based on the clinical staging and pathological staging was used as a reference standard 
of the tumor stage for our study. 
In addition, for all bladder cancer lesions, a radiologist measured the longest diameter on 
the pre-treatment scans by using an electronic caliper provided by an in-house developed 
graphical user interface. 
  The 84 bladder cancer lesions were separated into two classes. The first class consisted 
of 41 cancers that were stage T2 or above and the patients were treated with neoadjuvant 
chemotherapy. The second class consisted of 43 cancers that were below stage T2 and patients 
were not referred to neoadjuvant chemotherapy treatment. The data set was then split randomly 
by case into two sets with 42 cancers each while keeping the proportion of cancers between the 
two classes similar. The first set (Set 1) consisted of 22 cancers below stage T2 and 20 cancers 
stage T2 or above. The second set (Set 2) consisted of 21 cancers below stage T2 and 21 cancers 
stage T2 or above.  
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(a) (b) 
Figure 7.3:  Distribution of tumor sizes (the longest diameters) for Set 1 and Set 2. (a) Set 1: The average tumor sizes 
of stage < T2 and ≥ T2 were 26.4±17.3 mm and 45.6±19.1 mm respectively. (b) Set 2: The average tumor sizes of 
stage < T2 and ≥ T2 were 27.3±10.8 mm and 40.6±17.3 mm respectively. 
 
 
In Set 1, two patients had two lesions and one patient had three lesions. In Set 2, three patients 
had two lesions. In Set 1, the average tumor sizes (the longest diameters) of stage < T2 and > T2 
were 26.4±17.3 and 45.6±19.1 mm, respectively (Figure 7.3(a)). In Set 2, the average tumor 
sizes (the longest diameters) of stage <T2 and >T2 were 27.3±10.8 mm and 40.6±17.3 mm, 
respectively (Figure 7.3(b)). 
 
7.3.2 Segmentation of bladder lesions on CT urography 
Our previously developed method for bladder lesion segmentation using an auto-initialized 
cascaded level set (AI-CALS) was used
47
, which was previously described in Chapter IV, section 
4.3.4.1. The details of the AI-CALS method can be found in our previous paper
47
. 
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Figure 7.4: Block diagram of the auto-initialized cascaded level sets (AI-CALS) method. 
 
7.4 Classification 
7.4.1 Feature extraction  
Following automated computer segmentation, texture features and morphological 
features were extracted to characterize the lesion. The mass size was measured as its 3D volume. 
Five morphological features were extracted based on the normalized radial length (NRL). NRL is 
defined as the radial length normalized relative to the maximum radial length for the segmented 
object
51
. The NRL features extracted include zero crossing count, area ratio, standard deviation, 
mean, and entropy. In addition, ten contrast features and a number of features including 
circularity, rectangularity, perimeter-to-area ratio, Fourier descriptor, gray level average, 
Cascaded Level Set 
3D Gradient Magnitude 
and Direction Images 
3D Smoothing, Region 
Growing 
Auto-Initialization 
Automatic Segmentation 
Volume of Interest 
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standard deviation of gray level, mean density, eccentricity, moment ratio, and axis ratio were 
extracted as shape descriptors.  
The texture of the tumor margin can provide important information about its 
characteristics. We calculated texture features from the rubber band straightening transform 
(RBST) images
66
 of the tumor margin including those from the run-length statistics matrices, 
filtered Dasarathy east-west direction and filtered Dasarathy horizontal direction
30, 67
. The texture 
feature set also included the gray level radial gradient direction features.  
In total, 91 features were extracted to form the feature space, including 26 morphological 
features and 65 texture features.  
 
7.4.2 Feature selection/classification  
A block diagram of the machine learning based bladder cancer staging system is shown 
in Figure 7.5. Stepwise feature selection was used to select the best subset of features to create 
an effective classifier
68
. A number of different classification experiments were performed to 
determine the best collection of input features. The classification performance was compared in 
three feature spaces: (1) morphological features only, (2) texture features only, and (3) 
morphological and texture features combined. A two-fold cross validation was conducted by 
partitioning the data set into Set1 and Set 2. In the first fold, Set 1 was used for feature selection 
and classifier training. The trained classifier was then tested on Set 2. In the second fold, feature 
selection and classifier training were performed on Set 2 and then tested on Set 1.  
When training on a given fold (for example, Set 1) a leave-one-case-out resampling 
scheme with stepwise feature selection was used to reduce the dimensionality of the feature 
space. In stepwise feature selection, one feature is entered or removed in alternate steps while 
their effect is analyzed using the Wilks’ lambda criterion68.  The significance of the change in the 
Wilks’ lambda when a feature is included or removed was estimated by F statistics. Fin, Fout, and 
tolerance are the parameters of the stepwise feature selection that define the thresholds for 
inclusion or exclusion of a given feature. A range of Fin, Fout, and tolerance values is evaluated 
by using an automated simplex optimization method. The set of Fin, Fout, and tolerance values 
that lead to the highest classification result with the lowest number of features based on the 
training set are selected. A smaller number of features are preferred in order to reduce the chance 
of overfitting.  Once the set of Fin, Fout, and tolerance is selected, the stepwise feature selection 
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with the selected parameter set is applied to the entire training fold to select a single set of 
features and train a single classifier.  After the classifier is fixed it is applied to the test fold (for 
example, Set 2) for performance evaluation.  
Four different classifiers were evaluated in this study. The same partitioning of Set 1 and 
Set 2 was used for all classifiers.  We compared the four classifiers for this classification task.  
The first classifier was linear discriminant analysis (LDA)
69, 70
. The LDA with the stepwise 
feature selection was used to determine the most effective features using the training set in each 
fold, as described above.  The second classifier was a back-propagation neural network (NN) 
71
 
with a single hidden layer and a single output node. The selected features from LDA were used 
for this classifier and they determined the number of input nodes to the NN. The parameters for 
the NN were adjusted using the training set, and the best performing network was applied to the 
test set. The third classifier was a support vector machine (SVM)
72, 73
 with a radial basis kernel. 
Using training data, a SVM determines a decision hyperplane to separate the two classes by 
maximizing the distance, or the margin, between the training samples of both classes and the 
hyperplane. The width of the SVM radial basis kernels γ was varied between 0.02 and 0.14 for 
the experiments. The best parameters for the SVM kernels for a specific experiment were 
selected using the training set, which were then applied to the test set. The LDA selected features 
were also used as the input to the SVM.  The fourth one is the Random Forest (RAF) classifier
74
.  
We used the WEKA
75
  implementation and selected 50 to 100 trees and 5 to 7 features per tree 
for our classification task using the training set in each fold. The parameters for the random 
forest classifier were determined experimentally using the training sets. All 91 features were 
used as an input to the RAF. 
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Figure 7.5: Block diagram of our machine learning based staging system. We compared the linear discriminant analysis (LDA), 
back-propagation neural network (NN), Support vector machine (SVM), and Random forest classifiers (RAF) in the 
classification stage for this study.  
 
7.4.3 Evaluation methods  
 Lesion segmentation performance was evaluated using radiologists’ 3D hand-segmented 
contours as reference standards. The hand outlines of all 84 lesions were obtained from an 
experienced abdominal radiologist (RAD1). Hand outlines for a subset of 12 lesions were 
obtained from a second experienced abdominal radiologist (RAD2). The average distance and 
the Jaccard index
29
 were calculated between the computer outlines and the hand outlines, using 
methods described in Chapter II, section 2.3.5.  
To evaluate the classifier performance, the training and test scores output from the 
classifier were analyzed using the receiver operating characteristic (ROC) methodology
76
. The 
classification accuracy was evaluated using the area under the ROC curve, Az.  The statistical 
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Feature Extraction  
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Segmentation  
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117 
 
significance of the differences between the different classifiers and feature spaces were estimated 
by the CLABROC program using ROC software by Metz et al.
77, 78
. 
 
7.5 Results 
The lesion segmentation performance of the AI-CALS compared to the radiologist hand outlines 
for the 84 lesions are shown in Table 7.1. Table 2 shows the computer segmentation performance 
compared to two different radiologists’ hand outlines for a subset of 12 lesions. 
Table 7.1: Segmentation performance of the 84 lesions compared 
to hand-outlines performed by radiologist 1 (RAD1). 
 
AI-CALS vs. RAD1 
Average distance 
AVDIST 
4.9 ± 2.7 mm 
Jaccard index 
JACCARD3D 
43.5 ± 14.0% 
 
 
Table 7.2: Segmentation performance for a subset of 12 lesions compared to hand-outlines performed by two different radiologists 
(RAD1, RAD2). 
 
AI-CALS vs. RAD1 AI-CALS vs. RAD2  RAD1 vs. RAD2 
Average distance 
AVDIST 
5.2 ± 2.5 mm 4.1 ± 1.5 mm 2.9 ± 1.1 mm 
Jaccard index 
JACCARD3D 
43.2 ± 13.2% 50.1 ± 14.7% 58.7 ± 11.1% 
 
 
The performance of the classifiers based on different machine learning techniques, the 
LDA, NN, SVM, and RAF, is summarized in Table 7.3. Different feature spaces containing the 
morphological features, the texture features, and the combined set of both morphological and 
texture features were used for classification. The features selected with LDA were used in the 
SVM and NN classifiers. The LDA classifier with morphological features achieved a training Az 
of 0.91 on Set 1 and a test Az of 0.81 on Set 2. For training on Set 2 it achieved a Az of 0.97 and 
a test Az of 0.90 on Set 1. The selected features on the training sets included volume, a contrast 
feature, and gray level feature. The test Az of the NN for Set 1 and Set 2 was 0.88 and 0.91 
respectively. The SVM achieved test Az of 0.88 on Set 1 and test Az of 0.90 on Set 2. The test Az 
of the RAF for Set 1 and Set 2 was 0.83 and 0.88 respectively. The distribution of the 
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discriminant scores from the four classifiers for testing on Set 1 and Set 2 in two fold cross-
validation in the morphological feature space is presented in Figure 7.6. It can be observed that 
most of the classifiers were able to provide a relatively good separation between the two classes.  
By using the texture features the LDA classifier achieved a test Az of 0.91 on Set 1 and a 
test Az of 0.88 on Set 2. When trained on Set 1 or Set 2 the stepwise feature selection procedure 
selected subsets of the filtered Dasarathy east-west direction features, the filtered Dasarathy 
horizontal direction features and the gray level radial gradient direction features. The test Az of 
the NN classifier for Set 1 and Set 2 was 0.89 and 0.92, respectively. The SVM classifier 
achieved test Az of 0.91 on Set 1 and test Az of 0.89 on Set 2. The test Az of the RAF classifier 
for Set 1 and Set 2 was 0.89 and 0.97, respectively. 
When the morphological and the texture features were combined, the LDA classifier 
achieved a test Az of 0.89 on Set 1 and a test Az of 0.90 on Set 2. When trained on Set 1 or Set 2 
the stepwise feature selection procedure selected a contrast feature, subsets of the filtered 
Dasarathy horizontal direction features, and subsets of the gray level radial gradient direction 
features. The test Az of the NN classifier for Set 1 and Set 2 was 0.91 and 0.95, respectively. The 
SVM classifier achieved test Az of 0.92 on Set 1 and test Az of 0.89 on Set 2. The test Az of the 
RAF classifier for Set 1 and Set 2 was 0.86 and 0.96, respectively. The test ROC curves for all of 
the classifiers when tested on Set 1 and Set 2 in the two fold cross-validation in the different 
feature spaces are shown in Figure 7.7. 
The differences in the Az values between pairs of classifiers did not achieve statistical 
significance.  The classifiers achieved slightly higher Az values in the texture and combined 
feature spaces than in the morphological feature space; however, the differences did not achieve 
statistical significance after Bonferroni correction for the multiple comparisons (p-value < 
0.05/18=0.0028 to be considered significant). 
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Table 7.3: Summary results for LDA, NN, SVM and RAF classifiers in morphological, texture, and combined feature spaces. The 
column “Number of Features” did not apply to the RAF classifier. All features were used for the RAF classifier. The differences 
in the Az values in pair-wise comparison of the different classifiers did not achieve statistical significance after performing 
Bonferroni correction for the 18 comparisons (p>0.0028).   
  
  
LDA NN SVM RAF 
Feature Type 
Number 
of 
Features 
Training Testing Training Testing Training Testing Training Testing 
Morphological 
Features        
  
Training (Set 1) 
Testing (Set 2) 
4 0.91 0.81 0.96 0.91 0.95 0.90 1 0.88 
Training (Set 2) 
Testing (Set 1) 
4 0.97 0.90 0.98 0.88 0.97 0.88 1 0.83 
Texture 
Features        
  
Training (Set 1) 
Testing (Set 2) 
2 0.91 0.88 0.95 0.92 0.92 0.89 1 0.97 
Training (Set 2) 
Testing (Set 1) 
7 1 0.91 1 0.89 1 0.91 1 0.89 
Combined 
Features        
  
Training (Set 1) 
Testing (Set 2) 
3 0.92 0.90 0.97 0.95 0.92 0.89 1 0.96 
Training (Set 2) 
Testing (Set 1) 
7 1 0.89 1 0.91 1 0.92 1 0.86 
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Figure 7.6: Distribution of the classifiers discriminant scores for testing on Set 1 and Set 2 in two-fold cross validation using the 
morphological features. (a) LDA (Set 1) Az = 0.90, (b) LDA (Set 2) Az = 0.81, (c) SVM (Set 1) Az = 0.88, (d) SVM (Set 2) Az = 
0.90, (e) NN (Set 1) Az = 0.88, (f) NN (Set 2) Az = 0.91, (g) RAF (Set 1) Az = 0.83, (h) RAF (Set 2) Az = 0.88. 
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Figure 7.7:  ROC curves for testing on Set 1 and Set 2 in two-fold cross validation for LDA, SVM, NN, and RAF classifiers: Left 
column: testing on Set 1, right column: testing on Set 2.  (a) and (b) morphological features; (c) and (d) texture features; (e) and 
(f) combined features. 
 
7.6 Discussion 
The agreement between the AI-CALS lesion segmentation and the radiologists’ manual 
segmentation was slightly lower than the agreement between two radiologists’ hand outlines, 
indicating that the computer segmentation will need to be further improved. An improved 
method for the bladder lesion segmentation is presented in Chapter VIII. Both the morphological 
and the texture features were important for classifying the bladder cancer stage. When only 
morphological features were used in the classifier, volume and contrast features were always 
selected. Volume was the primary feature used to describe lesion size.  When the classifier used 
only the texture features, the features from the 3 main groups, the filtered Dasarathy east-west 
direction features, the filtered Dasarathy horizontal direction features, and the gray level radial 
gradient direction features were consistently selected. There was essentially no change in 
classification accuracy when the morphological features were added to the texture features in the 
combined set.  
The LDA, SVM, and NN classifiers all led to relatively consistent results. There was no 
statistically significant difference in the performances between pairs of the classifiers. The best 
overall results for the two-fold cross validation were obtained when a combined feature set was 
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used with an NN classifier. Using Set 1 for training, the training Az was 0.97 and the test Az was 
0.95. Using Set 2 for training, the training Az was 1.00 and the test Az was 0.91.  
The RAF classifier showed greater imbalance between Set 1 and Set 2 than the other 
classifiers. When training was done on Set 2 and testing on Set 1, the Az were substantially lower 
than the Az values when training was done on Set 1 and testing on Set 2. For example, the test Az 
decreased from 0.88 to 0.83 for morphological features, from 0.97 to 0.89 for texture features 
only, and from 0.96 to 0.86 for the combined features. This imbalance between the two sets 
could be due to the fact that RAF utilized all the features in the subspace whereas the other three 
classifiers involved feature selection.  
Examples of bladder cancers with stages ≥ T2 or < T2 and the corresponding classifier 
scores are shown in Figure 7.8. The reported scores are test scores for the LDA, SVM, NN, and 
RAF classifiers based on the morphological features. In Figure 7.8(a), (b) and Figure 7.8(c), (d) 
are shown T1 stage cancers of different sizes that were correctly classified with low scores by all 
classifiers. Note that the output score ranges are different for different classifiers so that the score 
values should not be compared across classifiers. T3 stage and T2 stage cancers that were 
correctly classified with high scores from all classifiers are presented in Figure 7.8(e), (f) and 
Figure 7.8(g), (h), respectively.  A case that was clinically identified as T1 stage pre-surgery but 
later was identified as a T2 stage cancer post-surgery is shown in Figure 7.8(k), (l). The 
classifiers classified the cancer as ≥ T2 with high scores. Figure 7.8(m), (n) show a T2 stage 
cancer that was incorrectly identified by the LDA, SVM, and NN classifiers with low scores, but 
correctly identified by the RAF with a high score. 
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We also have extracted features from the manually segmented bladder lesions and 
applied the 4 different types of classifiers with the different feature sets to the cancer stage 
prediction.  The classifiers using features extracted from the manually segmented lesions 
  
  
(a) (b) (c) (d) 
LDA= -1.85;  SVM= -0.95;  NN= 0.04;  RAF= 0.28 LDA= -2.44;  SVM= -1.50;  NN= 0.05;  RAF= 0.20 
  
    
(e) (f) (g) (h) 
LDA= 7.46;  SVM= 2.13;  NN= 1.00;  RAF= 0.86 LDA= 1.62;  SVM= 1.73;  NN= 0.91;  RAF= 0.54 
  
  
  
(k) (l) (m) (n) 
LDA= 3.42;  SVM= 1.50;  NN= 1.00;  RAF= 0.82 LDA= -0.97;  SVM= -0.55;  NN= 0.33;  RAF= 0.69 
Figure 7.8: Examples of bladder cancers with stages ≥ T2 or < T2. The blue outlines represent the AI-CALS segmentation. The reported 
scores are test scores for the LDA, SVM, NN, and RAF classifiers based on the morphological features.  Note that the output score 
ranges are different for different classifiers so that the score values should not be compared across classifiers. The two cases in (a)(b) and 
(c)(d) both contained was a T1 stage cancer that was properly classified with low scores from all classifiers. (e)(f) was a T3 stage case 
that was properly classified with high scores from all classifiers. (g)(h) was a T2 stage case that was properly classified with high scores 
from all classifiers. (k)(l) was a case that was clinically identified as T1 pre-surgery but was identified as a T2 stage cancer post-surgery. 
The classifiers classified the cancer as ≥T2 with high scores. (m)(n) was T2 stage cancer that was incorrectly identified by the LDA, 
SVM, and NN classifiers with low scores and correctly identified by the RAF with a high score. 
125 
 
performed similarly to the classifiers using features extracted from the AI-CALS segmented 
lesions. The test Az values ranged from 0.77 to 0.95. For 6 out of the 24 experiments the 
classifiers using features extracted from the manually segmented lesions performed better than 
classifiers using features extracted from the AI-CALS segmentations. However, the differences 
did not reach statistical significance. Therefore, although the performance of the AI-CALS lesion 
segmentation was slightly lower than the radiologists’ hand outlines the final classification 
results were similar. 
The main limitation of the study is the small data set.  Another limitation is that we have 
not applied the deep learning convolution neural network (DLCNN) to this bladder cancer 
staging task.  DLCNN has been shown to be superior to conventional classifiers in many 
classification tasks, especially the classification of natural scene images with millions of training 
samples. It also shows promise in number of medical imaging applications
79, 80
 including bladder 
segmentation
2
 and bladder cancer treatment response monitoring
10
.   However, our experience 
with DLCNN also indicates that it is not always the best, perhaps limited by the relatively small 
annotated training set in medical imaging, even with transfer learning.  As the performances of 
the four conventional classifiers used in this study were quite high, it would not be a fair 
comparison for DLCNN if we do not have adequate training for it.  We will continue to collect 
additional cases and compare the conventional classifiers with DLCNN for bladder cancer 
staging in a future study. 
 
7.7 Conclusion 
In this preliminary study we proposed machine learning methods for prediction of 
bladder cancer stage. It was found that the morphological features and texture features were 
useful for assessing the stage of bladder lesions. The LDA, SVM, and NN classifiers all led to 
relatively consistent results. There was a trend that the SVM and NN classifier slightly 
outperformed the LDA classifier. The best overall results for the two-fold cross validation were 
obtained when a combined feature subspace was used with the NN classifier. Further studies are 
under way to improve the staging of bladder cancer and test the classifier on a larger data set, 
and to investigate the potential of improving the predictive model by combining imaging 
biomarkers with non-imaging biomarkers.  
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Chapter VIII 
Bladder Cancer Segmentation in CT for Treatment Response Assessment: Application of 
Deep-Learning Convolution Neural Network - A Pilot Study  
 
8.1 Abstract 
Assessing the response of bladder cancer to neoadjuvant chemotherapy is crucial for 
reducing morbidity and increasing quality of life of patients. Changes in tumor volume during 
treatment are generally used to predict treatment outcome. We are developing a method for 
bladder cancer segmentation in CT using a pilot data set of 62 cases. 65,000 regions of interests 
were extracted from pre-treatment CT images to train a deep-learning convolution neural 
network (DL-CNN) for tumor boundary detection using leave-one-case-out cross-validation. The 
results were compared to our previous AI-CALS method. For all lesions in the data set, the 
longest diameter and its perpendicular were measured by two radiologists, and 3D manual 
segmentation was obtained from one radiologist. The World Health Organization (WHO) criteria 
and the Response Evaluation Criteria In Solid Tumors (RECIST) were calculated, and the 
prediction accuracy of complete response to chemotherapy was estimated by the area under the 
receiver operating characteristic curve (AUC). The AUCs were 0.73 ± 0.06, 0.70 ± 0.07 and 0.70 
± 0.06, respectively, for the volume change calculated using DL-CNN segmentation, the AI-
CALS and the manual contours. The differences did not achieve statistical significance.  The 
AUCs using the WHO criteria were 0.63 ± 0.07 and 0.61 ± 0.06, while the AUCs using RECIST 
were 0.65 ± 007 and 0.63 ± 0.06 for the two radiologists, respectively. Our results indicate that 
DL-CNN can produce accurate bladder cancer segmentation for calculation of tumor size change 
in response to treatment. The volume change performed better than the estimations from the 
WHO criteria and RECIST for the prediction of complete response. The results presented in this 
chapter have been published
4
. 
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8.2 Introduction 
The standard treatment method for bladder cancer involves radical cystectomy of the 
bladder; however, approximately 50% of the patients who have under gone cystectomy and were 
thought to have only locally invasive cancer at the time of the surgery develop metastatic disease 
within 2 years and subsequently die of the disease
81
. This may be due to the presence of micro-
metastatic disease, or presence of neoplasms that had spread to perivascular tissue, with the 
spread not detected at the time of the treatment. Neoadjuvant chemotherapy has been shown to 
improve resectability of large tumors, as well as being beneficial for the treatment of 
micrometastases before radical cystectomy
58-60
. The methotrexate, vinblastine, doxorubicin, and 
cisplatin (MVAC) treatment regimen has been shown to decrease the chance for finding residual 
cancer after cystectomy than cystectomy alone, and increase the survival of patients with locally-
advanced bladder cancers
82, 83
. The side effects of this treatment are severe, however, which 
include neutropenic fever, sepsis, mucositis, nausea, vomiting, malaise, and alopecia
84
. As there 
are no reliable methods at present to predict a patient’s response to chemotherapy, it is possible 
that patients suffer through these conditions while having to endure treatment that may or may 
not achieve the desirable benefits. Therefore, early assessment of the bladder cancer treatment 
response is important, as it may allow the clinician to stop the treatment early if the treatment 
does not work well.  This will help reduce morbidity of the patient and increase their quality of 
life. It may also preserve the patient’s physical conditions and allow the patient to pursue 
alternative treatment that may be more beneficial. 
The response to treatment can be measured via pathological information from the 
removed bladder after cystectomy or other surgical procedures such as transurethral resection of 
bladder tumor (TURBT).  However, as these patients are receiving chemotherapy, surgery may 
not be the ideal method for assessing treatment response. The patients are weak from going 
through the chemotherapy and may have difficulties with the additional burden of surgery in the 
middle of their chemotherapy treatment; therefore, noninvasive evaluation would be preferable. 
Image-based evaluation, using CT or MRI images, can noninvasively visualize the tumor during 
the chemotherapy treatment. Specific features from these images, known as radiomics features, 
may be extracted and analyzed to determine the properties of the tumors.  
The clinical estimation of the tumor size and its response to treatment is based on the 
World Health Organization (WHO) criteria
85
 and the Response Evaluation Criteria in Solid 
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Tumors (RECIST)
86
. In the WHO criteria, the longest diameter of a tumor and its perpendicular 
diameter are measured. The response to treatment is defined as the percentage reduction of the 
products of the two diameters between the pre- and post-treatment measurements. The RECIST 
criteria use the percentage reduction of the longest diameter between the pre- and post-treatment 
measurements. Both of these methods can be inaccurate and can have large inter- and intra-
observer variations, especially for tumors with irregular and complex shapes
87
. As RECIST 
criteria and the WHO criteria involve only one-dimensional (1D) and 2D measurements, 
respectively, the volumetric (3D) information from a CT scan is not fully utilized, and it is 
possible that 3D information may provide better response evaluation.   
The gross tumor volume (GTV), can be effectively measured in CT images, and has been 
shown previously to predict outcomes of bladder cancers
88
. For an accurate GTV measure from 
the CT images, the bladder tumor in the images needs to be delineated slice by slice; however, 
this is a time and labor intensive procedure, thus the burden of the additional workload on the 
radiologists cannot be ignored. Computerized segmentation tools that can automatically or semi-
automatically delineate the tumors from its surroundings would greatly reduce the additional 
workload. In our previous preliminary study, we have shown that our method for computerized 
segmentation of bladder tumors, Auto-Initialized Cascaded Level Sets (AI-CALS) can reliably 
produce 3D segmentation for a variety of bladder tumors
47
, and that the volume estimates more 
accurately predict the complete response to treatment compared to the WHO and the RECIST 
criteria on a small data set
89
. 
Although the 3D volumetric measurement by AI-CALS provides better estimates than the 
1D and 2D estimates in tumor size changes, the segmentation method still needs improvement in 
many cases given the wide variety of the tumor shapes and characteristics in the patient 
population. In this study, we explored the application of deep-learning convolution neural 
network (DL-CNN) to the segmentation of bladder tumors. Convolution neural networks (CNNs) 
have been used previously to classify patterns in medical images for use with computer-aided 
detection, specifically for microcalcification and mass detection in mammograms
31, 32, 34-38, 90, 91
. 
The training set used in these applications were typically small, generally less than 500 samples. 
With the advances in computation power, it becomes practical to design CNNs with very large 
and complex architectures that require massive number of training samples to solve more 
challenging pattern recognition problems. The deep-learning CNN (DL-CNN) using graphics 
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processing units (GPU) has been shown to be successful in classifying natural scene images 
using a large training set. Krizhevsky et al.
39, 40
 has demonstrated that high classification 
accuracy can be achieved using DL-CNN on the ImageNet ILSVRC-2010 and ILSVRC-2012 
data sets
41
, and the CIFAR-10 data set
42
. DL-CNN has also been successfully used for computer-
aided detection in medical imaging
92
. We have previously applied DL-CNN to the segmentation 
of whole bladders in CT images
2
; however, the segmentation of the tumors are more difficult 
because contrast material is generally not used in CT for patients undergoing chemotherapy, 
resulting in low contrast between the tumor and the inside of the bladder. 
In this pilot study, we applied DL-CNN to bladder lesion segmentation. For this task, the 
DL-CNN was trained to recognize the patterns in the regions that were inside and outside of the 
bladder lesion and generate a lesion likelihood map. Minor refinement on the likelihood map was 
performed by level sets to obtain the segmented boundaries of the bladder cancer.  
The bladder cancer segmentation performance of the DL-CNN and the AI-CALS were compared 
quantitatively with the radiologists’ manual outlines. The cancer volumes were calculated from 
the segmented tumor boundaries, and the GTV change in response to neoadjuvant chemotherapy 
was calculated. The results obtained from the DL-CNN were compared to the results obtained 
using our previous AI-CALS segmentation method, a radiologist’s manual outlines, as well as 
the response estimation using the WHO and the RECIST criteria. 
 
8.3 Materials and Methods 
8.3.1 Data set 
A data set of 62 cases was collected retrospectively from the Abdominal Imaging 
Division of the Department of Radiology at the University of Michigan with Institutional Review 
Board approval for this pilot study. All of the patients in the data set had undergone CT 
examination before and after chemotherapy, and subsequently underwent cystoscopy, biopsy, or 
radical cystectomy. The CT scans used in this study were acquired in our clinic with GE 
Healthcare LightSpeed MDCT scanners. The images were acquired using 120 kVp and 120 – 
280 mA and reconstructed at a slice interval of 0.625, 1.25, 2.5, or 5 mm with pixel sizes ranging 
from 0.586 to 0.977. The data set contained 64 tumors forming 74 temporal pairs, and 27% 
(17/62) of the cases had stage pT0 after surgery, indicating a complete response to treatment. 
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 A reference standard for the computerized segmentation was obtained via 3D hand-
segmented contours of the bladder tumors in the pre- and post-treatment CT of the 62 cases. An 
experienced radiologist with 27 years of experience reading CT bladder cases identified and 
marked focal tumor locations within the CT scans. The radiologist also manually outlined the 
full 3D contour for all cases (reference standard 1), and measured the longest diameter and its 
perpendicular using a graphical user interface (GUI) that we have developed. A second 
radiologist with 17 years of experience in CT bladder cases also manually outlined the bladder 
tumors in the pre- and post-treatment CT for a subset of 29 cases (reference standard 2), and 
measured the longest diameter and its perpendicular independently following the WHO criteria 
and RECIST criteria for all 62 cases. 
 
8.3.2 DL-CNN training 
 Our research work on whole bladder segmentation using DL-CNN was expanded further 
to bladder tumor segmentation. The DL-CNN by Krizhevsky et al. called cuda-convnet
39, 40
 was 
used. The neural network was trained to classify regions of interests (ROIs) on 2D slices as being 
inside or outside of the bladder cancer. Details on the DL-CNN can be found in the literature
2
 
and in Chapter III. The DL-CNN was trained with the pre-treatment scans of the cases. For each 
axial slice of the cases, a large number of overlapping 16 x 16-pixel ROIs were extracted from 
the region including the cancer marked by the radiologist. If more than 80% of an ROI was 
within the hand-outlined bladder cancer, the ROI was labeled as being inside of the cancer, 
whereas the ROI had to be completely outside of the cancer in order for it to be classified as 
being outside the cancer. ROIs not labeled as either inside or outside of the cancer were excluded. 
The ROI size of 16 x 16-pixels was used to ensure sufficiently accurate coverage of both small 
and large cancers. This size also allows for the ROIs to contain mostly regions that are either 
inside of the cancer or outside of the cancer. Figure 8.1 shows an example of ROIs obtained from 
a CT slice. The number of ROIs within the two classes was balanced, resulting in approximately 
65,000 ROIs. Figures 8.2(a) and (b) show examples of ROIs inside and outside of the bladder 
cancer, respectively, used to train the DL-CNN. 
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(a) (b) 
  
(c) 
Figure 8.1: An axial slice of a pre-treatment CT scan from a training case. (a) Cropped CT slice centered at the bladder. (b) 
Radiologist’s hand-outline of the cancer overlaid on the CT slice. (c) ROIs extracted from this slice. The yellow ROI shows the 
size of a 16 x 16-pixel ROI. The ROIs are partially overlapping. The blue ROIs are labeled as inside the bladder cancer. The pink 
ROIs are labeled as outside the bladder cancer for training the DL-CNN. 
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(a) 
  
(b) 
Figure 8.2: Composite images of the 65,000 ROIs from the training set used to train the DL-CNN. Each ROI is 16 x 16 pixels. (a) 
ROIs labeled as being inside bladder cancers. (b) ROIs labeled as being outside bladder cancers. A portion of each composite 
image is enlarged to show the typical ROIs in each class. 
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The network architecture used in this study consists of five main layers: two convolution 
layers, two locally connected layers, and one fully connected layer. The first convolution layer 
consists of 64 kernels with a size of 5 x 5 pixels. The output of this layer is pooled, normalized 
and input into the second convolution layer that also consists of 64 kernels with a size of 5 x 5 
pixels. The output of this layer is also pooled, normalized and input to the first locally connected 
layer that has 64 kernels with a size of 3 x 3 pixels. The second locally connected layer has 32 
kernels with a size of 3 x 3 pixels and output to the fully connected layer. The fully connected 
layer outputs two values to a Softmax layer that converts the values to a range from 0 to 1. The 
output of the DL-CNN can be interpreted as the likelihood of an input ROI being classified into 
one of the two categories. The neural network was trained for 1500 iterations, which was 
sufficient for the classification error rate to converge to a minimum and remained stable. Leave-
one-case-out cross-validation was employed for this study. In each of the leave-one-case-out 
partitions, all ROIs associated with a case were removed and the DL-CNN was trained using the 
remaining ROIs.  The training of the DL-CNN for one partition took approximately 1.5 hours on 
average using an Nvidia Tesla K20 GPU. 
 
8.3.3 Bladder cancer likelihood map generation using DL-CNN 
For each leave-one-case-out partition, the trained DL-CNN network was applied to the 
removed case to generate the bladder cancer segmentation likelihood map. A bladder cancer 
likelihood map was generated by applying the trained DL-CNN to a volume of interest (VOI) of 
a CT scan that contained the bladder tumor to be segmented.  In this study, a VOI that 
approximately enclosed the bladder cancer was manually marked in each CT scan. For every 
voxel within the VOI, an ROI of 16 x 16 pixels in size centered at the voxel was automatically 
extracted from the corresponding axial slice and input into the DL-CNN that estimated a 
likelihood score that the voxel was inside the tumor. After the likelihood values were estimated 
for all voxels in the VOI, the likelihood values on each slice constituted a 2D likelihood map on 
the axial slice, and the stack of 2D likelihood maps provided the 3D map for the VOI. Figure 8.3 
shows the bladder cancer likelihood map for the CT slice shown in Figure 8.1.  The DL-CNN 
was applied to the CT scan for both the pre- and post-treatment scans for each bladder cancer 
case.  
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Figure 8.3: Bladder Cancer likelihood map of the CT slice shown in Figure 8.1. Regions that are highly likely to be bladder 
cancer have higher intensity values. The VOI that was used for this lesion is shown in blue. For demonstration purposes, the 
bladder cancer likelihood map was generated in the region around the entire bladder. 
 
8.3.4 Bladder cancer segmentation from likelihood map 
 As seen in the example of Figure 8.3, the likelihood map identifies the bladder tumor 
region very well but the tumor boundary is not sharply demarcated.  The level sets, therefore, are 
used to perform minor refinements to the contour. First, a binary cancer mask, DLMask is 
generated by applying the following equation to every pixel of every slice of the likelihood map: 
 
𝐷𝐿𝑀𝑎𝑠𝑘(𝑥, 𝑦) = {
1, 𝐷𝐿𝑆𝑐𝑜𝑟𝑒(𝑥, 𝑦) ≥ 𝜌
0, 𝐷𝐿𝑆𝑐𝑜𝑟𝑒(𝑥, 𝑦) < 𝜌
 
(8.1) 
where DLMask(x,y) is the pixel value on the cancer mask at the coordinates (x,y) of a slice, 
DLScore(x,y) is the bladder cancer likelihood score at the coordinates (x,y), and ρ is the likelihood 
score threshold. The value of ρ was experimentally determined to be 0.60 to generate reasonable 
binary masks in comparison to radiologist’s manual segmentation. A morphological dilation 
filter with a spherical structuring element of two voxels in radius, 3D flood fill algorithm, and a 
morphological erosion filter with a spherical structuring element of two voxels in radius are used 
to smooth the cancer mask and connect neighboring components in order to extract an initial 
segmentation surface, 𝜙0(𝑥). 
 The initial segmentation surface is refined using level sets. For this study, the level set 
uses the following equation: 
 
{
𝜕
𝜕𝑡
𝛹(𝑥) = −𝛼𝐴(𝑥)𝛻𝛹(𝑥) − 𝛽𝑃(𝑥)|𝛻𝛹(𝑥)| + 𝛾𝜅(𝑥)|𝛻𝛹(𝑥)|
𝛹(𝑥, 𝑛 = 0) = 𝜙0(𝑥)
 (8.2) 
where 𝛼, 𝛽, and 𝛾  are the coefficients for the advection, propagation, and curvature terms, 
respectively, 𝐴(𝑥) is a vector field image that drives the contour towards regions of high gradient, 
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𝑃(𝑥) is a scalar speed term between 0 and 1 causing the contour to expand at the local rate, and 
𝜅(𝑥) = 𝑑𝑖𝑣 (
𝛻𝛹(𝑥)
|𝛻𝛹(𝑥)|
) is the mean curvature of the level set at point x. The symbol 𝛻 denotes the 
gradient operator and 𝑑𝑖𝑣 is the divergence operator28.  𝑛 is the number of iterations. 
A 3D level set with a predefined set of parameters is applied to the initial segmentation 
surface, and the segmentation on each slice is further refined by a 2D level set. The parameters 
of the 3D and 2D level sets are presented in Table 8.1. 
Table 8.1: Parameters for the level sets. 
Level set: α β γ n 
3D 1 0.4 q 20 
2D 4.0 0.2 0.5 10 
 
 
 The 3D level set brings the contour towards the sharp edges, but also expands it slightly 
in regions of low gradient. The parameter “q” in Table 8.1 is defined to be a linear function 
𝜎𝑀 + 𝜆  of the 2D diagonal distance M of the VOI box in millimeters (mm), where 𝜎 =
0.06, 𝜆 = −0.11 as shown previously 28. After the 3D level set refinement, a 2D level set is 
applied to every slice of the 3D contours to further refine the contours. Details on the level sets 
used can be found in the literature
28
. Figure 8.4 shows the final contour of the bladder cancer on 
the CT slice from Figure 1 using the likelihood map shown in Figure 8.3.  
 
Figure 8.4: Bladder cancer segmentation on the CT slice shown in Figure 8.1 using the bladder likelihood map shown in Figure 
8.3. 
 
8.3.5 Evaluation methods 
Segmentation performance was evaluated by comparing the automatic segmentation 
results to the 3D hand-segmented contours. The average minimum distance, and the Jaccard 
index
29
 between the hand-segmented contours and computer segmented contours were calculated. 
The performance metrics are described in Chapter II, section 2.3.5. 
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 Receiver operating characteristics (ROC) analysis and area under the curve (AUC) was 
used to estimate the accuracy for the prediction of T0 disease (complete response) after surgery 
based on the calculated change in GTV between pre- and post-treatment CT scans using the DL-
CNN, AI-CALS, and the manual segmentation methods.  The AUCs from the radiologists’ WHO 
criteria and RECIST estimates were also calculated. 
 
8.4 Results 
Examples of DL-CNN segmented bladder cancer on pre- and post-treatment CT scans, 
along with the AI-CALS segmentation, are shown in Figure 8.5. The segmentation performance 
measures of both the DL-CNN and AI-CALS methods compared with reference standard 1 
averaged over the pre-treatment lesions, post-treatment lesions, and all lesions, along with the p-
values from Student’s two-tailed paired t-test for the differences between the methods, are 
presented in Table 8.2. For all lesions, the difference in the average minimum distance was 
statistically significant with a p-value of 0.001, while the difference in the Jaccard index 
approached significance with a p-value of 0.058. The differences in the pre-treatment lesion 
segmentation performances were statistically significant with p-values of less than 0.001 and 
0.015 for the average minimum distance and the average Jaccard Index, respectively. The 
differences in the post-treatment lesion segmentation performances did not reach statistical 
significance. 
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(a) (b) 
   
(c) (d) 
    
(e) (f) 
Figure 8.5: Examples of segmentations of bladder tumors in pre-treatment (a, c, e) and post-treatment (b, d, f) CT scans. The DL-
CNN segmentation is shown in light blue. The AI-CALS segmentation is shown in pink. The hand outline is shown in dark blue. 
(a) DL-CNN segmentation with AI-CALS segmentation and hand outline for the cancer shown in Figure 1. Both computer 
methods segmented the lesion reasonably. (b) The cancer shrunk due to treatment, and became a part of the bladder wall. The 
DL-CNN under-segmented the cancer, not extending enough into the bladder wall. AI-CALS over-segmented the lesion, leaking 
into the bladder. (c) The DL-CNN segmentation outlined the cancer relatively accurately, while the AI-CALS segmentation 
leaked. (d) In this post-treatment scan, the cancer along the bladder wall was reasonably segmented by DL-CNN, while the AI-
CALS was unable to follow the shape and leaked into the bladder. (e) Both DL-CNN and AI-CALS segmented the bladder 
cancer reasonably well, but the AI-CALS slightly under-segmented the cancer. (f) The bladder cancer responded to treatment, 
thus had shrunk considerably, making the segmentation difficult. Both the DL-CNN and the AI-CALS under-segmented the 
lesion. 
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Table 8.2: Segmentation evaluation using reference standard 1 (RS1). The results are shown in groups of pre-treatment, post-
treatment, and both pre- and post-treatment lesions (126 lesions). The p-values from Student’s two-tailed paired t-test for the 
differences between the DL-CNN and the AI-CALS segmentation methods are also shown. Some post-treatment lesions were 
determined to have shrunk completely by radiologist, thus no segmentation was performed. 
 
 DL-CNN vs. RS1 AI-CALS vs. RS1 p-value  
Average 
minimum 
distance 
AVDIST 
Pre-treatment 4.8±2.3 mm 6.1±3.6 mm 0.001* 
 
Post-treatment 4.6±1.8 mm 4.9±2.6 mm 0.389 
 
Both 4.7±2.1 mm 5.5±3.2 mm 0.001* 
 
Jaccard index 
JACCARD3D 
Pre-treatment 39.5±17.1% 34.7±15.8% 0.015* 
 
Post-treatment 32.6±17.8% 32.7±14.4% 0.936 
 
Both 36.3±17.7% 33.8±15.1% 0.058 
 
* Statistically significant at p < 0.05  
 
 
The segmentation performance measures of the DL-CNN and AI-CALS methods 
compared with the two reference standards averaged over the pre-treatment lesions, post-
treatment lesions, and both pre- and post-treatment lesions for a subset of 29 cases are presented 
in Table 8.3. None of the differences reached statistical significance for this subset of cases. 
 
Table 8.3: Segmentation evaluation results for a subset of 29 cases divided into pre-treatment, post-treatment, and both pre- and 
post-treatment lesions (58 lesions) between hand-segmented reference standards (RS1, RS2) by two different readers for DL-CNN 
and the AI-CALS segmentation methods.  None of the paired differences between the two methods reached statistical significance 
for this subset, probably due to the small sample size. 
 
 
DL-CNN vs. RS1 AI-CALS vs. RS1 DL-CNN vs. RS2 AI-CALS vs. RS2 
Average 
minimum 
distance 
AVDIST 
Pre-treatment 4.8±1.8 mm 5.3±2.7 mm 4.9±3.4 mm 4.5±1.9 mm 
Post-treatment 4.3±1.7 mm 4.4±1.8 mm 4.7±3.1 mm 4.9±3.7 mm 
Both 4.6±1.8 mm 4.8±2.3 mm 4.8±3.2 mm 4.7±2.9 mm 
Jaccard index 
JACCARD3D 
Pre-treatment 45.3±8.5% 42.5±14.1% 46.8±9.3% 42.8±12.5% 
Post-treatment 29.8±17.7% 32.9±14.8% 28.8±19.7% 28.6±18.2% 
Both 37.5±15.8% 37.7±15.2% 37.8±17.8% 35.7±17.1% 
 
 
Table 8.4 shows the AUC values for the different methods. The AUC for the prediction 
of complete response using GTV calculated using the DL-CNN segmentation achieved 0.73 ± 
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0.06, while the AI-CALS segmentation achieved 0.70 ± 0.07, compared to 0.70 ± 0.06 for the 
radiologist’s hand outline based GTV. The differences between the three methods did not reach 
statistical significance. For the WHO criteria, the AUCs were 0.63 ± 0.07 and 0.61 ± 0.06 for the 
two radiologists. For the RECIST estimates, the AUCs were 0.65 ± 0.07 and 0.63 ± 0.06 for the 
two radiologists. Figure 8.6 compares the ROC curves for the different methods. 
 
Table 8.4: AUC values for prediction of cancer stage pT0 
after surgery. 
Method AUC 
Volume  
    DL-CNN 0.73 ± 0.06 
    AI-CALS 0.70 ± 0.07 
    Hand Outline 0.70 ± 0.06 
WHO criteria  
     Radiologist 1 0.63 ± 0.07 
     Radiologist 2 0.61 ± 0.06 
RECIST  
     Radiologist 1 0.65 ± 0.07 
     Radiologist 2 0.63 ± 0.06 
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Figure 8.6: ROC curves for the prediction of complete response to chemotherapy. The AUCs for GTV-based estimates were 0.73 
± 0.06 for DL-CNN, 0.70 ± 0.07 for AI-CALS, 0.70 ± 0.06 for the radiologist’s hand outlines; The AUCs for the WHO criteria 
based estimates were 0.63 ± 0.07 for radiologist 1 (Rad 1) and 0.61 ± 0.06 for radiologist 2 (Rad 2); and the AUCs for the 
RECIST based estimates were 0.65 ± 0.07 for radiologist 1 and 0.63 ± 0.06 for radiologist 2. 
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8.5 Discussion 
The results of this pilot study show that DL-CNN can be trained to segment bladder 
cancers in CT. The trained DL-CNN generates a likelihood map that identifies regions in the CT 
scans that are likely to be bladder cancers. By thresholding this map and performing minor 
refinement with level sets, we are able to obtain reasonable bladder cancer segmentations. 
 In our previous work on bladder segmentation with DL-CNN, level sets were also used to 
refine the output of the DL-CNN; as the contrast between the bladder and its surroundings is 
relatively high, cascaded level sets can refine the bladder boundary with high accuracy. On the 
other hand, with bladder cancer segmentation, the contrast between the tumor and the inside of 
the bladder can be much lower because contrast material is often not used for the pre- and post-
treatment CT. The level sets did not perform as well under these conditions, causing the 
segmentation to leak or shrink incorrectly. Therefore, only a few iterations of the level sets were 
applied to the bladder cancer likelihood map to fill holes and smooth the segmentation. 
The segmentation performance of the DL-CNN was better than the performance of AI-
CALS in comparison with a radiologist’s reference standard using the entire data set. The 
differences in the average minimum distance were statistically significant, while the difference in 
the Jaccard index approached significance (Table 8.2). When the data set is divided into pre-
treatment and post-treatment lesions, the DL-CNN performed significantly better than the AI-
CALS for the pre-treatment lesions, while the two methods performed comparably on the post-
treatment lesions. The pre-treatment lesions are generally better defined than the post-treatment 
lesions. As the lesions change due to the treatment, the lesion generally shrink and the 
boundaries become less distinct, making the post-treatment lesions more difficult to segment. 
Nevertheless, the changes in GTV estimated by the two computer methods were comparable to 
the estimates using radiologist’s hand outlines at prediction of complete response to treatment 
(Table 8.4). 
The segmentation performances for the DL-CNN and the AI-CALS were compared with 
two reference standards in the subset that had both radiologists’ manual outlines (Table 8.3). The 
results indicate that the performances of the two methods were consistent regardless of which 
reference standard was used.    
 The change in GTV estimated by the new DL-CNN segmentation method performed 
better than that by our previous AI-CALS system at prediction of complete response to treatment. 
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While the difference in the AUC for prediction of complete response to treatment did not reach 
statistical significance, probably due to the small data set, the segmentation performance results 
show that the segmentation by DL-CNN is better than that by AI-CALS.  
 Comparisons of the volume measurements with the WHO criteria and the RECIST show 
that 3D measure of the bladder cancer (GTV) performs better than the 2D (WHO criteria) and 
the 1D (RECIST) measurements. The WHO criteria and the RECIST measurements performed 
worse compared to the GTV measures. This indicates that the 3D information (GTV) may be 
more reliable for assessment of bladder cancer treatment response. 
 There are limitations in this study. While the data set was expanded compared to our 
previous study, the number of cases was still relatively small. Testing the method on a larger data 
set with wider ranges of sizes and types of bladder cancers would allow us further validate the 
generalizability of the method. We will continue to enlarge the data set. Another limitation is that 
we have only one set of radiologist’s hand segmentations as reference standard for the entire data 
set. In order to study the inter- and intra-observer variability in the hand segmentations of the 
bladder cancer, additional independent hand segmentations by different radiologists would be 
needed. 
Bladder cancer segmentation is important as it defines the regions to be analyzed for the 
characterization of the lesion. We plan to expand our work to investigate if radiomics features 
extracted from the segmented bladder cancers, in conjunction with the GTV change, can improve 
the assessment of response to chemotherapy or other treatments. Although the DL-CNN method 
shows more promising results than the AI-CALS method at present, there is still more room for 
improvement on the segmentation performance of both methods, especially for the post-
treatment tumors. Further development and validation with a larger data set are also needed to 
confirm the relative performance of the two approaches. 
 
8.6 Conclusion 
Our results demonstrate that DL-CNN is useful for 3D segmentation of bladder cancers 
for a variety of bladder cancer shapes and sizes. The DL-CNN and the AI-CALS methods were 
able to automatically segment the cancers, with results similar to those of the radiologists. The 
3D information from CT may provides more accurate information on the changes in the tumor 
size in response to treatment compared to the 2D (WHO criteria) and 1D (RECIST) estimations 
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used in current clinical practice. This study suggests that computerized segmentation of bladder 
cancers using DL-CNN has the potential to assist in the assessment of tumor volume and 
treatment response of bladder cancer by providing the more accurate 3D information without the 
extensive effort of manual segmentation. 
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Chapter IX 
Bladder Cancer Treatment Response Assessment in CT using Radiomics with Deep-
Learning
 
9.1 Abstract 
Cross-sectional X-ray imaging has become the standard for staging most solid organ 
malignancies. However, for some malignancies such as urinary bladder cancer, the ability to 
accurately assess local extent of the disease and understand response to systemic chemotherapy 
is limited with current imaging approaches. In this study, we explored the feasibility that 
radiomics-based predictive models using pre- and post-treatment computed tomography (CT) 
images might be able to distinguish between bladder cancers with and without complete 
chemotherapy responses. We assessed three unique radiomics-based predictive models, each of 
which employed different fundamental design principles ranging from a pattern recognition 
method via deep-learning convolution neural network (DL-CNN), to a more deterministic 
radiomics feature-based approach and then a bridging method between the two, utilizing a 
system that extracts radiomics features from the image patterns. Our study indicates that the 
computerized assessment using radiomics information from the pre- and post-treatment CT of 
bladder cancer patients has the potential to assist in assessment of treatment response. The results 
presented in this chapter have been published
5
. 
9.2 Introduction 
Radical cystectomy provides the best local control for patients with localized muscle 
invasive or recurrent non-muscle invasive bladder cancer. Despite adequate local cancer control, 
approximately 50% of patients who have undergone cystectomy develop metastases within two 
years of cystectomy and subsequently die of the disease. This is likely due to the presence of 
regional or distant microscopic metastatic disease at the time of surgery.  
Neoadjuvant chemotherapy prior to cystectomy utilizing a cisplatin-based regimen has 
been shown to decrease the probability of finding extravesical disease when compared to radical 
cystectomy alone and also improve survival
58-60
. Patients with a complete local response within 
144 
 
their bladder following neoadjuvant chemotherapy (approximately 30% of the patients) have 5-
year recurrence free survival, equivalent to patients who undergo cystectomy for non-muscle 
invasive disease (85-90%). Currently, there is no reliable method for predicting the response of 
an individual case to neoadjuvant chemotherapy prior to or during its administration.  As a result, 
some patients may suffer from adverse reactions to the drugs without achieving beneficial effects.  
Furthermore, these patients may miss the opportunity to receive alternative therapy as a result of 
the deterioration of their physical condition from the initial chemotherapeutic regimen. 
Early assessment of therapeutic efficacy and prediction of treatment failure would help 
clinicians decide whether to discontinue chemotherapy at an early phase before additional 
toxicity develops, thus improve the quality of life of a patient and reduce unnecessary morbidity 
and cost. The ultimate goal is to improve survival for those with a high risk of recurrence while 
minimizing toxicity to those who will have minimal benefit. Therefore, development of an 
accurate and early predictive model of the effectiveness of neoadjuvant chemotherapy is 
important for patients with bladder cancer.  Many bladder cancers are well visualized with CT
93-
95
. It might be possible to characterize the responsiveness of a cancer to chemotherapy by 
changes in its imaging characteristics.  
Radiomics is the study of using radiological images to analyze anatomic or physiologic 
abnormalities based upon the imaging characteristics
96-98
. Previous studies decoded tumor 
phenotypes
99
 using radiomics features, or evaluated the correlation between radiomics features 
with radiation therapy dose and radiation pneumonitis
100
 in lung CT. A review paper on 
radiomics for lung cancer concluded that radiomics have the potential to improve lung cancer 
diagnosis
101
. 
One promising method that may be useful for extracting image information for radiomics 
application is convolution neural network (CNN). A CNN learns the underlying patterns and 
features in the input training images using many small convolution kernels that contain the 
weights that the network incorporates the knowledge learned from the training images and 
generalizes it to recognize unknown images outside the training set. CNN has been used for 
many years and has been implemented successfully to classify different types of medical image 
patterns
31, 34-38, 90, 102, 103
. With the recent increase in the power for parallel computing, primarily 
resulting from the development of powerful graphics processor units (GPUs), training of a very 
large CNN with many layers and connections in the network has become feasible. Deep-learning 
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convolutional neural networks (DL-CNN) are CNNs capable of learning complex patterns using 
large numbers of input images via a large neural network with many connections.  The 
application of DL-CNN to various tasks in medical image analysis has been examined recently
2, 
104-106
.  
We have shown in Chapter VIII that the change in gross tumor volume can be used to 
distinguish between bladder cancers that have fully responded to chemotherapy and those that 
have not. In this study, we explored the possibility that radiomics-based predictive models might 
be able to distinguish between bladder cancers that have fully responded to chemotherapy and 
those that have not, based upon analysis of pre- and post-treatment CT images. We evaluated 
three unique radiomics predictive models that employ different fundamental design principles:  1) 
a pattern recognition method (DL-CNN), 2) a more deterministic radiomics feature based 
approach (RF-SL), and 3) a bridging method between the two that extracts radiomics features 
from image patterns (RF-ROI). We studied both the properties of the different predictive models 
and the relationship between these different radiomics approaches. We also compared the 
performance of the models in predicting a complete response of bladder cancer to neoadjuvant 
chemotherapy with that of expert physicians. 
 
9.3 Materials and Methods 
9.3.1 Data set 
The patient images were collected and de-identified using methods approved by our 
Institutional Review Board (IRB) and are HIPAA compliant. All methods were performed in 
accordance to the guidelines and regulations of the IRB.  A training data set of 82 patients (67 
males, 15 females, age 64.0 ± 10.6, age range 37-84) with 87 bladder cancers was collected. The 
CT scans used in this study were acquired with the process described in Chapter II, section 2.3.4. 
A total of 172 CT scans (pixel size range 0.586 – 0.977 mm, slice thickness range 0.625 – 7 mm) 
were obtained for the training set, of which 28 scans were performed without contrast material, 
while the remaining 144 scans were contrast-enhanced CT scans. Using the 87 lesions, 104 
temporal lesion pairs were generated. Twenty-seven percent (28/104) of the lesions pairs had T0 
cancer after neoadjuvant chemotherapy that corresponds to a complete response to treatment, 
using the clinical information available from the patient files as reference truth. These temporal 
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lesion pairs were used to generate 6,700 pre-post-treatment paired ROIs for use with DL-CNN 
and RF-ROI.  
In addition, a test data set of 41 patients (33 males, 8 females, age 60.9 ± 9.2, age range 
42-84) with 42 lesions was collected. A total of 88 CT scans (pixel size range 0.586 – 0.977 mm, 
slice thickness range 0.5 – 7.5 mm) were obtained for the test set, of which 16 scans were 
performed without contrast material, while the remaining 72 scans were contrast-enhanced CT 
scans.   Fifty-four temporal pairs were generated from the 42 lesions.  Twenty-two percent 
(12/54) of the lesion pairs had T0 cancer after neoadjuvant chemotherapy. Chemotherapy 
regimens used for the majority of these patients were MVAC (methotrexate, vinblastine, 
doxorubicin, and cisplatin treatment), while other patients were treated with regimens including 
carboplatin, paclitaxel, gemcitabine, and etoposide. The pre-treatment scans were acquired 
approximately 1 month (max 3 months) before the first cycle of chemotherapy. The post-
treatment images were acquired after the completion of three cycles of chemotherapy, generally 
within 1 month (max 2 months) of cessation of the therapy. The pre-post-treatment scans were 
on average acquired 4 months apart. Each patient underwent cystectomy at the end of his or her 
chemotherapy, usually 4-6 weeks after completion of neoadjuvant chemotherapy, which is 
generally within 4 months after the post-treatment CT scan. Pathology obtained from the bladder 
at the time of surgery was used to determine the final cancer stage after chemotherapy and was 
used as the reference standard to determine whether or not the patient had responded completely 
to treatment. 
 
9.3.2 Lesion segmentation 
The AI-CALS system was used for the segmentation of the bladder lesions. Additional 
information regarding the AI-CALS system can be found in literature
47
. Figure 9.1 shows 
examples of segmented lesions. 
 
9.3.3 DL-CNN predictive model 
To train the DL-CNN with both the pre- and post-treatment bladder lesion information, 
we generated a single image containing information from the bladder lesion at the two time 
points. From every slice of a segmented bladder lesion, ROIs with dimension 16 x 32 pixels that 
were shifted with respect to one another but stayed within the segmented bladder lesion were 
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extracted. If the bladder lesion was smaller than the ROI size, a single ROI centered at the 
centroid of the bladder lesion was extracted. Once these ROIs were extracted from both the pre- 
and post-treatment CT of a temporal lesion pair, the ROIs were combined by pasting them side-
by-side, with a pre-treatment lesion ROI located on the left half and a post-treatment lesion ROI 
located on the right half of the combined ROI. The resulting image was a paired 32 x 32-pixel 
ROI containing both pre-and post-treatment information (Figure 9.2). Different combinations of 
the pre- and post-treatment lesion ROIs from the same case were used to form multiple paired 
ROIs. Each paired ROI was labeled as having or not having responded completely to treatment 
based on whether the cancer went down to stage T0 or not after treatment as determined by 
clinical information from the patient files. If the post-treatment ROI of a paired ROI was stage 
T0, the paired ROI was labeled as having complete response, but if the stage was greater than T0, 
the paired ROI was labeled as not having complete response. Figure 9.2 shows an example of 
how a paired ROI was formed and examples of paired ROIs and their labels. A total of 6,700 
pre-post-treatment paired ROIs were generated (Figure 9.3).  
A DL-CNN learns patterns of different classes from a set of labeled training images that 
are representative of the population of patterns being classified. After the user specifies a few 
parameters that control the training process, the DL-CNN reads the labeled images and learns the 
differences between the classes without any additional inputs. We applied the DL-CNN 
developed by Krizhevski et al., called cuda-convnet
39, 40
, to the classification of the paired ROIs 
with complete response, and those without.  The parameters of the original network were 
modified, and a set of parameters was found that worked best for the task of identifying cases 
that completely responded to treatment using the training set. The network consists of five main 
layers: two convolution layers, two locally-connected layers, and one fully-connected layer. The 
locally-connected layers perform the same operation as the convolution layer except that, instead 
of applying a single convolution kernel to every location of the input image to obtain a kernel 
map, different convolution kernels are applied to every location of the input image and the 
resulting values are collected into the corresponding neurons within the corresponding kernel 
map. The fully-connected layer uses every kernel map element multiplied by a weight as input. 
Pooling and normalization are performed after each of the two convolution layers. All 
convolution layers consist of 16 kernels with a kernel filter size of 3x3. The “per-lesion” score 
was obtained by using the average value among the ROIs associated with the lesion. We trained 
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a DL-CNN to distinguish between bladder lesions that were diagnosed as stage T0 post-
treatment (no residual tumor) and those that were greater than stage T0 (any residual tumor) 
(Figure 9.4).  
 
    
(a) (b) 
  
  
(c) (d) 
Figure 9.1: Bladder lesion segmentations. Two segmented bladder cancers are illustrated.  The lesions in the pre- and post-
treatment scan pairs shown in (a) and (b) are segmented using AI-CALS, as shown in (c) and (d), respectively. The pre-treatment 
scan is on the left and the post-treatment scan is located on the right of each pair. 
 
 
 
(b) 
 
(a) (c) 
Figure 9.2: Creating ROIs to train the DL-CNN. (a) ROIs were generated by 
combining regions from the pre- and post-treatment scan lesions. In this 
example, the pre-treatment stage was T3, and the post-treatment stage was T2. 
Therefore, the ROI was labeled as being greater than stage T0 after treatment. 
(b) ROI of a case that was stage T3 pre-treatment and stage T0 after treatment. 
(c) ROI of a case that was stage T2 pre-treatment and stage T4 post-treatment. 
Therefore the ROI was labeled as greater than stage T0 after treatment.  
 
T2 T3 
T0 T3 
T4 T2 
Pre-
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(a) 
  
(b) 
 
Figure 9.3: Subset of Paired ROIs used to train the DL-CNN. Each ROI is 32x32 pixels. (a) ROIs that were labeled as being stage 
T0 after treatment. (b) ROIs that were labeled as being greater than stage T0 after treatment. A portion of ROIs in each class is 
zoomed in to illustrate the content of typical ROIs. 
 
 
150 
 
 
Figure 9.4: DL-CNN Structure. An input ROI is convolved with multiple convolution kernels, and the resulting values are 
collected into the corresponding kernel maps. This process repeats for several layers, giving the “deep” convolutional neural 
network. The network used in this study contains two convolution layers and two locally-connected layers, each of which 
contains 16 kernels. 
 
9.3.4 RF-SL predictive model 
For this predictive model, a radiomics-feature-based analysis was applied to the 
segmented lesions (RF-SL). We extracted 91 radiomics features from every segmented lesion. 
Four types of features were extracted: (1) morphological features, such as volume, circularity, 
rectangularity, and Fourier descriptor, (2) gray level features, such as the average gray level and 
contrast features, (3) texture features, such as run length statistics, and (4) gradient field features, 
such as the gradient magnitudes statistics for all voxels on the surface of the segmented lesion. 
Shape-based features and the contrast features were extracted from the central slice of the lesion. 
Other features, such as the gray-level features, texture features, and the gradient field features, 
were extracted from the segmented lesion in 3D after performing interpolation to obtain isotropic 
images. For every temporal lesion pair, the percent change between each radiomics feature 
extracted from the pre- and post-treatment lesion was calculated. These features were found to be 
potentially useful for lesion classification from our previous experience with breast masses and 
lung nodules
30, 50
.   Features that were useful specifically for the bladder cancer treatment 
response assessment were further identified during the training of the predictive model. The 
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percent change of each of the feature values before and after the treatment was calculated. 
Feature selection was performed and a random forest classifier using 6 trees and the minimum 
number of observations per tree leaf set of 13 was trained to use the selected radiomics features 
to predict the likelihood of the post-treatment lesion being T0 stage. The parameters were 
selected experimentally using the training set. 
 
9.3.5 RF-ROI predictive model 
In this model, the radiomics-feature-based analysis was applied to the paired ROIs (RF-
ROI). Gray-level and texture features were extracted from the paired ROIs used for the DL-CNN. 
Thirty-eight features, including gray-level histogram statistics, and run length statistics features, 
were calculated for every ROI. The “per-lesion” features were generated by averaging the feature 
values among the ROIs associated with the lesion. Similar to the RF-SL model, feature selection 
was performed and a random forest classifier using 2 trees and the minimum number of 
observations per tree leaf set of 29 was trained to use the selected radiomics features to predict 
the likelihood of the post-treatment lesion being T0 stage. The parameters were selected 
experimentally using the training set. 
 
9.3.6 Expert physician performance 
An observer study with two experienced fellowship-trained abdominal radiologists, one 
with 17 years of experience and the other with 27 years of experience, was performed as 
references for comparison with the three predictive models. Each radiologist independently read 
the pre- and post-treatment images of patients that were loaded side-by-side, and estimated the 
likelihood of the patient having stage T0 cancer post-treatment. The images were presented in a 
randomized order to reduce potential observer bias. 
 
9.3.7 Performance evaluation 
For the three methods, the trained model was applied to the test set and the area under the 
curve (AUC) was calculated using the scores from the test cases. For the radiologists, the AUC 
was calculated for the test cases using their given likelihood of complete response to treatment. 
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9.4 Results 
Receiver operating characteristic (ROC) analysis was performed and the area under the 
curve (AUC) was calculated as a measure of performance. Figure 9.5 shows the ROC curves for 
the DL-CNN, RF-SL, and RF-ROI methods and the radiologists for the test set. Table 9.1 shows 
the performances for the DL-CNN, RF-SL, and RF-ROI methods, along with the radiologists’ 
results for the test set.  
Table 9.1: Performances of bladder cancer treatment response assessment in the test set. 
 DL-CNN RF-SL RF-ROI Radiologist 1 Radiologist 2 
AUC 0.73 ± 0.08 0.77 ± 0.08 0.69 ± 0.08 0.76 ± 0.08 0.77 ± 0.07 
 
 
DL-CNN: Deep-learning convolution neural network 
RF-SL: Radiomics features extracted from segmented lesions 
RF-ROI: Radiomics features extracted from pre- and post-treatment paired ROIs 
The area under the curve (AUC) is shown with the standard deviations 
The areas under the curve (AUC) for prediction of T0 disease after treatment were similar. 
The performances of all three methods are comparable to those of the radiologists. The 
differences between any two AUCs did not reach statistical significance.  Examples of the 
treatment response prediction of pre- and post-treatment case pairs are shown in Figure 9.6. 
Figure 9.7 shows examples of cancers that responded fully to treatment and the differences in the 
predictions by the computer models and the radiologists. 
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Figure 9.5: Test set ROC curves for the three models and two expert radiologists. The results from the test set for prediction of 
T0 stage after neoadjuvant chemotherapy for the three models. The differences between any pairs of AUCs did not reach 
statistical significance. 
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(a) (b) 
  
  
(c) (d) 
Figure 9.6: Examples of pre- and post-treatment bladders and their predictions. (a) The computer methods and the radiologists 
correctly predicted the treatment outcome for this case, which was a non-responding, progressive disease that went from stage T2 
before treatment to T3a after treatment. (b) In this stable disease case (stage T3), the computer methods and the radiologists 
correctly identified the case as non-responding. (c) This case fully responded, going from stage T2 to T0, and the computer 
methods and the radiologists correctly predicted the treatment response. (d) A full-responding case, going from stage T3 to T0. 
The computers correctly predicted the response, while the radiologists did not. The region around the right ureterovesical 
junction was asymmetrically thickened, which might have misled the radiologist to assess that cancer was present. The pre-
treatment scan is on the left and the post-treatment scan is located on the right of each pair. The box on the pre-treatment scan 
represents the location of the lesion as marked by one of the radiologists. 
 
 
 
 
  
  
(a) (b) 
   
 
 (c)  
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Figure 9.7: Examples of pre- (on the left side of each image pair) and post- (on the right side of each image pair) treatment 
bladders that responded fully to treatment, and the differences in the predictions by the computer models and radiologists. (a) All 
three computer methods and the radiologists correctly predicted the outcome of treatment for this case. (b) The three computer 
methods correctly identified the case as becoming T0 tumor, while the radiologists did not. There was residual bladder wall 
thickening, presumably related to the treatment, causing the radiologists to falsely conclude that there was persistent tumor. (c) 
The radiologist correctly identified that there was no residual tumor on post-treatment images, while the three computer methods 
failed to classify this case correctly. This was likely due to misidentification of perivesical tissue (arrow) as residual tumor by the 
computer models.  The box on the pre-treatment scan represents the location of the lesion as marked by one of the radiologists. 
 
9.5 Discussion 
In this study, we evaluated a system that can distinguish between bladder cancers that 
have completely responded to neoadjuvant chemotherapy from those that have not, based upon 
computer analysis of pre- and post-treatment CT images. Although we used CT images before 
and after completion of three cycles of chemotherapy, we expect that the trained predictive 
models will be applicable to any treatment time points because they are trained to recognize the 
change in the image patterns to T0 stage regardless of when it occurs.  If the models are 
validated, the models may be used to assess treatment response at any clinically relevant time 
point, and the treatment may be stopped or changed prior to the appearance of other toxic effects 
if the cancer is resistant to the treatment. The performance of the DL-CNN was compared against 
a radiomics feature-based method, where the percent change in the features extracted from the 
segmented lesions pre- and post-treatment was used (RF-SL), and against a third method 
extracting radiomics features from the paired ROIs used by the DL-CNN (RF-ROI). 
 For the RF-SL, five features were consistently selected which included a contrast feature 
and four run length statistics texture features. We have also performed an ordering of importance 
on the radiomics features based on the AUC of the individual features, and found that the 
selected features were highly ranked. For the RF-ROI, the gray-level average, the skewness of 
the gray-level histogram, and two run length statistics texture features were consistently selected. 
These results show that the texture, which characterizes the heterogeneity, of the bladder lesions 
is an important indicator for the estimation of full responders to chemotherapy. 
 All three methods performed comparably to the two expert radiologists. The RF-SL 
performed slightly better than the DL-CNN; however, the RF-ROI method resulted in worse 
performance compared to the DL-CNN, indicating that the DL-CNN is able to better characterize 
the paired ROIs to identify full responders compared to extracting features from the ROIs and 
using the random forest classifier. The absence of contrast material in some of the CT scans did 
not affect the results of the computer system or the radiologists. The pre- or post-treatment 
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cancer stage did not have an observable effect on the performances of the system or the 
radiologists either. Although the overall performance was similar across the methods, there are 
variations in the prediction performance in individual cases. In the case shown in Figure 9.7(a), 
all methods and radiologists correctly identified that the detected cancer had responded fully to 
treatment. However, in the case shown in Figure 9.7(b), the computer methods correctly 
identified the cancer as having a complete response, while the radiologists did not. Upon further 
review, the radiologists commented that the uncertainty was due to the presence of 
residual/persistent bladder wall thickening in the region of the tumor (which turned out to be 
benign at surgery). In the case shown in Figure 9.7(c), the radiologists correctly identified the 
case as having responded fully to treatment, whereas the computer indicated that the case had not. 
The lesion in this case was located at the top of the bladder, and the automated computer 
segmented region incorrectly extended into the perivesical tissue outside the bladder.  The 
analysis of this extravesical tissue by the computer models might have caused the incorrect 
decision that residual tumor was present. 
 
  
(a) (b) 
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(c) (d) 
 
(e) 
Figure 9.8: Venn diagrams of different methods and their assessments for the test set. The inner three circles compare the 
methods when at least one method correctly predicted the treatment outcome for a pre- and post-treatment pair. The outer circle 
contains the pre- and post-treatment pairs for which all three methods incorrectly predicted the treatment outcome. (a) The three 
computer methods correctly predicted the same outcome of the patients for 39% (21/54) of the pre- and post-treatment pairs. (b-
c) The two radiologists correctly agreed on the outcome of 43% of the cases ((18+5)/54 for (b) and (17+6)/54 for (c)). (d-e) 
Radiologists 1 correctly agreed with the DL-CNN and the RF-SL methods for 19 and 20 cases, respectively, while Radiologist 2 
correctly agreed with the DL-CNN and the RF-SL methods for 24 and 21 cases, respectively. 
  
Given the fact that in some instances the computer models were correct about complete 
tumor responses and the radiologists were incorrect, we speculate that use of one or more of 
these models alongside a radiologist might improve the radiologist’s ability to identify patients 
who responds fully to chemotherapy. Venn diagrams depicting the agreements of the 
assessments performed by the computer methods and the radiologists are shown in Figure 9.8. In 
cases like that in Figure 9.6(d), radiologists will generally decide that the case is a non-responder 
because they see residual bladder wall thickening, which is an indicator of cancer. If the 
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computer models suggested that there was a high likelihood of T0 after treatment in this case, it 
might lead the radiologists to re-evaluate their decision, and, possibly come to a different (and 
correct) conclusion. In the case shown in Figure 9.1(a), the tumor stage was found to be T2 at the 
time of subsequent cystectomy. Even though the computer indicated that the case had a high 
likelihood of having fully responded, the radiologist might have concluded that cancer was still 
present on the post-treatment images and decided not to be influenced by the computer’s 
opposite (and incorrect) prediction. Such decisions could lead to a higher accuracy in 
determining whether a patient had responded completely to neoadjuvant chemotherapy. Of 
course, it is also possible for the computer models to sway a radiologist’s decision in the wrong 
direction.  
All currently approved Food and Drug Administration (FDA) computer-aided detection 
(CAD) devices are labeled for use as “second readers”, i.e., the workflow is to use the CAD 
system as a second opinion rather than a first reader or concurrent reader. For future decision 
support systems for treatment response assessment or other applications, it is unknown what the 
best approach is at this point. One possibility is to follow the second opinion approach: the 
clinician will first make his/her assessment without being influenced by the computer. The 
computer then shows the clinician its prediction. The clinician may reconsider his/her assessment 
using the computer’s prediction as additional information. Alternatively, a concurrent approach 
could be used, where prediction by the decision support system may be displayed from the 
beginning and it is up to the clinician to use the prediction as additional information in his/her 
decision making process. Generally, when clinicians’ assessments differ from each other, they 
may discuss and try to reach consensus or bring in additional expert opinion. If the clinician 
disagrees with the computer, he/she can override it because the computer models, in the current 
state of development, does not consider many other factors, such as clinical, genetic, or 
demographic factors, which a clinician may figure into their decision.  The clinician may also 
bring in additional expert opinion if he/she deems it necessary.  
Further study of the accuracy of the computer models in tandem with radiologist 
assessment is needed to determine whether or not such decision support systems will improve 
radiologist performance in treatment response assessments for bladder cancers. Previous 
observer performance studies showed that when radiologists and the computer systems had 
comparable performances individually, using the computer system to assist the radiologists 
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improved their performance for breast cancer detection
107
, breast mass classification
108, 109
, and 
colon polyp detection
110
. We plan to perform an observer performance study using either the 
second opinion approach or the concurrent approach to evaluate if a similar trend will be 
observed for bladder cancer treatment response assessment. 
 There are several limitations to this study. First, the results of this study need to be 
improved. An AUC values in the range of 0.69 to 0.77 is not optimal for distinguishing between 
fully and partially or non-responding bladder cancers. Nevertheless, our feasibility study is the 
first to demonstrate the promise of using radiomics methods, as well as the DL-CNN to 
distinguish patients who respond to bladder cancer treatment from those who do not. Second, our 
pilot training data set was relatively small, consisting of only 82 patients with bladder cancer and 
subsequent generation of 6,700 ROIs. This is a very small number of ROIs for training a DL-
CNN. The limited training set size could be a major factor that impacted the performance of a 
DL-CNN, compared to other pattern recognition tasks such as natural scene classification that 
can collect millions of training samples much more easily than collecting medical images. Table 
9.2 shows the number of correctly identified completely responding pairs and non-completely 
responding pairs at the operating point used to generate the Venn diagrams in Figure 9.8. 
Table 9.2: Number of correctly predicted bladder cancer treatment response assessment of the test set at an operating point 
determined using the training set. 
 
 DL-CNN RF-SL RF-ROI Radiologist 1 Radiologist 2 
Complete 
Response 
6/12 6/12 8/12 11/12 11/12 
Non-complete 
Response 
34/42 33/42 23/42 18/42 16/42 
 
 
DL-CNN: Deep-learning convolution neural network 
RF-SL: Radiomics features extracted from segmented lesions 
RF-ROI: Radiomics features extracted from pre- and post-treatment paired ROIs 
 
We can see from the table that the accuracy of correctly identified completely responding 
lesion pairs for the DL-CNN and the RF-SL are lower than the RF-ROI and the two Radiologists. 
We also see that for those two methods, the accuracy of correctly identifying the non-completely 
responding lesions is higher than the accuracy for the completely responding lesion pairs. This is 
a limitation of our small and unbalanced data set. The operating points that each of the methods 
performed similarly to the others on the training set were chosen. While the performances on the 
training set were similar at this point, we see that the performances on the test set vary. A larger 
data set is needed so that hopefully, the populations in the training and testing data sets are 
159 
 
similar. We want a representative training population, which can be achieved with large number 
of training cases. If a bigger training data set was used, we hope that the methods would be more 
generalizable, thus this issue would not occur. If both the training and testing are unbalanced 
similarly, we will likely not see as much of a difference between the two classes. This pilot study 
indicates the potential of using DL-CNN and radiomics methods for treatment response 
prediction. We still need to study in greater detail the generalizability of the methods using larger 
data sets in future studies. A third limitation is that this study is a retrospective study. In the 
future, after the development is completed and the performance of the system is further improved, 
a prospective clinical trial should be conducted to assess its robustness in the population. 
 
9.6 Conclusion 
This study indicates that the computerized assessment using radiomics information from 
the pre- and post-treatment CT of patients who have undergone neoadjuvant chemotherapy for 
bladder cancer has the potential to assist in assessment of treatment response. This topic is 
further studied in Chapter X. 
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Chapter X 
Observer Performance Study for Bladder Cancer Treatment Response Assessment in CT 
Urography with and without Computerized Decision Support
 
10.1 Abstract 
We evaluated whether a computerized decision support system for bladder cancer 
treatment response assessment (CDSS-T) can assist radiologists in identifying patients who have 
complete response after neoadjuvant chemotherapy. With IRB approval, pre- and post-
chemotherapy CTU scans of 123 patients with 158 bladder cancers were collected 
retrospectively, resulting in 158 pre- and post-treatment lesion pairs. The pathological cancer 
stage after treatment, as determined by cystectomy, was collected as the reference standard in 
order to determine whether a patient fully responded to treatment. Twenty-five percent of the 
lesion pairs (40/158) had a complete response, or T0 disease, after chemotherapy. We have 
developed a CDSS-T system that uses a combination of DL-CNN and radiomics features to 
distinguish between cases that have fully responded to treatment (T0 disease) and those that have 
not (>T0 disease). Six abdominal radiologists, four residents trained in abdominal radiology, and 
one urologist estimated the likelihood of stage T0 disease (complete response) after treatment by 
viewing each pre-post-treatment CTU pair displayed side by side on a graphic user interface 
designed for CDSS-T. Each observer provided an estimate without CDSS-T first and then 
revised the estimate, if desired, after taking into consideration the CDSS-T score. The cases were 
randomized differently for each observer. The observers’ estimates with and without CDSS-T 
were analyzed with multi-reader, multi-case (MRMC) receiver operating characteristic (ROC) 
methodology. The area under the curve (AUC) and the statistical significance of the difference 
were calculated. The AUC for prediction of T0 disease after treatment was 0.80±0.04 for the 
CDSS-T alone. Ten out of the 11 observers’ performance improved with the aid of CDSS-T. The 
average AUC for the observers was 0.74 (range: 0.72-0.77) without CDSS-T, and 0.77 (range: 
0.73-0.81) with CDSS-T. The differences in the average AUC values between without CDSS-T 
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and with CDSS-T were statistically significant (p < 0.01). The study demonstrated that our 
CDSS-T system for bladder cancer treatment response assessment in CTU can improve 
radiologists’ performance in identifying patients who fully responds to treatment. The 
preliminary results using methods presented in this chapter have been accepted for presentation 
at the RSNA 2017 conference. Preparation for submission as a journal article is underway at the 
time of this dissertation. 
 
10.2 Introduction 
Early assessment of therapeutic efficacy and prediction of neoadjuvant chemotherapy 
failure would help clinicians decide whether to discontinue treatment at an early phase before 
additional toxicity develops, thus improve the quality of life of a patient and reduce unnecessary 
morbidity and cost. The ultimate goal is to improve survival for those with a high risk of 
recurrence while minimizing toxicity to those who will have minimal benefit.  
In Chapter IX, we have introduced methods that can estimate the likelihood that a patient 
responds completely to treatment after neoadjuvant chemotherapy. In this study, we explored the 
potential that a computerized decision support system for bladder cancer treatment response 
assessment (CDSS-T) can assist radiologists in better identifying patients who have complete 
response after neoadjuvant chemotherapy. We compared the performance of three different 
methods: 1) the CDSS-T alone, 2) the radiologist alone, and 3) radiologists with the CDSS-T. 
 
10.3 Materials and Methods 
10.3.1 Data set 
With the approval of the Institutional Review Board (IRB), a data set of 123 patients with 158 
bladder cancers who were evaluated with CTU before and after the administration of 
neoadjuvant chemotherapy was collected retrospectively, resulting in 158 lesion pairs. 
Chemotherapy regimens used for the majority of these patients were MVAC (methotrexate, 
vinblastine, doxorubicin, and cisplatin treatment), while other patients were treated with 
regimens including carboplatin, paclitaxel, gemcitabine, and etoposide. The pre-treatment scans 
were acquired approximately 1 month (max 3 months) before the first cycle of chemotherapy. 
The post-treatment images were acquired after the completion of three cycles of chemotherapy, 
generally within 1 month (max 2 months) of cessation of the therapy. The pre-post-treatment 
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scans were on average acquired 4 months apart. Each patient underwent cystectomy at the end of 
his or her chemotherapy, usually 4-6 weeks after completion of neoadjuvant chemotherapy, 
which was generally within 4 months after the post-treatment CT scan. Pathology obtained from 
the bladder at the time of surgery was used to determine the final cancer stage after 
chemotherapy and was used as the reference standard to determine whether or not the patient had 
responded completely to neoadjuvant chemotherapy. 
 
10.3.2 Computerized decision support system for treatment response assessment (CDSS-T) 
 We have developed a CDSS-T system that uses a combination of DL-CNN and 
radiomics features to distinguish between cases that have fully responded to treatment and those 
that have not. The detailed description of the CDSS-T system can be found in Chapter IX. A 
brief summary is given below. 
 
10.3.2.1 Bladder Lesion Segmentation 
 The bladder lesions were segmented using our previously developed method known as 
auto-initialized cascaded level set (AI-CALS)
47
. The details of the AI-CALS method can be 
found in our previous paper
47
. 
 
10.3.2.2 DL-CNN predictive model 
Regions of interest (ROIs) were extracted from within the segmented lesions from 
corresponding pre- and post-treatment scans of a patient and were paired together in multiple 
combinations to generate pre-post-treatment paired ROIs, as shown in Chapter IX, section 9.3.3. 
We trained a DL-CNN to distinguish between bladder lesions that were diagnosed as stage T0 
post-treatment (no residual tumor) and those that were greater than stage T0 (any residual tumor). 
For training and testing of the predictive model, a leave-one-case-out cross-validation scheme 
was used. For each leave-one-case-out partition, the trained DL-CNN outputted a likelihood of 
stage T0 score for the left-out test case ROIs. The “per-lesion” score was obtained by using the 
average value among the ROIs associated with the lesion. 
 
10.3.2.3 Radiomics predictive model 
163 
 
For this predictive model, a radiomics-feature-based analysis was applied to the 
segmented lesions. We extracted 91 features for every segmented lesion, subdivided into four 
different types: (1) morphological features, such as volume, circularity, rectangularity, and 
Fourier descriptor, (2) gray level features, such as the average gray level and contrast features, (3) 
texture features, such as run length statistics, and (4) gradient field features, such as the gradient 
magnitudes statistics for all voxels on the surface of the segmented lesion. For every temporal 
lesion pair, the percent differences of each radiomics features between the pre- and post-
treatment lesions were calculated. A two-loop leave-one-case-out cross-validation scheme
111
 was 
used for this predictive model. The two-loop leave-one-case-out involves two loops: The inner 
loop that is used to select the subset of features using a leave-one-case-out scheme on the 
training partition, and the outer loop that generates the scores for the left-out test case. An 
average of four features was selected, including two run-length statistics features and two 
contrast features. 
 
10.3.2.4 Score generation 
 A combined score using the test scores from both the DL-CNN and the radiomics 
predictive model were generated by taking the maximum of the two scores. A relative computer-
aided diagnosis (CAD) score was obtained by linearly scaling the combined score within the 
interval between 1 and 10, rounding to the nearest integer. A score of 1 corresponded to the 
lowest likelihood that the lesion pair completely responded (greater than stage T0). A score of 10 
corresponded to the highest likelihood that the lesion pair completely responded (stage T0). This 
transformation is more intuitive than presenting the raw scores to the observers. The ROC 
analysis was performed on the combined scores. Curves were fitted to the linearly-transformed 
distribution of the non-responders and the complete responders, and the area under both of the 
distribution curves were normalized to a value of one, to obtain fitted distribution for both 
categories. The distribution of the fitted scores was displayed to the observers as reference, 
which is shown in Figure 10.1. 
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Figure 10.1: The fitted normalized distribution of the scores generated by the combined DL-CNN and radiomics predictive 
models. 
 
10.3.3 Observer performance study 
 Six abdominal radiologists, four residents trained in abdominal radiology, and one 
urologist estimated the likelihood of stage T0 disease (complete response) after treatment by 
viewing each pre-post-treatment CTU pair displayed side by side on a specialized graphic user 
interface designed for CDSS-T. The observers were instructed to look within the VOI used for 
the AI-CALS segmentation, as some cases had multiple lesions, and the CAD score was on a 
per-lesion basis. 
 The observer provided an estimate of likelihood of stage T0 disease after treatment, 
first without CAD, on a scale of 0% to 100%, where 0% indicates that it is very unlikely that the 
cancer has responded completely to treatment (not T0), while a 100% indicates that it is very 
likely that there is no residual disease (T0) after treatment. Once the observer had given their 
likelihood, the CAD score, along with the fitted CAD score distribution was displayed. The 
observer then may revise their estimate of the likelihood of stage T0, if he or she so desired. The 
observer was not allowed to change his or her likelihood estimate for without CAD assessment 
once the CAD score had been displayed. 
 All observers read the CTU pairs independently, and were allowed unlimited time for 
the evaluation. The cases were randomized differently for each observer. Figure 10.2 shows the 
graphical user interface for the reading without, then with the CDSS-T system.  
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(c) 
Figure 10.2: The graphical user interface for reading with and without our computer-aided diagnosis (CAD) system designed for 
supporting treatment response assessment (CDSS-T). (a) The pre- and post-treatment scans are shown side-by-side, and (b) the 
observer estimates the treatment response. (c) The observer is shown the CAD score. The score distribution of the two classes is 
displayed for reference. The observer may revise their treatment response assessment after considering the CAD score. 
 
10.3.4 Evaluation 
 The observers’ estimates with and without CAD were analyzed with multi-reader, 
multi-case (MRMC) receiver operating characteristic (ROC) methodology
112
. The area under the 
curve (AUC) and the statistical significance of the difference read with and without CAD were 
calculated. 
 The average standard deviation of the likelihood estimates given by the observers per 
treatment pair was analyzed to study the effects of CAD on the inter-observer variability. The 
effects of CAD based on the difficulty of the treatment pairs were also studied. The difficulty of 
a case was estimated by the standard deviation of the observers’ likelihood estimates, assuming 
that the inter-observer variability would be smaller for easier cases. Using a threshold of the 
standard deviation value of 25, the treatment pairs were categorized into easy (value ≤ 25) or 
difficult treatment pairs (value > 25). The threshold was determined by taking into consideration 
the data set balance, including the number of T0 treatment pairs. This resulted in 93 treatment 
pairs categorized as easy with 17.2% (16/93) of them being complete responders, and 65 
treatment pairs categorized as difficult, with 36.9% (24/65) of them being complete responders. 
Update treatment response 
estimation with CDSS-T 
CDSS-T Score Provided 
Treatment response 
estimation  
CDSS-T Score 
Distribution 
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10.4 Results 
The AUC for prediction of T0 disease after treatment was 0.80 ± 0.04 for the CDSS-T 
alone. The AUC values of the observers are shown in Table 10.1. A graph of the results for 
individual observers is shown in Figure 10.3. The average ROC curves for the observers with 
and without the aid of CDSS-T are shown in Figure 10.4. 
 
Table 10.1: AUC of observers with and without CAD. 
Observer 
Number 
Without CAD With CAD 
1 0.76 ± 0.04 0.79 ± 0.04 
2 0.74 ± 0.04 0.76 ± 0.04 
3 0.74 ± 0.04 0.77 ± 0.04 
4 0.74 ± 0.04 0.76 ± 0.04 
5 0.72 ± 0.04 0.76 ± 0.04 
6 0.75 ± 0.04 0.80 ± 0.04 
7 0.73 ± 0.04 0.73 ± 0.04 
8 0.75 ± 0.04 0.77 ± 0.04 
9 0.73 ± 0.04 0.75 ± 0.04 
10 0.77 ± 0.04 0.81 ± 0.04 
11 0.73 ± 0.04 0.76 ± 0.04 
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Figure 10.3: AUC values for the 11 observers with and without CDSS-T. The performance of the CDSS-T is shown with the 
dashed line. The performance all but one of the observers increased with using CDSS-T. 
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Figure 10.4: Average ROC curves for prediction of T0 stage after neoadjuvant chemotherapy for the 11 observers viewing the 
pre- and post-treatment CTU pairs without and then with CAD. The average AUC without CAD was 0.74, while it was 0.77 with 
CAD. 
 
In general, the observers’ performances increased with the aid of CDSS-T. The average 
AUC for the observers were 0.74 (range: 0.72-0.77) without CDSS-T, and increased to 0.77 
(range: 0.73-0.81) with CDSS-T. The differences in the average AUC values between without 
CDSS-T and with CDSS-T were statistically significant (p = 0.01). The average standard 
deviations of the likelihood estimates given by the observers per treatment pair were 20.0 
without CAD and 17.4 with CAD with the difference being statistically significant (p < 0.001).  
The average AUC of the observers increased from 0.83 without CAD to 0.85 with CAD 
for the easy treatment pairs. The average standard deviation of the observers’ likelihood 
estimates decreased from 13.5 without CAD to 12.0 with CAD. The decrease was statistically 
significant (p = 0.005). For the difficult treatment pairs, the average AUC of the observers was 
0.56 without CAD and 0.60 with CAD, and the average standard deviation of the observers’ 
likelihood estimates decreased from 29.2 without CAD to 25.1 with CAD. The decrease was also 
statistically significant (p < 0.001) (Table 10.2). 
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Table 10.2: Average AUC and average standard deviation of the observers’ likelihood estimates with and without CAD 
for the entire set of cases, and the subsets of easy, and difficult treatment pairs. 
 Without CAD With CAD 
 
 
Average 
AUC 
Average 
standard deviation 
of observers’ 
likelihood estimates 
Average 
AUC 
Average 
standard deviation 
of observers’ 
likelihood estimates 
Difference in 
standard 
deviation 
(Without CAD 
– With CAD) 
p-value 
Entire Set 0.74 20.0 0.77 17.4 2.6 < 0.001* 
Easy Subset 0.83 13.5 0.85 12.0 1.5 0.005* 
Difficult 
Subset 
0.56 29.2 0.60 25.1 4.1 < 0.001* 
* p < 0.05 is considered statistically significant 
 
10.5 Discussion 
In this study, we studied the effect of a decision support system for treatment response 
assessment on clinician performance. As far as we are aware, this is the first study of this type. 
We observed an increase in performance for the estimation of T0 disease by the observers when 
they read with CDSS-T. On average, we saw an increase of 0.03 in AUC between all of the 
observers. While the difference in the AUC with and without CAD for the individual observers 
did not reach statistical significance for 6 out of the 11 observers, performing the MRMC 
analysis with all of the observers showed a statically significant difference between reading with 
and without CAD. The AUC of only one observer reading with CDSS-T exceeded the AUC of 
the CDSS-T by itself. 
The abdominal radiologists performed slightly better on average without CAD (AUC = 
0.75) compared to the residents (AUC = 0.74), while they had the same performance with CAD 
(AUC = 0.77). The urologist performed similarly to the average performance of all observers. 
The average standard deviation of the likelihood estimates given by the observers per 
treatment pairs decreased with CAD, which shows that for the task of identifying complete 
responders vs non-complete responders, CAD reduces the inter-observer variability. Upon 
further review of the observers’ likelihood estimates, it was noted that the observers were 
resistant to call a case complete response.  
The performance with CAD increased with both easy and difficult treatment pairs. We 
observed a larger increase in the performance with CAD on the treatment pairs categorized as 
difficult, which indicates that the observers tend to consider more the second opinion by the 
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computer assessment for the difficult treatment pairs. The larger decrease in the standard 
deviation for the difficult treatment pairs with CAD indicates that the inter-observer variability is 
reduced more for the pairs when the observers have less confidence in their own readings 
without CAD.  
There are several limitations to this study. First, due to the lack of a large data set, the 
CAD scores were obtained through leave-one-case-out cross-validation. Ideally, we should 
evaluate the system on an independent test set
113
. On the other hand, the leave-one-case-out 
cross-validation is well established in the pattern recognition literature as a statistically valid 
technique for estimation of the classifier performance in an unknown population. 
Second, we were unable to train the observers to familiarize them with the performance 
of the CAD system and build up their confidence in using CAD, again due to the lack of a large 
data set. Although the score distributions of complete responders to non-complete responders 
were shown to the observers, they were not familiar with the characteristics of the CTU scans 
that may influence the CDSS-T to give a higher or lower score.  In the future, when we collect a 
larger data set, we will evaluate our system on an independent test set after giving the observers a 
training session to get acquainted with the performance of the CDSS-T. 
 
10.6 Conclusions 
Our study demonstrated the potential that our CDSS-T system for bladder cancer 
treatment response assessment in CTU can improve clinicians’ performance in identifying 
patients who fully responds to treatment. 
 However, further improvement in the performance of the CDSS-T will be needed and a 
large scale observer study with independent test cases should be conducted to validate the impact 
of the CDSS-T system on clinicians for treatment response assessment of bladder cancer patients. 
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Chapter XI 
Simulation of Incomplete Data for Bladder Cancer Treatment Response Assessment
 
11.1 Abstract 
Predictive models using multidimensional input from different sources are useful but may 
have higher risk of having incomplete input data for a given case. It is important for a decision 
support system to be able to handle cases with incomplete data, as this situation may not be 
uncommon clinically. We studied the effect of incomplete data on the classification of pre- and 
post-neoadjuvant chemotherapy treatment into complete responders and non-complete 
responders by a simulation experiment. Using a subset of data set studied in Chapter VIII that 
had additional clinical information, a linear discriminant (LDA) classifier was built with the new 
data set. The incomplete data was simulated by randomly replacing a specific feature value with 
the average feature value estimated from the training set for a fraction of the test cases, and the 
area under the receiver operating characteristic curve (AUC) was calculated for the entire test set. 
The experiment was performed with different features used in the LDA classifier, missing one at 
a time, and repeated multiple times to estimate the average AUC for a given condition. We 
observed that the impact of missing different features affected the models to a different degree, 
likely depended on the importance of the specific feature. The test AUC decreased on average 
compared to without missing data, but the average performance was higher than that obtained 
with a classifier trained without the missing feature when the proportion of test cases with 
missing data was small. 
 
11.2 Introduction 
Predictive models using multidimensional input from different sources are useful but may 
have higher risk of having incomplete input data for a given case. It is important for a decision 
support system to be able to handle cases with incomplete data, as this situation may not be 
uncommon clinically. For bladder cancer, other clinical information in addition to CT radiomic 
features may be useful for decision support. For example, urologists perform examination under 
anesthesia (EUA) by pushing on the bladder with both hands to see whether the bladder is 
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mobile, or whether they can feel a palpable mass or a fixed bladder. Other clinical information, 
such as the urine cytology results may also be useful information, although urine cytology results 
may not be readily available. However, not all patients undergo the EUA or the clinical 
examinations such that these patients may have incomplete data for the predictive model. We 
conducted a study to investigate the effect of incomplete data on the classification of pre- and 
post-neoadjuvant chemotherapy treatment into complete responders and non-complete 
responders. We simulated missing clinical data by removing feature data from random subset of 
cases. We used the EUA as a clinical feature that was removed to simulate incomplete data for 
the study. We also simulated additional incomplete clinical data other than EUA by removing 
radiomic features as substitutes of the unavailable clinical information.  
 
11.3 Materials and Methods 
11.3.1 Data set 
 The data set used in this study is a subset of the data set described in the study in Chapter 
VIII. In addition to the imaging data, we obtained the results of the patients who had undergone 
EUA and were categorized as positive EUA (mass/cancer likely present) or negative EUA 
(abnormality not observed). The training set consisted of 68 patients with 84 bladder cancers, 
resulting in 84 pre- and post-treatment lesion pairs, 30% (25/84) of which had completely 
responded (stage T0) to neoadjuvant chemotherapy. The test data set consisted of 30 cases with 
38 temporal lesion pairs, with 26% (10/38) of cancers had complete response to treatment (stage 
T0). Pathology obtained from the bladder at the time of surgery was used to determine the final 
cancer stage after chemotherapy. 
 
11.3.2 Radiomic features – segmented lesions (RF-SL) predictive model 
 Using the current training set, two different Radiomic Features – Segmented Lesions 
(RF-SL) predictive models described in Chapter IX, section 9.3.4 were built: one incorporating 
the EUA information as a feature, and the other without. Briefly, we extracted 91 radiomics 
features from every segmented bladder lesion. For every temporal lesion pair, the percent change 
between each radiomics feature extracted from the pre- and post-treatment lesion was calculated. 
Feature selection was performed, and a linear discriminant analysis (LDA) classifier was built 
using the training set, and applied to the test set. 
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11.3.3 Simulating incomplete data 
 To simulate the situation in which a radiomics feature used in the RF-SL model is 
missing, the value of the selected feature of the RF-SL model on a test case was randomly 
replaced with the average of the feature values estimated from the training set. A series of 
experiments was performed where the fraction of the cases with missing data was set to a range 
between 10% and 100% of the test set for each feature in the predictive model. For each feature 
and each fraction, the experiment was repeated 100 times for 3 different random seeds. 
Two series of experiments were performed: one when the clinical feature (EUA) was not 
selected for the RF-SL model, and the other when the EUA was selected for the RF-SL model. 
LDA classifiers were also built on the training set without the chosen studied feature to obtain 
the performance of the classifier without the feature as a reference for comparison. 
 
11.3.4 Performance evaluation 
 For every experiment, receiver operating characteristic analysis was performed, and the 
average area under the curve (AUC) of the test set was calculated for the different levels of 
missing data. 
 
11.4 Results 
 From the training set with all the available features, the features selected for the RF-SL 
model include two contrast features (CONT33, CONT35), and three run-length-statistics texture 
features (FDH_4, FDH_5, FDH_12), as well as the EUA feature. Without simulating the 
incomplete data, the test AUC values were 0.76 for RF-SL without EUA, and 0.78 for RF-SL 
with EUA. Tables 11.1 and 11.2 shows, without EUA and with EUA, respectively, the change in 
the test AUC as a larger fraction of the test set was missing a feature that was then replaced with 
the average feature value of the training set. Figures 11.1 and 11.2 show the corresponding 
graphs.  
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Table 11.1: Test AUC values of the RF-SL model without EUA with simulated incomplete data on the test set. The last row 
shows the test AUC of the model trained without the given feature. 
Missing Data % 
Feature  
CONT33 FDH_4 FDH_5 CONT35 FDH_12 
0% 0.76 0.76 0.76 0.76 0.76 
10% 0.73 0.70 0.74 0.73 0.74 
20% 0.72 0.67 0.73 0.72 0.73 
30% 0.72 0.64 0.72 0.71 0.73 
40% 0.71 0.62 0.72 0.70 0.72 
50% 0.70 0.59 0.71 0.69 0.72 
60% 0.69 0.57 0.70 0.69 0.71 
70% 0.69 0.54 0.70 0.68 0.71 
80% 0.68 0.52 0.70 0.67 0.70 
90% 0.67 0.50 0.70 0.66 0.70 
100% 0.67 0.49 0.71 0.66 0.70 
RF-SL w/o Feature 0.66 0.64 0.69 0.68 0.71 
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Figure 11.1: Each curve shows the change in AUC of the predictive model as a single feature for different fractions of samples 
from the test set is missing. The missing feature data was replaced with the average of the feature values in the training set for the 
RF-SL model without EUA. The dashed lines show the test AUC if the model was trained without the given feature. 
 
 
 
Table 11.2: Test AUC values of the RF-SL model with EUA with simulated incomplete data on the test set. The last row shows 
the test AUC of the model trained without the given feature. 
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Missing Data % 
Feature  
CONT33 FDH_4 FDH_5 CONT35 FDH_12 EUA 
0% 0.78 0.78 0.78 0.78 0.78 0.78 
10% 0.77 0.75 0.77 0.77 0.77 0.77 
20% 0.77 0.72 0.77 0.76 0.77 0.77 
30% 0.76 0.70 0.76 0.75 0.77 0.76 
40% 0.76 0.68 0.76 0.75 0.76 0.76 
50% 0.76 0.66 0.76 0.74 0.76 0.75 
60% 0.75 0.64 0.76 0.73 0.76 0.75 
70% 0.75 0.61 0.75 0.73 0.76 0.74 
80% 0.74 0.60 0.75 0.72 0.75 0.74 
90% 0.73 0.59 0.74 0.72 0.75 0.73 
100% 0.72 0.60 0.73 0.72 0.75 0.72 
RF-SL w/o Feature 0.75 0.72 0.75 0.71 0.77 0.76 
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Figure 11.2: Each curve shows the change in AUC of the predictive model as a single feature for different fractions of samples 
from the test set is missing. The missing feature data was replaced with the average of the feature values in the training set for the 
RF-SL model with EUA. The dashed lines show the test AUC if the model was trained without the given feature. 
 
11.5 Discussion 
 Removing any of the features in even 10% of the cases for the two model resulted in 
worsening of the test performance. As a feature is missing from more cases, the test AUC 
continues to drop.  The FDH_4 feature had the most impact on the classification performance. 
The general trend between the model with and without the EUA feature was similar. 
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This simulation study is limited by the number of available cases and the number of 
features in the predictive model. A more thorough simulation study may be performed in the 
future by (1) replacing real patient cases with a simulated population with multi-dimensional and 
multi-domain features so that a large number of samples can be available, (2) studying the effect 
of feature correlation on the missing feature, (3) study various ways to estimate the missing data, 
(4) missing multiple features at once, (4) studying the sensitivity to missing data for different 
classifiers such as neural network, support vector machine, and random forest, and (6) studying 
the effects of missing data in the training set as well as in test cases. 
In the future, additional studies using more clinical features will be conducted when 
different clinical features capable of distinguishing between completely responding cancers and 
non-completely responding cancers are utilized in the predictive model. Another planned future 
effort is to implement a system capable of switching between two different classifiers: one 
trained with all the features, and one trained without the features that are likely to be missed in 
the test cases. As the results show, the performance of the classifier built with all the features 
drops when it is used to evaluate a case with a missing feature. The average performance in 
terms of AUC therefore decreases as more cases miss the feature.  However, it is important to 
note that the prediction accuracy on individual test cases is independent such that the prediction 
for an individual case without missing data will not be affected by the prediction for the cases 
with missing data although the average performance over the entire test set (or “population”) 
drops.  Comparing the classifier built with all selected features (the AUC at 0% cases with 
missing feature) to the classifiers built without an individual feature one at a time (the AUCs 
plotted on the right vertical axis), it can be seen that the AUC of the classifier built with all 
selected features is consistently higher. On the other hand, the performances of most of the 
classifiers built without an individual feature are still higher than applying the classifier built 
with all features to the test cases missing the feature.  The results indicate that a better strategy 
will be building more than one predictive models, one with the complete set of features and the 
others with missing a certain feature or features in anticipation of cases with missing data. For a 
new patient case, such a system will first determine whether all data are available or missing 
certain data and then triage the case to the appropriate predictive model for assessment.  We plan 
to further study the effectiveness of various clinical data in combination with radiomics features 
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and compare the different strategies of building and applying the predictive models when a large 
data set with the variety of clinical tests used in bladder cancer management is available.  
 
11.6 Conclusion 
Our study demonstrates that for the task of using the RF-SL model to predict complete 
response to chemotherapy, the average performance of the predictive model on a test set with 
missing data replaced with the average value of the training set decreased on average compared 
to that without missing data, likely due to the prediction on the test cases with missing data being 
poor. The average performance was higher than retraining the classifier without the missing 
feature when the proportion of test cases with missing data was small. However, the higher 
performance was most likely contributed by the cases with complete data such that prediction for 
these cases was better than the model trained without the feature. As the fraction of test cases 
with missing feature increased, the AUC would mainly be determined by cases with missing data, 
and the average performance could drop below the model trained without the feature due to the 
mismatching between the model and the input data for the majority of the cases. This preliminary 
study indicates that applying a model built with a certain set of input data to a case missing some 
of the input data increases the likelihood of obtaining erroneous prediction result.  Further study 
is needed to investigate the best strategy to handle missing clinical test data due to physician’s 
preference or case characteristics, which can often happen in clinical practice. 
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Chapter XII 
Summary and Future Work 
 
12.1 Summary 
We have investigated the feasibility of developing a computer-aided image processing 
and decision support system for bladder cancer. For this dissertation, we focused on CT 
urography (CTU) images of the bladder. We automatically segmented the bladder using different 
methods including level sets in combination with other techniques, and achieved reasonable 
results when comparing the segmentations to the manual hand outlines of radiologists. We were 
able to reduce the number of inputs from two manually defined region of interest to one and 
improve the segmentation performance by applying deep learning convolutional neural network 
(DL-CNN) to the task of bladder segmentation. By training the network to distinguish between 
regions inside and outside of the bladder, a bladder likelihood map was generated which was 
used as an initial contour for the level set segmentation. We saw that the DL-CNN by itself is not 
guaranteed to perform better than the conventional methods previously developed. We did see, 
however, that combining DL-CNN with the conventional methods can increase the performance 
for a given task. 
Using the segmentations, we were able to automatically detect bladder cancers on CTU 
images. We first detected masses that were present within the contrast-filled region of the 
bladder where the contrast between the masses and the urine within the bladder is generally high. 
We then extended the methods to work with detecting masses within the region that is not filled 
with contrast material, which makes the masses much more subtle. We adapted the method again 
to work with finding areas of bladder wall thickening. 
Accurate staging of bladder cancer is crucial in providing proper treatment to the patient. 
Superficial bladder cancers (stage < T2) can be managed with less aggressive treatment than 
invasive diseases (stage > T2), whereas patients with stage T2 to T4 carcinomas of the bladder 
are referred for neoadjuvant chemotherapy. We extracted radiomics features from the segmented 
179 
 
lesions, and built classifiers to distinguish between lesions whose stage is > T2 or < T2, using 
different machine learning classifiers. 
Early assessment of therapeutic efficacy and prediction of neoadjuvant chemotherapy 
treatment failure for bladder cancer would help clinicians decide whether to discontinue 
chemotherapy at an early phase before additional toxicity develops, thus improving the quality of 
life of a patient and reducing unnecessary morbidity and cost. The ultimate goal is to improve 
survival for those with a high risk of recurrence while minimizing toxicity to those who will 
have minimal benefit. Therefore, development of an accurate and early predictive model of the 
effectiveness of neoadjuvant chemotherapy is important for patients with bladder cancer. We 
applied DL-CNN for the task of bladder lesion segmentation, and attempted to predict complete 
response to treatment by measuring the change in gross tumor volume calculated from the lesion 
segmentations. We developed multiple predictive models to estimate the likelihood that a pre- 
and post-treatment lesion pair has completely responded to treatment. We built different systems 
using DL-CNN and radiomic features, and found that they performed comparably to radiologists 
in distinguishing complete responders to non-complete responders. We built a decision support 
system that combines the DL-CNN and the radiomics features, tested to see whether such a 
system can help observers identify lesions that fully respond to treatment and found that our 
system can improve the clinicians’ performances. 
Working with multi-modality data could mean that the data for certain patients may be 
incomplete. We simulated what would happen to a predictive model for bladder cancer treatment 
response assessment if we estimated missing data on the test set using the average data from the 
training set. 
 
12.2 Future Work 
 The computer-aided image processing and decision support system for bladder cancer 
developed and presented in this dissertation demonstrated the feasibility of several systems that 
may help clinicians diagnose and manage bladder cancer patients. Further development is needed 
to bring the systems demonstrated in this dissertation to clinical practice. These include the 
following: 
 Develop a deep learning system for tasks other than classification, such as directly giving 
segmentation contours, and detection of bladder cancers. 
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 Optimize the parameters for DL-CNN for a given task to obtain high performance while 
reducing over-fitting. As there are many parameters involved in training of a DL-CNN, 
the different combinations of variables such as random seed, initial weights, learning rate, 
and network structure, need to be optimized for a task. With the accumulating experience 
of designing DL-CNN, we will be able to decide on many of these parameters faster, and 
in a more systematic way for future tasks. 
 Improve bladder segmentation performance by reducing errors caused by poor image 
quality due to patient size or presence of hip prosthesis. Segmentation errors due to 
bladder cancer spreading into neighboring organs would also be need to be addressed. 
 Increase performance for the detection of lesions within the bladder (both masses and 
wall thickening) by training with a much larger data set and testing it on a much larger 
independent test set to study the robustness of the methods. One possible method for 
removing additional false positive findings would be to automatically detect the prostate, 
and remove it before running the algorithm for bladder lesion detection. 
 Perform an observer performance study with the bladder cancer detection system to see 
whether a detection system used as an adjunct can improve clinicians’ sensitivity in 
identifying bladder cancers. 
 Find incorrectly staged bladder cancers, and see if our staging system can correctly 
classify these cases. 
 Increase the performance of the bladder cancer treatment response assessment system, as 
the performance is relatively low compared to other tasks. Although the performance of 
the current system is already comparable to the radiologists, the performance is low 
compared with other tasks tested in these studies; increasing the performance of the 
system would increase its potential benefit to clinicians. 
 Develop a system for bladder cancer treatment response assessment that evaluates 
changes in bladder wall thickening and estimates the likelihood of complete response to 
treatment, as our currently developed system only applies to bladder masses. 
 Apply the bladder cancer treatment response decision support system to a larger 
independent test set and assess its performance, and perform another observer 
performance study to check the robustness of the system on a much larger and more 
diverse data set. 
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